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ABSTRACT 
 
Design of Novel Dyes Towards the Near-Infrared. (December 2007) 
Aurore Loudet, B.S.; M.S., Universite Paul Sabatier, Toulouse, France 
Chair of Advisory Committee: Dr. Kevin Burgess 
 
A series of seven functionalized near-infrared aza-BODIPY dyes have been 
synthesized and their spectroscopic properties measured. Their fluorescence emissions could 
be tuned by altering the electronic substituents on the aryl-groups. A through-bond energy 
transfer cassette featuring two fluorescein units as donor, and an aza-BODIPY dye as 
acceptor, was then synthesized and its preliminary spectroscopic properties examined.  This 
cassette exhibited absorption and fluorescence characteristics that were highly dependent on 
the pH and the solvent polarity.  Furthermore, no energy transfer was observed upon excitation 
of the donor. 
Novel near-infrared aza-BODIPY were also synthesized via a one-pot, two step 
reaction. Upon demethylation and intermolecular cyclization onto the B-atom, a ~ 100 nm red-
shift of both the absorption and fluorescence emission maxima could be observed. 
Through-bond energy transfer cassettes based on squaraines have also been 
synthesized and their spectroscopic properties studied.  These cassettes exhibited fast and 
efficient energy transfer from the donor to the acceptor.  
In depth experiments have also been realized to correlate the rate of energy transfer 
and structure on 3 different sets of through-bond energy transfer cassettes.  No correlations 
could be made between the rate of the energy transfer and the nature of the acceptor, and the 
distance between the donor and acceptor.  
Finally, the use of DPP (diketo-pyrrolopyrolle) pigment as a potential donor for through-
bond energy transfer cassettes was investigated.  Three water-soluble DPPs dyes were 
prepared and studied.  They all displayed weak fluorescence in water.  
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CHAPTER I 
BODIPY DYES AND THEIR DERIVATIVES: SYNTHESES 
AND SPECTROSCOPIC PROPERTIES* 
 
A. Introduction 
Advances in imaging techniques now make it feasible to do things that were not previously 
possible.  Experiments in which interacting proteins are observed inside living cells are now 
common for dynamically averaged systems,1-3 and the field is close to observation of similar 
events on a single molecule level.4-8 Labels can be attached to proteins, eg antibodies, which 
accumulate in specific organs for imaging in animals and human subjects.9  The technological 
advances in this area are remarkable.  However, there is a growing realization that imaging 
events in cells and whole organisms by fluorescence is limited by the probes available.  For 
instance, there are few that emit at 800 nm or above, yet living tissues are most transparent to 
light at and above this wavelength.   
4,4-Difluoro-4-bora-3a,4a-diaza-s-indacene, or BODIPY (hereafter abbreviated to 
BODIPY) dyes tend to be strongly UV-absorbing small molecules that emit relatively sharp 
fluorescence peaks with high quantum yields.  They are relatively insensitive to the polarity and 
pH of their environment, and are reasonably stable to physiological conditions.  Small 
modifications to their structures enable tuning of their fluorescence characteristics, consequently 
these dyes are widely used to label proteins10-14 and DNA15.   However, these compounds also 
have some undesirable characteristics for many applications in biotechnology.  For instance, 
most emit at less than 600 nm, and only a handful of water-soluble derivatives has been made.  
Thus, there is the potential that modifications to the BODIPY framework will lead to probes that 
can be used more effectively for imaging in living cells and whole organisms, but that is largely 
unrealized. 
 
 
This dissertation follows the style of Journal of Organic Chemistry. 
*Reprinted with permission from “BODIPY Dyes and Their Derivatives: Syntheses and 
Spectroscopic Properties” by Aurore Loudet, Kevin Burgess, 2007. Chemical Reviews, 107, 
4891- 4932; copyright 2007, American Chemical Society. 
 
2 
N N
B
F2
BODIPY dyes
small, intensely fluorescent systems
N N
B
F2
1
2
43 5
6
78 !
"
meso
 
 
 
Our research group is interested in making BODIPY-related probes that will realize some 
of their potential for intracellular imaging.  This review is intended to facilitate this process by 
summarizing the basic chemistry and spectroscopic properties of common BODIPY-derivatives, 
and highlighting ways in which other interesting probes could be prepared.  Readers particularly 
interested in applications of BODIPY dyes as labeling reagents,11,13,16-43 fluorescent switches,44,45 
chemosensors46-83 and as laser dyes84 may be interested in this review as a guide to synthesis 
and spectroscopic properties, but details on use of the dyes in those ways are not included here.  
Readers interested in small amounts of commercially available dyes for labeling should also 
consult the Invitrogen (formely Molecular Probes) catalog.11,85  
 
B. The BODIPY Core 
The IUPAC numbering system for BODIPY dyes is different to that used for 
dipyrromethenes,86 and this can lead to confusion.  However, the terms α-, β-positions, and 
meso- are used in just the same way for both systems. 
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3 
1. Fundamental Properties 
BODIPY 1, which has no substituents, has not been reported in the literature.  This may be 
because of synthetic difficulties obtaining this compound related to the fact that none of the 
pyrrole-based carbons are blocked from electrophilic attack.  Synthesis of the corresponding 
dipyrromethene precursor has been reported, but this compound is unstable and decomposes 
above -30° to -40° C.87 The symmetrical, dimethyl-substituted compound 2 has been prepared88 
and could be considered as a reference to which other simple alkylated BODIPYs can be 
compared.  The symmetrically substituted systems 3 and 4 have apparently not been reported, 
reflecting synthetic limitations for even some simple BODIPY systems.  However, the 
unsymmetrically substituted BODIPYs 5 and 6 have been prepared.89  There are relatively minor 
differences in the reported UV-absorption maxima, fluorescence emission maxima, and quantum 
yields of these compounds, and these should not be over-interpreted because small calibrations 
errors are common in these types of experiments.  However, when the symmetrically-, tetra-, 
hexa-, and hepta-alkylated systems 7,89,90 8, and 9 are included in the comparison then an 
unambiguous trend towards red-shifted absorption and emission maxima with increased 
substitution becomes apparent.    
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11
 MeOH, ! 0.19
"max abs 508 nm
"max emiss 521 nm
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 MeOH, ! 0.65
"max abs 498 nm
"max emiss 508 nm
1 7
 
 
Alkylation or arylation at the meso position has no special effect on the absorption and 
emission wavelengths (compare 2 with 11, and 7 with 12) even though this substitution position 
is structurally unique.  However, the quantum yield of the meso-phenyl compound 11 is 
appreciably less than the more substituted analog 12.  Such differences are widely attributed to 
1,7-substituents preventing free rotation of the phenyl group reducing loss of energy from the 
excited states via non-irradiative molecular motions.  Consistent with this, introduction of ortho-
substituents on the phenyl ring has been observed to increase quantum yields, and similar 
explanations have been invoked.   
BODIPY derivatives in which aliphatic rings have been fused to the pyrrole fragments are 
perhaps more constrained than ones bearing acyclic aliphatic substituents.  Nevertheless, the 
effects on their emission maxima are not always easily rationalized.  Compound 13 has a shorter 
emission wavelength maximum than 9 even though both have three substituents on the pyrrole 
rings.  On the other hand, 14 has only two such attachments, yet it has the longest wavelength 
fluorescence emission. 
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N N
B
F2
N N
B
F2
13
EtOH, ! 0.81
"max abs 512 nm
"max emiss 535 nm
14
EtOH, ! 0.84
"max abs 535 nm
"max emiss 560 nm  
 
2. Syntheses From Pyrroles and Acid Chlorides or Anhydrides 
8-Substituted BODIPY dyes A (ie ones with substituents in the meso position) tend to be 
relatively easy to prepare via condensation of acyl chlorides with pyrroles (reaction 1).91,92  
These transformations involve unstable dipyrromethene hydrochloride salt intermediates.  The 
intermediate dipyrromethene hydrochlorides are easier to handle and purify as C-substitution 
increases but, even so, these are not generally isolated in syntheses of BODIPY dyes.   
NH
R2
R3
N HN
R3
R2
R1
R4 R3
R2
R1R1
meso
R4COCl
CH2Cl2, 40 °C, 1 h
then 
petroleum ether, 25 °C, 12 h
HCl
not isolated  
 
8
(i) Et3N or 
iPr2EtN,
MePh, 25 °C, 15 min
(ii) BF3•OEt2
80 °C, 15 min
N N
R1
R2
R3
R4 R1
R2
R3
B
F2
A
R4 = alkyl, aryl  
reaction 1 
 
Other activated carboxylic acid derivatives could be used in place of acid chlorides in 
reaction 1.  In the particular case of acid anhydrides, this concept has been reduced to practice.  
Reaction 2 shows how the BODIPY derivative 15 was prepared from glutaric anhydride.37  An 
attractive feature of this chemistry is that a free carboxylic acid is produced, and this may later 
be used to attach the probe to target molecules. 
6 
NH
+ O
O
O (i) BF3•OEt2
neat, reflux, 5h
(ii) BF3•OEt2, 
Et3N, 25°C, 12h
N
B
F2
N
HO2C
3
15  16 %  
reaction 2 
 
3. Syntheses From Pyrroles and Aldehydes 
Syntheses similar to those depicted in reactions 1 and 2 but which use aromatic 
aldehydes14 (to the best of our knowledge, aliphatic aldehydes have not been reported in this 
reaction) require oxidation steps.   The reagents for these oxidations can introduce experimental 
complications.  Thus in reaction 3 the oxidant used was p-chloranil and eventually the 
byproducts from this had to be removed (in fact, this was done after complexation with the 
boron).  
 
NH
+
I
CHO
1 mM TFA
CH2Cl2, 25 °C
1.5 h
NH HN
I
95 %  
 
NH N
(i) Et3N
(ii)BF3•OEt2
MePh, 25 °C
1 h
N
B
F2
N
I I
16  15 %not isolated
p-chloranil
MePh, 25 °C
 5 min
 
reaction 3 
 
 
α,β-Unsubstituted BODIPYs eg 17 can also be prepared from aldehydes using neat 
conditions.14   The aldehyde is dissolved in excess pyrrole at room temperature, and the 
7 
dipyrromethane intermediate (the reduced form of the dipyrromethene) was formed and isolated.  
The BODIPY dye was obtained after oxidation with DDQ and complexation with boron (reaction 
4).  Acid chlorides probably would be too reactive to use with pyrrole (since it is unsubstituted 
and more reactive) so this aldehyde-based approach is the method of choice.   
 
N
B
F2
N
CHO
excess
 pyrrole
acid
neat
 25 °C
NH HN
(i) DDQ
MePh, 25 °C
5 min
(ii) Et3N
(iii) BF3•OEt2
30 min
17  22 %45-80 %  
reaction 4 
 
Use of, for instance, halogenated benzaldehydes (or halogenated acid chlorides above) 
broadens the scope of the reaction by offering the potential for elaboration of these groups in 
compounds like 16.  In another example, systems 18 and 19 were prepared from benzaldehyde 
derivatives that have long chain acid substituents.  These probes were used to investigate 
dynamic effects in membranes.2   Presumably ortho-substituents were included on the meso-
aromatic group to restrict rotation of that ring and increase quantum yields. 
 
O CO2Et10
N
B
F2
N
O CO2Et10
N
B
F2
N
18
CH2Cl2, ! 0.36
"max abs 508 nm
"max emiss 524 nm
19
CH2Cl2, ! 0.94
"max abs 501 nm
"max emiss 512 nm  
 
 
The fact that a diverse set of aldehydes could be used to prepare meso-substituted 
BODIPYs provides a means to introduce more sophisticated functionalities for specialized 
purposes.  For instance, 8-hydroxyquinoline-2-carboxaldehyde was used to prepare the Hg2+-
8 
selective chromo- and fluoroionophore 20.60  This probe is highly fluorescent in the presence of 
transition-metal ions (Co2+, Ni2+, Cu2+, and Zn2+) and heavy-metal ions (Pb2+, Cd2+), but 5 equiv. 
of mercuric ions reduced its emission by more than 98% (the color of the solution also changed 
from light amber to red enabling the progress of the complexation event to be visualized).  A 1:1 
complex with Hg2+ is formed in which the dipyrromethene core of 20 adopts a nearly orthogonal 
conformation with the 8-hydroxyquinoline moiety because of the methyl groups in positions 1- 
and 7- on the BODIPY core.  This particular arrangement displays the binding site of 8-
hydroxyquinoline for complexation of metal ions.  The shape of these BODIPY-based ligand is 
such that 2:1 L:M complexes are sterically disfavored. 
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N
HO
20
Hg2+ complexes
here
 
 
 
Fluorescent pH probes 21 - 24 have been prepared from phenolic benzaldehydes (a case 
where the acid chloride approach would have raised chemoselectivity issues).68 These 
compounds are weakly fluorescent in the phenolate form presumably due to charge transfer 
from the phenolate donor to the excited-state indacene moiety.  The pKa of the different 
derivatives was tuned by varying the aromatic substituent.   
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21
MeOH, ! 0.28
"max abs 505 nm
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22
MeOH, ! 0.16
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9 
 
N
B
F2
N
pKa 9.20
N
B
F2
N
pKa 9.34
23
MeOH, ! 0.19
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"max emiss 521 nm
24
MeOH, ! 0.025
"max abs 508 nm
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It is unusual to use any aldehydes that are not aromatic to prepare BODIPY derivatives.  In 
this sense the vinylic thioether probe 25 is exceptional.  A catalytic amount of ytterbium (III) 
trifluoromethane sulfonamide was used to mediate the condensation process, the intermediate 
dipyrromethane was oxidized with DDQ, and complexation with boron trifluoride gave the 
product, though in very poor yield.93  The fluorescence emission of compound 25 was red-shifted 
relative to dyes with a phenyl group at the meso position (eg 11).  Compound 26 has a sulfide in 
conjugation with the BODIPY core, just as 25 does. The fluorescence emission maximum of 25 
is 26 nm red-shifted compared to 26, indicating that electron donating groups in this position 
tend to have that effect. 
 
NH
+
(i) Yb(NTf2)3 5 mol%
(ii) DDQ
(iii) NEt3, BF3•OEt2
CH2Cl2, 25 °C
N
B
F2
N
SPh
25  2 %
MeOH, ! na
"max abs 528 nm
"max abs 580 nm
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SPh
 
reaction 5 
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MeOH, ! 0.37
"max abs 530 nm
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4. Syntheses From Ketopyrroles 
Condensations of pyrroles with acid chlorides or with benzaldehyde derivatives, as 
outlined above, are direct and convenient methods to access symmetrically substituted BODIPY 
dyes.  However, another approach is required to form unsymmetrically substituted ones.  
Generally, this is achieved via preparations of ketopyrrole intermediates, followed by a Lewis 
acid mediated condensation of these with another pyrrole fragment.   
Schemes 1.1 a and b show reactions of magnesium anions of pyrroles with activated 
carboxylic acid derivatives to give the corresponding 2-ketopyrroles.94,95  In part c, one such 
ketopyrrole is condensed with another pyrrole unit to give a BODIPY framework.  That example 
gives a symmetrical product, but the method is particularly valuable for unsymmetrical ones, as 
in Scheme 1.1d. 
 
 
 
 
 
 
 
 
 
 
11 
Scheme 1.1.  a and b two different methods for production of ketopyrroles from 
magnesium derivatives of pyrrole, and application of these starting materials in the production of 
c symmetrical, and d unsymmetrical dyes. 
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R
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N
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N
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Scheme 1.1.  Continued. 
d 
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B
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C. Modifications to meso-Aromatic Substituents On The BODIPY Core 
The BODIPY core is robust enough to withstand a range of chemical transformations, and 
a variety of aromatic groups can be introduced at the meso-position for appropriately 
functionalized BODIPY dyes.  Alternatively, dyes with special meso-groups can be produced via 
in vivo synthesis.  These strategies have been used to produce several dyes for many different 
applications; just a few illustrative ones are shown in Figure 1.1.   For instance, derivatives of 
this type have been formed as selective sensors of particular redox active molecules (27,62 28,65 
29,48 and 30,96 Figure 1.1a), pH probes (3155 and 3251, 1b), metal-chelators (33,79 34,79 35,74 
36,67 37,66 38,53 39,80 40,78 41,82 and 42,71 1c), and as biomolecule conjugating groups (43,49 
44,81 and 45,97 1d).   
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N
B
F2
N
R
R =
NH2
27
nitrite probe
HN
NH2
nitric oxide probes
NH2
NH2
28 29
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30
antioxidant indicator  
b 
N
B
F2
N
R
R =
N
OHOH HOOH
pH probes
31 32
 
c 
N
B
F2
N
R
N
HO OHPb
2+
R =
N
H3COCO OCOCH3Cu
2+
33 34  
Figure 1.1.  Selected BODIPYs with meso-modifications to give: a selective sensors of 
particular redox active molecules;  b pH probes; c metal-chelators; and, d biomolecule 
conjugating groups. 
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Figure 1.1.  Continued  
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Figure 1.1.  Continued 
 
 
Here we intend to restrict the discussion to the general concepts that influence the 
fluorescence properties of meso-modified BODIPY dyes; this review does not attempt to give a 
comprehensive list of all the compounds made.  Without exception, the chemosensors operate 
by perturbing the reduction potential of the meso-substituent.  The next section discusses the 
electronic effects of these perturbations on fluorescence. 
1. Fluorescence Control via Photoinduced Electron Transfer 
Transfer of electrons between non-planar parts of fluorescent molecules modifies their 
fluorescence intensities. 98  This has been known for sometime but Nagano, Ueno and co-
workers have skillfully applied calculated orbital energy levels and experimentally determined 
electrochemical data to rationalize quantum yields. Their initial work with fluorescein 
derivatives,99,100 was later expanded to encompass BODIPY systems as described here.101 
Some non-planar fluorescent molecules can be regarded as a highly fluorescent group 
with non- (or significantly less) fluorescent substituents (Figure 1.2a).  Some such substituents, 
depending on their oxidation potentials relative to the excited state of the BODIPY core, can act 
as electron donors or acceptors.  If electron transfer occurs then the fluorescence is diminished 
when the fluorescent group in its excited state is reduced.  In this situation, the fluorescent group 
is acting as an acceptor, consequently this may be called reductive-PeT or a-PeT (“a” for 
acceptor; Figure 1.2b).   However, if the energy states are such that the excited state of the 
fluorescent group can donate electrons to the substituent LUMO then oxidative-PeT, d-PeT, 
occurs (“d” for donor; Figure 1.2c).  Indirectly, solvent polarity has an effect on this process.  This 
16 
is because photoexcitation and oxidation processes involve modification of ground state dipoles, 
and solvents may stabilize or destabilize these changes according to polarity.  
 
a 
HOMO
meso-
subst.
N N
B
F2
R
no electronic significant perturbation
fluorescent
LUMO
fluorescence
BODIPY
core  
 
b 
N N
B
F2
R
a-PeT (reductive PeT)
BODIPY
core
meso-
subst.
a-PeTfluorescence
diminished
LUMO
HOMOe-
 
 
Figure 1.2.  The meso-substituent provides: a no significant electronic perturbation; b 
electrons to the excited state; and, c a low lying LUMO to accept electrons from the excited 
state. 
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c 
HOMO
LUMO
d-PeT
e-
N N
B
F2
R
d-PeT (oxidative PeT)
fluorescence
diminished
BODIPY
core
meso-
subst.  
Figure 1.2.  Continued  
 
The feasibility of electron transfer can be judged from the change in free energy (ΔGPeT), 
as described by the Rehm-Weller equation:102 
 
ΔGPeT = E1/2 (D+/D) – E1/2 (A/A-) - ΔE00 – C 
 
where 
 E1/2 (D+/D) = ground-state oxidation potential of the donor 
 E1/2 (A/A-) = ground-state reduction potential of the acceptor 
 ΔE00 = excitation energy 
C = an electrostatic interaction term. 
 
Nagano and co-workers applied these principles to the triazole-BODIPY derivative 47 to 
develop a nitric oxide probe.61  The low fluorescence of the diamine 46 was explained in terms of 
reductive PeT (Figure 1.3).  When nitric oxide converts the diamine into the benzotriazole 47 
then reductive PeT does not occur and fluorescence is observed.  Scheme 1.2 outlines the 
synthesis of the probe and the oxidized product. 
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NHN
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quantum yield
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- 4.76 eV
- 6.73 eV
- 5.26 eV
- 5.27 eV
- 6.19 eV
- 7.09 eV
- 7.20 eV
0.003
0.005
0.83
0.92
0.85
 
 
Figure 1.3.  a Reductive PeT occurs when nitric oxide reacts with the diamine; b 
Calculated HOMO energy levels of meso-substituents for BODIPY 46 and 47. 
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Scheme 1.2.  Synthesis of diaminobenzene- and triazole- BODIPY derivatives 46 and 47. 
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0 °C N N
R R
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NHN
46 47
R = H, a; Et, b; CO2Et, c  
 
 
 
A refinement of the ideas presented above was used to explain the observation that 
fluorescence for the compounds 47 decreased in the order b > a > c (Figure 1.4).  This is 
because the nature of the substituent impacts the reduction potential of the BODIPY core in that 
order (b is the most negative).    
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Figure 1.4.  Reductive PeT increases in the order Et < H < CO2Et. 
 
 
Fluorescence of the Zn2= and NO2+ chemosensors 4863 and 49103 has been explained 
using reductive PeT concepts outlined above.  Chelation or nitration, respectively, makes the 
reduction potential of the meso-substituent more negative, PeT is switched-off, and the probes 
become fluorescent.  
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Strongly electron withdrawing substituents on aromatic meso-substituents lower the LUMO 
of the aromatic system to the level where it might accept electrons from the orbital containing the 
promoted electron in the BODIPY core (Figure 1.2c).  In such cases oxidative PeT comes into 
play.  Evidence for this is seen in the quantum yields of 50 - 52.103  For dye 52 oxidative PeT is 
21 
diminished because the ketones lower the energy of the BODIPY orbital containing the promoted 
electron. 
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There are at least two weaknesses associated with combining theoretical calculations and 
electrochemical data to rationalize quantum yields.  First, the reduction potentials for the two 
components are calculated on isolated systems: the fact that they are attached to each other 
must perturb the actual orbital levels.  Second, energies of excited states are notoriously difficult 
to calculate.   Nevertheless, the approach emphasized by Nagano and co-workers helps dispel 
dogmas that surround fluorescent probes.  For instance the assertion that nitro groups or heavy 
atom substituents always quench fluorescence is simply not true.  The reality is that they tend to 
do so but only if their orbital energy levels interact with the fluorescent chromophore in a way 
that facilitates PeT. 
 
D. BODIPYs with Heteroatom Substituents 
1. From Electrophilic Substitution Reactions 
Simple considerations of mesomeric structures reveal that 2- and 6-positions of the 
BODIPY core bear the least positive charge so should be most susceptible to electrophilic attack 
(Figure 1.5).  However, there is no definitive study of regioselectivities in these reactions for 
BODIPYs without pyrrole substituents; almost invariably some of the other positions are blocked 
by substituents. 
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Figure 1.5.  Electrophilic attack on tetramethyl-BODIPY . 
 
 
Sulfonation 
To the best of our knowledge, less than a handful of sulfonated BODIPY dyes have been 
reported.   They were obtained from tetra-, or penta-substituted BODIPYs via treatment with 
chlorosulfonic acid, then subsequent neutralization with a base (eg reaction 6).  Monosulfonated 
systems can be obtained when only one equivalent of chlorosulfonic acid is used.  Introduction 
of sulfonate groups do not change the absorption and fluorescence emission maxima 
significantly relative to the unsulfonated dye.  The sulfonated BODIPY dyes 53 – 56 are strongly 
fluorescent in water and/or methanol, and are claimed to have even better stability than the 
parent dyes.91,104-109 
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Nitration 
The 2,6-dinitro BODIPY dye 57 can be obtained via nitration with nitric acid at 0 °C 
(reaction 7).  Introduction of the nitro groups drastically reduces the fluorescence quantum 
yield.91,110-112  To the best of our knowledge, this is the only nitration of a BODIPY dye that has 
been reported in the literature. 
 
N N
B
F2
N N
B
F2
O2N NO2
57  72 %
MeOH
! na
"max abs 493 nm
"max emiss 533 nm
HNO3
0 °C, 1.5 h
 
reaction 7 
 
2,6-Dinitro-BODIPY 58113  and 59114-118 have also been reported in the Japanese patent 
literature for applications as sensitizers and inks.  We were unable to find procedures for their 
syntheses and spectroscopic data.  
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Halogenation 
Bromination of the 1,3,5,7,8-pentamethyl-substituted BODIPY PM 546 shown in reaction 8 
gave the dibromination product 60.91,119  Predictably, introduction of bromo substituent onto the 
dipyrromethene core causes a significant red-shift of both the UV-absorption and emission 
maxima, and it quenches the fluorescence quantum yield via the heavy atom effect.  
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B
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N N
B
F2
Br Br
60  50 %
9:1 MeOH:CH2Cl2
! 0.45 (CH2Cl2)
"max abs 516 nm
"max emiss 546 nm
Br2 (slow addn)
CH2Cl2, 25 °C
2 6
PM 546
MeOH, ! 0.95
"max abs 492 nm
"max emiss 504 nm
 
reaction 8 
 
2,6-Diiodo-tetramethyl BODIPY 61 was obtained via the route described in reaction 9.120  
Just as for the dibromo-BODIPY 60, iodo-substituents cause significant red-shift of the UV-
absorption and fluorescence emission maxima, and quenche the fluorescence quantum yield via 
the heavy atom effect.  Compound 61 is much more resistant to photobleaching than Rose 
25 
Bengal; this is because the BODIPY core has a more positive oxidation potential than the 
xanthone unit of Rose Bengal.  Compound 61 is an efficient photosensitizer. 
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reaction 9 
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2,6-Difluoro- and 2,6-dichloro- BODIPY derivatives 62113 and 63,114-118 have found 
applications as electroluminescent devices and sensitizers.  Their synthesis has not been 
reported.  
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Chlorination of the unsubstituted dipyrromethane shown in Scheme 1.3 occurs 
preferentially at the α-positions.  Thus the 3,5-dichloro BODIPY derivative 64 could be obtained 
after oxidation with p-chloranil and complexation with boron trifluoride etherate.  Applications of 
such chlorinated materials as SNAr electrophiles are described later in this review. 
 
 
Scheme 1.3.  Preparation of 3,5-dichloro-BODIPY via chlorination of a dipyrromethane 
intermediate. 
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Potential for Other Electrophilic Substitution Reactions 
BODIPY dyes are intrinsically electron rich, and the reactions shown above illustrate that 
they will react with electrophiles.  It is therefore surprising that the reactions shown above 
represent the state-of-the-art in this area.  There are very few sulfonation reactions despite the 
importance of water-soluble dyes; most of the sulfonated BODIPY compounds in the Invitrogen 
catalog feature carboxylic acids with sulfonated leaving groups.  There are no reports of some 
common electrophilic addition processes like Vilsmeyer-Haack reactions, but our group has 
investigated this type of reaction, and the mono-formylated BODIPY dye could successfully be 
synthesized in excellent yield (unpublished results). 
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2. From Nucleophilic Attack on Halogenated BODIPYs 
The most common approach to introduce substituents on the 3- and 5-positions of the 
BODIPY core involve de novo syntheses with appropriately substituted pyrroles, but an exciting 
recent development reaches the same goal via nucleophilic substitution on the 3,5-dichloro-
BODIPY 64.121,122 The nucleophiles used so far include alkoxides, amines, thioalkoxides, and the 
diethyl malonate anion.  These reactions can be stopped at the mono-substitution stage or 
forced to the disubstitution product (Scheme 1.4) hence they are useful for access to asymmetric 
65 and symmetric 66, hetero-substituted BODIPY dyes, which would be difficult to obtain by 
other routes. 
 
 
Scheme 1.4. BODIPY dyes via SNAr reactions. 
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The spectroscopic effects of electron donating groups attached to the BODIPY core for the 
compounds in Scheme 1.4 were studied.  The 3- and 5-substituents had significant effects, 
shifting both the absorption and/or emission spectra, and changing the fluorescence quantum 
yields.  For example, introduction of an amino- or sulfur-centered nucleophiles results in a 
significant bathochromic shift (red-shift) of both the absorption and emission.121 Data were 
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collected in methanol (Figure 1.6); the absorption and emission maxima were red-shifted in 
cyclohexane but otherwise it was quite similar to that for methanol (data not shown).  The 
quantum yields varied widely, but generally tended to be reduced relative to unsubstituted 
BODIPYs. 
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Figure 1.6.  Spectroscopic data for some BODIPYs formed by SNAr reactions. 
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Figure 1.6.  Continued  
 
8-(ω-Haloalkyl)-BODIPY dyes 67 and 68 are useful starting materials.  These are easily 
synthesized by condensation of a ω-haloacyl chloride with 3-ethyl-2,4-dimethyl pyrrole (reaction 
10).123  
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reaction 10 
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Compounds 67 and 68 can be functionalized by nucleophilic substitution reactions.58,123  
Thus 67 and 68 are precursors to a range of compounds B including fluorescent electrophiles, 
disulfides for chemoselective labeling of cysteine residues, fluorescent amino acids, and 
chemosensors for metal ions.58  
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3. From Palladium Mediated C-H Functionalization 
Pyrroles can be functionalized via palladium catalyzed activation reactions.124-126  Our 
group applied the same strategy to synthesize novel BODIPY dyes via palladium mediated C-H 
functionalization (reaction 11).127   This route provides a direct way to extend the conjugation of 
the BODIPY core, without a halogenated or metallated intermediate prior to the coupling 
reaction.  Highly fluorescent, mono- (69) or disubstituted (70) dyes can be obtained.  A water-
soluble, sulfonated BODIPY dye 69d was also prepared via this route, but in low yield (2 %).   
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 The C-H functionalization process was also applied to α, β-unsaturated esters to form 
compounds 71 and 72.  Mono- and disubstituted products were obtained, but the alkene double 
bond was shifted out of conjugation with the BODIPY core. 
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4. From Nucleophilic Attack at the meso-Position 
BODIPY systems with a meso-cyanide substituent are special insofar as they fluoresce at 
significantly longer wavelengths than the unsubstituted systems.128  Further, they can be 
accessed by direct addition of cyanide anion to the dipyrromethene core, followed by oxidation.  
The first synthetic route developed gave poor overall yields, mainly due to loss of material in 
forming the dipyrromethene,92 but an improved route was developed by Boyer (Scheme 1.5).129  
In that work, Knorr condensation of 3-ethylhexan-2,4-dione with diethyl aminomalonate give 
ethyl 3,4-diethyl-5-methylpyrrole-2-carboxylate. This pyrrole is then converted to the 
dipyrromethene hydrobromide via the presumed intermediacy of 2-methyl-3,4-diethylpyrrole and 
its condensation with the α-formyl derivative that is formed in situ.  
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Scheme 1.5.  Cyanopyrromethene-BF2 complexes via addition of cyanide. 
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 Comparison of compound 73 with other meso-cyano BODIPYs (eg 74 – 77) shows they 
fluoresce and absorb at about 60 nm longer wavelengths than simple alkyl-substituted 
BODIPYs. This large bathochromic shift seems attributable to a net stabilization of the LUMO 
level due to the cyano group decreasing the energy gap.  The presence of the cyano group also 
significantly reduces the molecular extinction coefficient.  Only in the case of 77 where the core 
bears two ester groups is this red-shift attenuated.  Presumably in this case the esters reduce 
the electron density on the BODIPY core that is available for delocalization into the nitrile, and 
this affects the fluorescence emission wavelength.   
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The red-shift in fluorescence observed when a cyano group is added to the meso-position 
is somewhat particular to that site.  2,6-Dicyano BODIPY 78 has two cyano groups, but neither 
occupies the meso-position.  Fluorescence from this compound peaks at about the same 
wavelength as similar BODIPYs without nitrile substituents, eg 79 and 8.129 Similarly, substitution 
at the 2 and 6-positions with carboethoxy, acetamido, sulfonate anion, bromo or nitro groups do 
not produce any red-shift.92,129,130 
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A synthesis of sulfur containing BODIPYs under mild conditions was recently achieved via 
reaction of thiophosgene with substituted pyrroles to give the corresponding thioketone 80.  The 
latter can then react with various electrophiles to form the dipyrromethene intermediates that 
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were combined with boron trifluoride in presence of base to afford the thio-BODIPY derivatives 
81.  These meso-thioalkyl groups can be displaced by nucleophiles to give anilino-substituted 
BODIPY derivative 82 (Scheme 1.6).  Amine adduct 82 was not fluorescent, presumably 
because of electron transfer from the amine group to the BODIPY core in the excited state.  
 
 Scheme 1.6.  Synthesis of sulfur- and anilino- BODIPY derivatives. 
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E. Aryl-, Alkenyl-, Alkynyl-substituted BODIPYs 
1. Aryl-substituted BODIPYs from Aryl-pyrroles 
Aryl-substituted BODIPY dyes can be formed via condensation of the corresponding 
pyrroles with acyl chlorides.131,132 The 2-aryl pyrroles used were prepared via Suzuki couplings133 
of N-tert-butoxycarbonyl-2-bromopyrrole (reaction 12); this was more convenient than starting 
with less accessible materials like 4-aryl-1-azidobutadienes134 or a N-tosylarylimine.135,136  
Removal of the N-BOC protecting group under basic conditions gave the desired aryl pyrroles.  
These products were found to decompose on standing, rapidly under acidic conditions, and were 
therefore best formed immediately before use. 
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H
Ar
 Ar = Ph, 1-Naph
4-MeOC6H4
4-FC6H4
2-MeOC6H4  
reaction 12 
 
3,5-Diaryl BODIPY dyes were obtained from the pyrroles shown above, via a one pot, two-
step process featuring 4-iodobenzoyl chloride.  The 3,5-aryl groups extend the conjugation of the 
BODIPY systems.  Compared to the alkyl-substituted derivatives eg 83 and 84 which have 
green, fluorescein-like emissions (λmax emis = 510 nm), both the absorption and emission maxima 
of 3,5-diaryl substituted BODIPYs 85 – 89 are shifted to longer wavelengths (λmax emis = 588 - 626 
nm).131,132  The para-electron-donating group of 87 gives a larger bathochromic shift and 
increased quantum yield, compared to the compound with that same substituents in the ortho-
position 89.  Similarly, the extended aromatic substituent naphthalene of 86 red-shifted the 
emission maximum for this compound.  However, the extinction coefficients for 85 – 89 were not 
markedly increased relative to the alkyl systems 83 and 84 and their fluorescence quantum 
yields were significantly lower due to non-radiative loss of energy via rotation around the C-Ar 
bonds.137 
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Fluorescence of BODIPYs in solution can be reduced at elevated concentrations due to 
intermolecular π-stacking.  BODIPY dyes can stack in two geometrically distinct forms: H- and J-
dimers (Figure 1.7).  The former is most likely a result of intramolecular dimerization, with the 
stacking of two BODIPY planes with almost parallel S0→S1 transition dipoles, and anti-parallel 
electric dipole moments.  This dimer is practically non-fluorescent, and exhibits blue-shifted 
absorption relative to that of the monomer.  The J-dimer, in which the S0→S1 transition dipoles 
are oriented in planes at 55°, is fluorescent and shows a red-shifted absorption relative to that of 
the monomer.138-140  
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Figure 1.7.  Structures of H-dimer and J-dimer. 
 
 
 
Compound 90 was designed as a probe that was sterically prevented from forming dimers 
in solution.141  Further, the hindered internal rotation of the mesityl rings reduces non-radiative 
relaxation of excited states, enhancing fluorescence quantum yields.   Dye 90 was prepared 
from mesityl aldehyde and pyrrole 91 (made via a Trofimov reaction).136     
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2. Condensation Reactions of the 3,5-Dimethyl Derivatives with Benzaldehyde 
Derivatives to Give Alkenyl Systems 
In the last few years it has been shown that 3- and 5-methyl BODIPY substituents are 
acidic enough to participate in Knoevenagel reactions.  Thus styryl-BODIPY derivatives can be 
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obtained by condensation of 3,5-dimethyl-BODIPYs with aromatic aldehydes (reaction 13).142,143  
With p-dialkylaminobenzaldehyde the reaction can be restricted to one condensation, but 4-
alkoxybenzaldehydes tend to give mixtures corresponding to one and two condensations.144 
Di(dimethylamino)styryl-substituted BODIPY dyes can be obtained with longer reaction time (7 
d).145  
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The condensation processes shown in reaction 13 provide direct entry into BODIPY 
derivatives that have red-shifted fluorescence properties, and functional groups that can be used 
in sensors and molecular logic gates.  UV-absorption spectra of compounds from one 
condensation (eg 94 and 95) tend to reach a maximum around 594 nm in MeOH, and their 
fluorescence emissions are similarly red-shifted.  Both the absorption and, particularly, the 
fluorescence spectra are dependant upon solvent polarity.146,147  The red-shift is more 
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pronounced in polar solvents indicating excitation of the dyes leads to more polarized excited 
states.   
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Structures 93 - 97 illustrate some effects of amino substituents in these styryl systems.  
When the amine is directly conjugated with the styryl group then a maximum red-shift is 
obtained, but when it is part of the meso-substituent then the bathochromic shift is less because 
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this meso substituent is non-planar.  Quantum yields for these materials are only high when the 
amine is protonated disfavoring Intramolecular Charge Transfer (ICT) in the excited state.142,147 
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Structures 95 - 97 were prepared as metal sensors where complexation to ions alleviates 
ICT and increases the quantum yields.  Comparison of the spectral data for 95 and 97 reveals a 
second styryl group gives a red-shift in the UV absorbance of almost 100 nm, and in about 50 
nm in the fluorescence spectrum.145 
There is no marked pH dependence for the alkoxy-substituted systems 98 and 99.144  
However, the amino-phenol 100 has quenched fluorescence when the hydroxyl group is 
deprotonated, but the UV absorbance and fluorescence remain the same; fluorescence is 
enhanced and there is a blue shift when the amine group is protonated.  This molecule has 
therefore been compared to a logic gate.75 
 
42 
N
B
F2
N
O O
98
iPrOH, ! 0.42
"max abs 657 nm
"max emiss 679 nm
fwhm 41 nm
Br Br
CO2
tButBuO2C
 
 
 
N
B
F2
N
N
100
THF, ! 0.25
"max abs 565 nm
"max emiss 660 nm
THF + H+, ! 0.85
"max abs 525 nm
"max emiss 560 nm
THF + OH-, ! 0.032
"max abs 565 nm
"max emiss 660 nm
OH
N
B
F2
N
O
99
iPrOH, ! 0.40
"max abs 657 nm
"max emiss 679 nm
fwhm 43 nm
O
CO2
tBu
O
CO2
tBu tBuO2C
deprotonation 
quenches the
fluorescence
protonation
enhances  and 
blue-shifts the
fluorescence
 
 
 
 
43 
Invitrogen’s BODIPY 630/650 and BODIPY 650/665 probes are the longest-wavelength 
amine-reactive BODIPY fluorophores reported to date. 
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Biomolecules labeled at relatively large BODIPY:protein ratios can have diminished 
fluorescence due to interactions between the probes; the fluorescence can also be red-shifted 
for the same reason.148  Small molecules containing two BODIPYs have been produced to test 
these types of effects.  The first prepared were somewhat flexible being based on 
cyclohexane.138,139 More recently, rigid test molecules with cofacial BODIPY dyes have been 
made and studied.  Only one transition dipole moment is possible for these structures.  The 
xanthane unit was chosen as a scaffold since it can be easily functionalized on its 4- and 5- 
positions.  Aldehyde or bis-aldehyde functionalities on the xanthane (101 or 105, respectively) 
were used to construct the BODIPY units by condensation with 2,4-dimethylpyrrole.  A 3-methyl 
substituent on the BODIPY was then reacted with p-dimethylaminobenzaldehyde to extend the 
conjugation (Scheme 1.7).149 
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Scheme 1.7.  Syntheses of BODIPY dyes anchored on xanthene units to test self-
quenching: a a system with one BODIPY dye; b a similar compound with two, where only one 
has extended conjugation; and, c another where both have extended conjugation. 
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Scheme 1.7.  Continued. 
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Scheme 1.7.  Continued.  
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Compound 106 has two cofacial BODIPY groups, and the UV absorption maximum of the 
BODIPY part is blue shifted (to 478 nm, with a shoulder at 504 nm) relative to 1,3,5,7-
tetramethyl-BODIPY 7 and the control compound 102.  Compound 107 which has one styryl-
extended BODIPY and one tetramethyl-BODIPY substituent has UV absorption peaks 
corresponding to both these substituents (455 nm and 575 nm).  Upon excitation at 480 nm, the 
monochromophoric system 102 exhibits a very strong emission at 500 nm, while the 
fluorescence emission of the di-BODIPY system 106 is significantly quenched; it shows two 
peaks, one at 505 nm and a broader excimer-type emission at 590 nm.  Efficient energy transfer 
from the donor (tetra-methyl BODIPY) to the acceptor (extended BODIPY) was observed for the 
system 107.  The cofacial chromophores are separated by approximately 4.5 Å, allowing both 
energy transfer and formation of an excimer-like state.  Incidentally, system 107 acts as an 
energy transfer cassette; fluorescence emission could be observed at 650 nm from the extended 
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BODIPY (acceptor) upon excitation of the other BODIPY (donor) at 480 nm.  More discussion of 
energy transfer cassettes follows in section F.   
3. From Palladium-catalyzed Coupling Reactions at the 3- and 5-Positions 
3,5-Dichloro BODIPY derivatives such as 64 have similar reactivities to heterocyclic 
imidoyl chlorides; this opens a new window for derivatization using transition-metal-catalyzed 
reactions.  Thus, new 3-, 5-aryl, ethenylaryl and ethynylaryl compounds 109 and 110 were 
obtained via Stille, Suzuki, Heck and Sonogashira couplings (reaction 14).150  The extended 
conjugation, and mono-/disubstitution patterns, of these dyes give dispersed fluorescence 
emission maxima within the series.  Absorption maxima for the monosubstituted compounds 109 
are blue-shifted by 20 to 50 nm relative to the disubstituted ones 110.  The largest red shift for 
both absorption and emission was observed for the styryl substituted derivatives.  The dyes with 
ethenyl- or ethynyl-aryl substituents gave the highest quantum yields (110c, 0.92; 109d, 0.98; 
and, 110d, 1.00).150  The mono-substituted BODIPY dyes can further be derivatized by 
nucleophilic substitution (see section above) or by another transition-metal-catalyzed coupling 
reaction to give unsymmetrically substituted probes. 
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"max emiss 579 nm
c MeOH; ! 0.92
"max abs 626 nm
"max emiss 639 nm  
 
MeOH; ! 0.98
"max abs 556 nm
"max emiss 569 nm
d MeOH; ! 1.00
"max abs 605 nm
"max emiss 622 nm  
reaction 14 
 
F. Energy Transfer Cassettes 
1. Through-space Energy Transfer Cassettes 
Two fluorescent entities may be joined in the same molecule to give a “cassette”.  One of 
these, the donor, may collect radiation efficiently at the excitation wavelength and pass this 
energy to the second fluorescent moiety that emits it at a longer wavelength.  If the mechanism 
of energy transfer is through space then this system might be called a through-space energy 
transfer cassette.  Through space-energy transfer cassettes are typically used to artificially 
enhance the Stokes’ shift of a probe.  Ones featuring BODIPY dyes have been somewhat useful 
for DNA sequencing on a genomic scale151 where four distinct fluorescent outputs are required, 
and usually only one excitation wavelength is used. 
Through-space energy transfer efficiencies depend on several factors, including: (i) 
spectral overlap of the donor emission with the acceptor absorbance; (ii) distance between the 
donor and the acceptor; (iii) the orientation factors; and, (iv) the effectiveness of alternative de-
excitation modes.  Cassettes desribed in this section have no obvious way to transfer energy 
from donors to acceptors via bonds. 
The dendritic light harvesting system 111 with four BODIPY donors and a perylenediimide 
(PDI) acceptor was constructed via click chemistry.152  Its UV spectrum is equal to the sum of the 
donor and acceptor components indicating they are not electronically perturbing each other.153  
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The extinction coefficients of 111 at 526 nm (BODIPY λmax) and 582 nm (PDI λmax) are 240 000 
and 45 000 M-1cm-1, respectively, hence the donor absorption is huge simply because four 
BODIPY units are involved. No green fluorescence emission from BODIPY was observed upon 
excitation at 526 nm, indicating efficient energy transfer (99 %).  Based on the energy transfer 
efficiency, the authors of this work calculated a Förster critical radius of 47 Å.  An “antenna 
effect” {emission intensity at 618 nm when excited at 526 nm (BODIPY core) divided by that from 
excitation at 588 nm (at the PDI core)} gave approximately a 3.5 fold enhancement.  
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Most studies on energy transfer between porphyrins and other chromophores have 
focused on electron and energy transfer in the plane of the porphyrin.  “Vertical” electron and 
energy transfer from axial ligands, on the other hand, has not been studied extensively but 
systems 112 – 115 were synthesized to study this phenomenon.  An antimony porphyrin was 
chosen as the acceptor because this central metal can coordinate to ligands with oxygen, 
nitrogen, or sulfur atoms.  Energy transfer from the excited singlet state of the BODIPY to the 
Sb(TPP) chromophore occurs for 112, 113 and 115.  This happens with efficiencies in the 13 – 
40 % range, decreasing as the length of the methylene bridge increases.  Little or no evidence 
was seen for quenching of the porphyrin excited singlet state by the BODIPY.  This was true 
even when polar solvents were used and the donor and acceptor fragments would be expected 
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to pack against each other.  However, for system 114, which differs from 112 only at the second 
axial ligand (phenoxy vs methoxy), the excited singlet state of the Sb(TPP)-acceptor was 
quenched by the BODIPY and phenoxy ligands.  The quenching by the phenoxy group occurs, 
at least in part, via a non-radiative electron-transfer process.154 
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System 116 is another artificial light harvesting system with BODIPY dye donors, but here 
the energy is transferred to a zinc porphyrin (ZnP) then electron transfer occurs to a fullerene 
(C60-Im) unit; thus the molecule was called a “supramolecular triad”.  The Zn-porphyrin connects 
to the fullerene component via metal to axial-ligand coordination.  Both steps in the process were 
efficient.  Overall, the system was said to mimic the “combined antenna-reaction center” events 
in natural photosynthesis.155 
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Like 112 - 116, complex 117 also features a donor and an acceptor system linked via axial 
coordination to a zinc porphyrin.156 This self–assembling system is based on the exceptional 
affinity of phenanthroline-strapped zinc porphyrins for N-unsubstituted imidazoles.157,158  Efficient 
net energy transfer (80 %) was observed for excitation of the  BODIPY at 495 nm and emission 
at the free porphyrin.  Energy transfer from the excited ZnP-Im complex to the free porphyrin 
was calculated to be 85%.  
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Compound 118 was designed to be a molecular switch.  It has two stable conformations 
governed by the bridged resorcin159 arene scaffold.160  In the absence of protons (or perhaps 
other guest cations) the molecule exists in a contracted geometry maximizing FRET 
(fluorescence resonance energy transfer) between the two BODIPY based probes.  Decreased 
pH values switch the molecule to the expanded conformation and this is evident by the reduced 
energy transfer.  An advantage of using BODIPY dyes in this study is their low sensitivity to pH 
changes. 
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The UV spectrum of 118 displays three strong absorption bands assigned to the spacer 
(λmax 332 nm), the donor (λmax 529 nm) and the acceptor dye (λmax 619 nm), respectively.  Upon 
excitation at 490 nm, two emission bands at 542 nm (donor dye) and 630 nm (acceptor dye) are 
observed, in a ratio of the donor/acceptor fluorescence intensity of 45:55, indicating low FRET 
efficiency (possibly due to unfavorable orientations of the transition dipole moments, and/or to 
the dynamic behavior of the cavitand part).  Upon addition of TFA, the emission from the 
acceptor is nearly completely quenched, whereas the donor fluorescence intensity doubles. 
2. Through-bond Energy Transfer Cassettes 
Porphyrin-based Systems as Models of Photosynthesis 
The prevalent mechanism of through-space energy transfer is likely to be via dipolar 
couplings, ie Förster energy transfer.  The rate and efficiency of this is governed by, among 
other things, the overlap integral between the donor fluorescence and the acceptor absorbance.   
If the donor and acceptor dyes are coupled to each other via a conjugated but twisted π-
system then the prevalent mechanism of energy transfer is likely to be through bonds.  
Constraints on through-bond energy transfer are not well understood, but it appears there is no 
requirement for a good overlap integral.   This is important in the design of fluorescent cassettes 
because, if this is true, there is no obvious limitation on the energy gap between the donor 
fluorescence and the acceptor absorbance, hence cassettes with huge “apparent Stokes’ shifts” 
could be produced. 
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 A pioneer of energy transfer systems featuring BODIPY donors was Lindsey who studied 
them in the context model porphyrin-based systems for photosynthesis.161  He proposed that the 
rates and efficiencies of through-bond energy transfer are influenced by the following factors: 
• steric interactions between the donor/acceptor wherein increased torsional constraints 
decrease rates and efficiencies of energy transfer; 
• frontier orbital characteristics for the HOMO and LUMO; and related to that, 
• the site of attachment of the donor/acceptor to the linker and the nature of the linker. 
 
Lindsey has described the through-bond energy transfer cassette 119 as a “linear 
molecular photonic wire”.  It features a BODIPY donor and a free base porphyrin acceptor.  This 
donor-acceptor pair is separated by 90 Å.  Efficient energy transfer (76 %) from the donor to the 
acceptor was observed upon excitation at 485 nm (ie the donor λmax abs).162   
Systems 120 and 121 were described as “molecular optoelectronic linear- and T-gates”, 
respectively.  In these cassettes, the emission of the acceptor can be turned on or off via 
reduction or oxidation of the attached magnesioporphyrin; the latter in its oxidized state 
quenches fluorescence via ICT.  For each cassette more than 80% of energy transfer was 
observed upon excitation of the BODIPY donor part.163 
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Compounds 122 - 125 are light-harvesting arrays featuring one, two, or eight BODIPY 
donors and one porphyrin acceptor.  Increasing the number of BODIPY donors from one to eight 
only increases the relative absorption at 516 nm from 68 to 94 % (of a BODIPY standard) for the 
free base porphyrins 122 - 125, and from 91 to 99 % for the Zn-porphyrin (not shown).  Near 
quantitative energy transfer was observed for the systems containing one or two BODIPY units, 
but 80-90 % energy transfer was observed for the system bearing eight BODIPY units.164 
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Cassettes 126 and 127 were synthesized from the corresponding 21-thia and 21-
oxoporphyrins by Sonogashira couplings with 8-(4-iodophenyl)-BODIPY.  Excitation of the 
BODIPY part at 485 nm gave weak emission from the BODIPY core and strong emissions from 
the porphyrin units, suggesting efficient energy transfer.  Direct comparison of the efficiencies of 
energy transfer is difficult because the separations and orientations of the donor and acceptor 
fragments are different.165,166  Interestingly, the analogous system with two sulfurs, 128, gave 
poor energy transfer (~ 11%) upon excitation at 485 nm,167 whereas 129 which has a normal 
porphyrin core gave 97% energy transfer.168 
 
N
F2B N N
SNH
N
N B
F2
N
126  
 
59 
N
ON
NH
N
F2B N
N
F2
B
N
127  
 
 
 
N S
NS
N
BF2
N
N
F2
BN
N
F2B
N
N
B
F2
N
128  
 
 
60 
N HN
NNH
N
BF2
N
N
F2
B
N
N
F2B
N
N
B
F2
N
129  
 
Polypyridine Complexes Containing Accessory BODIPY Chromophores 
The dual-dye systems 130 – 137 featuring one or more BODIPY chromophores and a 
Ru(II) polypyridine complex have been synthesized as models for solar energy conversion and 
storage.  The BODIPY chromophore was chosen for its strong fluorescence, whereas the Ru(II) 
polypyridine complex was chosen for its relatively intense and long-lived triplet metal-to-ligand 
charge transfer (MLCT) emission.  The pyridine based BODIPY dyes were synthesized by 
condensation of formylpyridine with 3-ethyl-2,4-dimethylpyrrole.169-172 The new compounds 
exhibit intense absorption in the visible region (acetonitrile solution), with a major sharp band at 
523 nm assigned to the π - π* transition for the dipyrromethene dye and a broader band of lower 
intensity between 450 and 500 nm.  The free ligands are strongly fluorescent both in solution at 
room temperature and at 77 K in a rigid matrix, but no luminescence could be observed in 
solution for the Ru complexes, independently of the excitation wavelength.  Nanosecond 
transient absorption spectra, however, revealed that a relatively long-lived (ms time scale) 
excited state was formed for all metal complexes.  The latter was identified as the BODIPY-
based triplet state, and is believed to be formed through a charge-separated level from the 
BODIPY-based 1π - π* state.  At 77 K, all the complexes studied except for 130, exhibit the 
BODIPY-based fluorescence, although with a slightly shortened lifetime compared to the free 
ligands.  However, the surprising finding was that 133 – 135 also exhibit a phosphorescence 
assigned to the BODIPY subunits (emission at 774 nm of 50 ms lifetime).  This is the first report 
of phosphorescence for BODIPY based dyes.  The authors propose that the phosphorescence is 
due to the presence of the heavy ruthenium metal, which facilitated intensity to be diverted into 
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the BODIPY 3π - π* state from the closely lying metal-based 3MLCT level (for which 
luminescence decay is highly efficient at 77 K).170,173,174  Phosphorescence from BODIPY units is 
certainly unusual.  It only was observed here at 77 K for a system coupled with a ruthenium 
complex, and the efficiency of the process was not determined. 
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Compounds 136 and 137 combine ruthenium polypyridine units with BODIPY fragments.  
The BODIPY part ensures a high molar absorption coefficient of the system in the metal-to-
ligand charge-transfer region (around 500 nm).  The singlet excited states of 136 and 137 are 
strongly quenched by the presence of ruthenium: energy transfers to the Ru center with high 
efficiency (93 % and 73 % for 136 and 137, respectively), where it is then dissipated via electron 
transfer and/or singlet to triplet intersystem crossing.  The net effect is that these complexes are 
not fluorescent.175 
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Loss of fluorescence when BODIPY dyes are conjugated with metal complexes is 
common.   For instance complexes 138 and 139 have greatly reduced fluorescence relative to 
the free ligands,171,172 presumably due to intramolecular electron transfer.171,176   
 
64 
N
N
F2B N
N
N
N
N
BF2N
N
N
Zn
138  
 
N
N
F2B N
N
N
N
N
BF2N
N
N
Zn
139  
 
Other complexes, eg of platinum,177 containing BODIPY-based ligands have been 
prepared, but without comment on their fluorescent properties.  It is unlikely that such materials 
will be useful as probes. 
 
Relatively Compact Systems as Potential Probes in Biotechnology 
Porphyrin-based cassettes tend to be larger than is ideal for applications relating to 
labeling of biomolecules, but the through-bond energy transfer aspect could be very useful for 
applications wherein one source is used and several different outputs must be observed 
simultaneously.  Thus, there has been interest in making smaller through-bond energy transfer 
cassettes. 
BODIPY-based cassettes featuring simple aromatic donors can be prepared from 
halogenated BODIPYs eg 140 via palladium mediated cross-coupling reactions.178  
Monoiodinated products can be quite useful for such syntheses.  For instance, reaction 15 
shows a typical stepwise BODIPY synthesis that was used for this. 178  
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Fluorescence quantum yields of compounds 141 - 144 excited at the donor λmax range 
from 0.02 to 0.75 (in chloroform).  In compound 145, the S1   S0 transition moments of the 
chromophores are mutually perpendicular in all conformations.  Fast energy transfer, of the order 
of 0.45 ± 0.08 ps, was observed for this compound.  For 141 - 144, the donor and acceptor S1 
S0 transition moments are mutually coaxial with the linker in all conformations.  The transfer rate 
for this set of compounds was even faster than for 145, ~ 200 fs; in fact, this was too fast to be 
measured accurately.179  Thus it appears from this data that parallel and aligned transition 
moments are ideal for extremely fast energy transfer.  The length of the linker in this series of 
compounds was also varied but not enough derivatives were made to arrive at conclusions 
relating this parameter with energy-transfer rates. 
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More recently, energy transfer cassettes like 145 have been prepared; these are very 
similar except that the meso-donor group is one or two pyrene units linked with alkynes.  It was 
shown that the energy transfer efficiency is reduced when alkyne units are added.  Of course, 
use of conjugated pyrenes as the donor increases the UV absorption at shorter wavelengths and 
the λmax for that donor-based band; the latter effect decreases the apparent Stokes’ shift 
observed.180 
Energy transfer cassettes like 146 – 148, in which two BODIPY chromophores are linked 
via an acetylenic linker, have been prepared.160  As the size of the linker increases, energy 
transfer efficiency decreases from about 98 % to ~ 35 %.  These were described as FRET 
cassettes, but there is a strong possibility that some of the energy transfer takes place through 
bonds. 
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G. Substitution of Fluoride Atoms in the BF2-Group 
1. With Alkyl Groups 
Some dialkyl-B BODIPY compounds have been prepared via reactions of the 
corresponding dipyrromethenes with bromodimethylborane, dibutylboron triflate, or 9-BBN 
triflate.  Increased steric bulk at the boron atom along this series correlated with decreased 
fluorescence quantum yields.  While the substituent at the meso position has no effect on the UV 
absorption and emission spectra, the fluorescence quantum yields strongly depend on the 
nature of the aryl group.  Introduction of steric constraints on the aryl ring increases the quantum 
yield (compare 149 and 152, 150 and 153).181 
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2. With Aryl Groups 
Aryl Grignards can displace fluoride from the boron difluoride entity of BODIPY dyes.  In 
Scheme 1.8a, at 0 °C, even with excess Grignard reagent, only the monosubstituted products 
154 and 155 were obtained, but the disubstituted product 156 was formed by adding the 
Grignard reagent at room temperature.  Reaction of aryl lithium reagents was much faster; these 
gave only the disubstituted products 157 - 159, even when just one equivalent of anion was 
added (Scheme 1.8b).    
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Scheme 1.8. Synthesis of C-BODIPYs using a aryl Grignard reagents; and, b aryl lithium 
reagents. 
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F Ar
1 eq. ArMgBr
Et2O, 0 °C
1 - 2 h
2 eq. 2-NapMgBr 
Et2O
 25 °C, 1 - 2 h
156
CH2Cl2, ! 0.80
"max abs 516 nm
"max emiss 552 nm
9
CH2Cl2, ! 0.83
"max abs 517 nm
"max emiss 538 nm
154  Ar = Ph
CH2Cl2, ! 0.90
"max abs 524 nm
"max emiss 543 nm
155  Ar = 2-Nap
CH2Cl2, ! 0.92
"max abs 513 nm
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Scheme 1.8. Continued.  
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 The new dyes 154 – 159 are highly fluorescent in solution.  While the absorption 
maximum of the BF2 parent dye is relatively insensitive to the solvent polarity, the B-Ar BODIPYs 
tend to undergo small red-shifts in more polar solvents.   The origin of this solvent dependence 
may be minimization of interactions of the B-aryl groups with more polar media.  The 
fluorescence emission maxima of 154 – 159 are also red-shifted relative to the parent BF2 
structures.   
UV absorbance by the aromatic substituents means that these compounds can be 
regarded as energy transfer cassettes, and when the B-Ar groups have good extinction 
coefficients then there may be some value in this aspect of their properties.  The dipyrene 
system 159 absorbs in the range 230 - 317 nm corresponding to the π   π* transition of the 
pyrene units, and emits exclusively (100 % energy transfer) from the BODIPY part.182  However, 
there is no immediate application of this effect. 
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3. With Alkyne Groups 
Acetylide anions are also good nucleophiles for the displacement of fluoride from the 
borondifluoride entity of BODIPY dyes.  The pyrromethene dialkynyl borane complexes 160 and 
161, for instance, were synthesized from 4-lithioethynyltoluene and 1-lithioethynylpyrene, 
respectively.183-185 
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CH2Cl2, ! 0.94
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Adding groups to the boron atoms does not bring them into conjugation with the BODIPY 
core.  Consistent with this, the absorption spectra of 160 and 161 have distinct BODIPY and 
ethynylaryl components.  Upon excitation at 516 nm, both 160 and 161 emit strongly, with high 
fluorescence quantum yield, in the region 535-540 nm.  For 161, excitation at 371 nm (pyrene 
absorption band) did not lead to emission from the pyrene but instead to emission characteristic 
of the indacene core, indicating an efficient energy transfer from the pyrene to the indacene 
moiety.183,184,186 
It is possible to add trimethylsilylacetylide to displace fluoride from BODIPYs, then 
desilylate under basic conditions and Sonogashira couple to the terminal alkyne eg 163 
(Scheme 1.9).  Whereas use of excess sodium hydroxide in the desilylation reaction affords the 
bis(ethynyl)BODIPY 163, the monoprotected derivative 164 can be obtained using limited 
amounts of NaOH and shorter reaction times.187,188  Access to the monoprotected derivative 
facilitates introduction of different substituents on the B-alkynes.184 
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Scheme 1.9.   a Two-steps synthesis of bis(ethynyl)BODIPY 163, and the monoprotected 
analog 164; and, b some examples of compounds that have been prepared via Sonogashira 
coupling of 163. 
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Compounds 165 – 166 can act as energy transfer cassettes, just like the B-aryl systems 
mentioned above. Irradiation of the donor (pyrene or anthracene) was observed to give only 
BODIPY emission, indicative of a near quantitative energy transfer. 
Terminal alkynes like 164 and 170 can be oxidatively dimerized (Pd(II) and CuI under 
aerobic conditions) to give butadiynes 168 and 171 (Scheme 1.10).187  Deprotection of the 
product butadiyne 168 was very slow, a mixture of monodeprotected 169a and bisdeprotected 
169b was isolated after 6 days. 187 
 
Scheme 1.10.  Synthesis of homocoupled products. 
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Scheme 1.10. Continued. 
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A very similar concept was explored by the same group but using 
diisoindolodithienylpyrromethene-dialkynyl borane dyes.189  These dyes have quite long 
wavelength emissions (over 750 nm); the parent BF2 dye 172 was known prior to this work.190  
Intermediate 173 was obtained by reaction of 172 with the appropriate alkynyl-Grignard reagent.  
Sonogashira coupling with various ethynyl-arene derivatives afforded the systems 174 - 178.  All 
the new dyes exhibit a UV absorption maximum at 708 nm with a molar absorptivity of ~80 000 
M-1 cm-1.  Higher energy absorption bands assigned to the pyrene, perylene, bis- and tri-pyridine 
were also observed near 350 and 450 nm.  Upon excitation at 708 nm, a broad emission band at 
750 nm, with quantum yields between 0.19 and 0.45 was observed in all cases.  Fast energy 
transfer to the central dipyrromethene core was observed upon irradiation of the pyrene and 
perylene units in 177 and 178, giving large virtual Stokes’shifts.  The efficiency of the energy 
transfer for compounds 177 and 178 was estimated to 58% and 38%, respectively.  Formation of 
aggregates was observed when the dyes were dissolved at concentrations higher than 10-7 M.   
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4. With Alkoxide Groups 
The first two B-methoxy BODIPYs prepared were 179 – 180.  These were made by 
reacting the corresponding BF2 compound with sodium methoxide in methanol (reaction 16).  
The shape of the absorption and emission spectra were the same for the starting material 12 
and the two products, suggesting the change in B-substituents had little effect on the electronic 
states of the boroindacene core.  Interestingly, the monomethoxy and dimethoxy products were 
more water-soluble than the corresponding BF2 compounds.83 
  
N
B
F2
N
NaOMe
MeOH 
reflux
N
B
N N
B
N
+
F OMe MeO OMe
12
MeOH, ! 0.46 
"max abs 497 nm
"max emiss 507 nm
179
MeOH, ! 0.45
"max abs 498 nm
"max emiss 509 nm
180
MeOH, ! 0.49 
"max abs 498 nm
"max emiss 509 nm  
reaction 16 
 
The only other report of B-OR BODIPYs systems C describes their syntheses via 
treatment of the corresponding BODIPY with various alcohols in the presence of aluminum 
trichloride (reaction 17).95 This study was more expansive than the first insofar as a more diverse 
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set of alcohols were studied.  Thus the alcohols used included simple alkoxy 181 - 183, aryloxy 
184 – 187, and several diol-derived systems 188 – 191.  Across this series there were only 
minor changes in the absorbance and emission spectra.  The dialkoxy-BODIPYs 181 – 183 
appear to have higher fluorescence quantum yields than the diaryloxy-ones 184 – 187, and the 
systems binaphthol- and catechol-derived systems 188 and 189 have extremely poor quantum 
yields. 
 
N
B
F2
N N
B
N
RO OR
I I
C
(i)AlCl3, CH2Cl2, reflux, 5 min
(ii) ROH, 25 °C, 5 min
 
 
181
CHCl3, ! 0.55 
"max abs 505 nm
"max emiss 519 nm
182
CHCl3, ! 0.76 
"max abs 504 nm
"max emiss 518 nm
183
CHCl3, ! 0.65
"max abs 506 nm
"max emiss 522 nm
R  =
Ph
 
 
184
CHCl3, ! 0.06 
"max abs 506 nm
"max emiss 517 nm
185
CHCl3, ! 0.004 
"max abs 507 nm
"max emiss 518 nm
OMe
Ph
186
CHCl3, ! 0.065 
"max abs 506 nm
"max emiss 520 nm
Cl
 
 
NO2
187
CHCl3, ! 0.54
"max abs 504 nm
"max emiss 516 nm  
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188
CHCl3, ! 0.002 
"max abs 506 nm
"max emiss 516 nm
O O
189
CHCl3, ! 0
"max abs 510 nm
"max emiss na
190
CHCl3, ! 0.14
"max abs 507 nm
"max emiss 521 nm
(RO)2 =
O O
O O
 
 
191
CHCl3, ! 0.54
"max abs 504 nm
"max emiss 522 nm
OH
 
reaction 17 
 
 
H. Use of Metals Other Than Boron 
The BODIPY core features a boroindacene unit, so compounds where the boron has been 
substituted with other metals are, strictly speaking, beyond the scope of this review.  However, 
there are a few dipyrromethene anion complexes of other metals that have highly fluorescent 
spectroscopic characteristics.  These are covered here because they are clearly relevant as 
probes.   
Free base dipyrrins react readily with a variety of metals salts to form the corresponding 
bis(dipyrrinato)-metal(II) or tris(dipyrrinato)-metal(III) complexes, but their fluorescence 
properties have rarely been studied and they have generally been regarded as non-
fluorescent.191-214  The first report (2003) of fluorescent properties was for zinc complexes of the 
boraindacene fragment.215,216  The complexes were prepared either from (i) treatment of a 
purified dipyrrin with zinc acetate; or, (ii) a two-step one-flask approach involving oxidation of a 
dipyrromethane and complexation of the resulting crude dipyrrin with a Zn(OAc)2 in presence of 
triethylamine.  Complexes 192 and 193 are weakly fluorescent but 194 is a stronger emitter (it 
has a multinanosecond excited-state lifetime); thus free rotation of the meso-phenyl is again 
implicated as a major pathway for non-radiative relaxation to the ground state for 192 and 193. 
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192
PhMe; ! 0.006
194
PhMe; ! 0.36
N N
N N
Zn
N N
N N
Zn
N N
N N
Zn
tBu
tBu
193
PhMe; ! 0.006
quantum yield increases as
the rotation of the meso
group is hindered
 
 
Porphyrin or phthalocyanine complexes of group 13 metals can be fluorescent; this 
inspired syntheses of two new dipyrromethenes 195 and 196 from gallium(III) and indium(III), 
respectively (reaction 18).  In hexanes the new compounds fluoresce green light, with quantum 
yields of 0.024 and 0.074 for the gallium(III) and indium(III) complexes, respectively.217 
 
HN
N
Cu(acac)2 N
N
Cu
2
crude product
after oxidation
purified
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N N
N
NN
N
M3+
KCN
NH N
MX3
enhanced purity
 
reaction 18 
 
N N
N
NN
N
Ga3+
195
hexanes, ! 0.024
"max abs 448 nm
"max emiss 528 nm  
 
N N
N
NN
N
In3+
196
hexanes, ! 0.074
"max abs 444 nm
"max emiss 522 nm  
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“Nanoarchitectures” 197a-d have been fabricated from Zn, Co, Ni, and Cu with 
dipyrromethene-based ligands, but are only strongly fluorescent with zinc.218  The fluorescence 
emission maxima of the zinc complexes in THF and in the solid state are around 510 - 515 nm 
and 532 – 543 nm, respectively.  In acetonitrile, no emission was observed possibly because of 
aggregation of the particles.   Fluorescence emission could be observed at submicron scale for 
particles derived from Zn-bridged dipyrromethene oligomers; this is significant because quantum 
dots formed from clusters of inorganic compounds are considerably larger.  
 
N
N N
N
spacer
n
M
HN
N
spacer
NH
N "M"
197a-d  
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a
b
c
d
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I. BODIPY-analogs With Extended Aromatic Conjugation 
1. Restricted Systems  
As mentioned previously, aryl-substituents on the BODIPY chromophore, eg in 85 and 86, 
red-shift the absorption and emission spectra, but decrease the fluorescence intensity, 
presumably because of the free rotation of the aryl groups.131,132  Consequently, more rigid 
systems like 198 and 199 were prepared and studied.219  These absorb and fluoresce more 
intensely at longer wavelengths, and their quantum yields are generally higher, with the 
exception of 198b. 
 
N N
Ar
B
F2
85
CHCl3, ! 0.20 
" max abs 555 nm
" max emiss 588 nm
N N
Ar
B
F2
86
CHCl3, ! 0.38 
" max abs 542 nm
" max emiss 607 nm  
 
N
B
F2
N
I
O O
198a
MeOH, ! 0.34
"max abs 637 nm
"max emiss 647 nm
N
B
F2
N
I
S S
198b
MeOH, ! 0.05
"max abs 658 nm
"max emiss 673 nm  
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199a
MeOH, ! 0.38
"max abs 634 nm
"max emiss 647 nm
199b
MeOH, ! 0.13
"max abs 658 nm
"max emiss 673 nm
N
B
F2
N
I
N
B
F2
N
I
MeO OMe
 
 
200
MeOH, ! 0.17
"max abs 634 nm
"max emiss 668 nm
N
B
F2
N
I
199c
MeOH, ! 0.72
"max abs 619 nm
"max emiss 629 nm
N
B
F2
N
I
 
 
 
The new derivatives 198 and 199 were obtained by condensation of 4-iodobenzoyl 
chloride with the corresponding pyrrole-based starting materials, which were prepared in several 
steps as described in Scheme 1.11.  Most of the effort here is in the preparation of the pyrrole 
based starting materials.   Part a of Scheme 1.11 shows a route that featured intramolecular C-H 
activation by a nitrene, b involves a Trofimov reaction, 136 and c shows a classical condensation 
route.220 
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Scheme 1.11.  Syntheses of the pyrrole-based starting materials. 
a 
X
CHO
(i) 
EtONa, EtOH, 0 °C, 1 h
(ii) MePh, reflux, 30 min
EtO
N3
O
X
N
H CO2Et
X = O, S  
(i) NaOH
EtOH(aq)
(ii) HCl(aq)
X
N
H CO2H
NaOH
HO
OH
120 °C, 30 min
X
N
H
X = O,  51 %
X = S,  36 %
X = O,  80 %
X = S,  91 %  
b 
 
Y
N
OH
acetylene
LiOH•H2O, DMSO, 140 °C, 5 h
HN
Y
Y = H, OMe Y = H,  71 %
Y = OMe,  65 %  
c 
O
+
OEt
O O
N
OH
Zn, NaOAc
HOAc
reflux, 1 h
HN
CO2Et
10 - 20 %  
 
(i) NaOH
EtOH(aq)
(ii) HCl(aq)
NaOH
HO
OH
120 °C, 30 min
HN
CO2H
HN
99 % 76 %  
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Oxidation of 199a was attempted, but only the half-oxidized product 200 could be 
obtained; further treatment with excess DDQ at room temperature for overnight gave no reaction 
(Scheme 1.12).  Semi-empirical calculations showed that the activation energy required to form 
201 was excessive compared with the half oxidized form 200 due to steric reasons.  The 
physical properties of the mono-oxidized product were somewhat surprising.  First, the maximum 
absorbance was not shifted to the red relative to 199a, only the fluorescence emission was 
shifted to the red by 21 nm.  Second, although the conjugation of the system was extended, the 
extinction coefficient was three times smaller than the reduced form of the dye 199a (41000 vs. 
126250 respectively); the quantum yield was also less than half that of 199a. 
 
 
 
Scheme 1.12.  Synthesis of more conjugated BODIPY derivatives. 
N
B
F2
N
I
3 eq DDQ 
CH2Cl2
25 ° C, 5 min N
B
F2
N
I
200  93 %
3 eq DDQ 
CH2Cl2, 25 ° C, 5 min
no reaction
reflux
decomposition
199a
 
N
B
F2
N
I
201
not formed  
 
2’-Methoxy groups on α-aryl groups provide a special opportunity for syntheses of 
constrained BODIPY dyes.  Thus 202, wherein rotation around a C-Ar bond was prevented by B-
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O bond formation, was conveniently obtained by demethylation and intramolecular cyclization of 
89 (Scheme 1.13).221 Dye 202 has a red-shifted, sharper fluorescence emission than the BF2 
parent dye and its quantum yield is 5.5-6.0 times larger.   
 
 
Scheme 1.13.  Synthesis of a new NIR BODIPY dye. 
N HN
I
MeO OMe
BF3•OEt2, NEt3
MePh, 80°C, 20 min
 
 
N N
I
MeO OMeB
F2
89
CHCl3, ! 0.08
"max abs 545 nm
"max emiss 598 nm
BBr3
0 to 25°C
5 h
N N
I
B
O O
202  93 % overall
CHCl3, ! 0.41
"max abs 630 nm
"max emiss 654 nm  
 
 
 
2. Extended Aromatic Systems 
Di(iso)indomethene Dyes 
Aromatic ring-fused BODIPY derivatives, boron-di(iso)indomethene dyes 204 have been 
prepared via retro Diels-Alder reactions222,223 featuring a norbornane-derived pyrrole (Scheme 
1.14).224 The spectroscopic data for the di(iso)indomethene derivatives 204 are shown below.   
The nature of the substituents at the meso position has no influence on the absorption and 
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emission properties of the new dyes. The new di(iso)indomethene dyes display a red-shifted 
absorption compared to the bicyclic-BODIPY precursors 203.  The more expanded, conjugated, 
and rigid di(iso)indomethene BODIPY dyes 204 are also characterized by a significantly higher 
extinction coefficient relative to the bicyclic-BODIPY dyes 203.  Due to their rigid-fused system, 
which prevents a non-radiative deactivation of the excited state, bicyclic-BODIPY 203 and 
di(iso)indomethene BODIPY dyes 204 have small Stokes’ shifts.  The Stokes’ shifts are, 
however, generally larger for bicyclic-BODIPY dyes 203 than for the di(iso)indomethene 
derivatives 204.  The absorption and emission spectra of bicyclic-BODIPY 203 and 
di(iso)indomethene BODIPY dyes 204 are independent of the solvent polarity.  The fluorescence 
quantum yield of the bicyclic-BODIPY dyes 203 is much higher than the one for the 
corresponding di(iso)indomethene  BODIPY dyes 204. 
 
 
Scheme 1.14.  Extended aromatic dyes from retro-Diels Alder reactions. 
NH
CO2Et
NH
LiAlH4
dry THF
reflux, 2h
(i) RCOCl, CH2Cl2
reflux, 3h
or
 RCHO, TFA
(ii) DDQ
(iii) BF3•OEt2, 
iPr2EtN
CH2Cl2  
 
N
B
F2
N
R
220 °C
 
30 min-2h N
B
F2
N
R
203 204  100 %  
 
R =
CH3
a
EtOH, ! 0.28
"max abs 603 nm
"max emiss 609 nm
b
EtOH, ! 0.33
"max abs 601 nm
"max emiss 608 nm
c
EtOH, ! 0.36
"max abs 602 nm
"max emiss 608 nm
for 204 .....
 
 
88 
Scheme 1.14.  Continued. 
 
d
EtOH, ! 0.26
"max abs 606 nm
"max emiss 614 nm
I
e
CH3CN, ! 0.87
"max abs 597 nm
"max emiss 606 nm
f
CH3CN, ! 0.022
"max abs 597 nm
"max emiss 605 nm
N
 
 
N O
O
O
O
g
CH3CN, ! 0.093
"max abs 598 nm
"max emiss 606 nm
O O
O
O
O
h
CH3CN, ! 0.86
"max abs 598 nm
"max emiss 607 nm  
 
 
 
Other indomethene dyes including 172190 and 206 - 209190,225 have been prepared via a 
different route.  Substituted 2-acylacetophenones 205, obtained from 2-hydroxyacetophenones 
and hydrazines,226 were condensed with ammonia to give the dibenzopyrromethene.  These 
were treated with boron trifluoride to give the 3,4:3’,4’-dibenzopyrrometheneboron difluoride core 
(Scheme 1.15).  The new dyes exhibit very long wavelength absorption and emission bands, and 
are relatively stable to photobleaching. 
89 
Scheme 1.15.  Synthesis of di(iso)indomethene dyes from 2-acylacetophenone 
derivatives. 
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H2N
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OH
OMe
+
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Pb(OAc)4
THF, 25 °C, 40 min
OMe
O
O
OMe
NH4OH
MeOH / AcOH
25 °C, 2 d
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NH N
MeO OMe
MeO OMe
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N
B
F2
N
MeO OMe
S S
OMe OMe
208
 CH2Cl2
!max abs 765 nm
!max emiss 827 nm  
 
N
B
F2
N
MeO OMe
S S
S S
209
CH2Cl2
!max abs 766 nm
!max emiss 831 nm  
 
 
 
Dyes Based On Benz[c,d]indole 
Benz[c,d]indole and its derivatives have been used to form deeply colored dyes.  
Compound 210, for instance, was obtained by condensation of 2-methylthiobenz[c,d]indolium 
iodide and 2-methylbenz[c,d]indolium iodide, followed by complexation with boron trifluoride 
etherate.  Its fixed planar structure exhibits a sharp absorption band at 618 nm, and fluoresces at 
625 nm.227,228 
 
 
 
91 
+
(i) pyridine, reflux, 45 min
(ii) C6H6, Et3N, BF3•OEt2N+
S
HI-
N+
HI-  
 
N N
B
F2
210
DMSO;  ! 0.52
"max abs 618 nm
# 94 000 M-1cm-1
"max emiss 625 nm  
reaction 19 
 
 
Porphyrin-fused Systems 
Systems 212 – 214 have edge-shared porphyrin and BODIPY parts.  They were 
synthesized from the formylated pyrroloporphyrin 211 via acid-catalyzed condensation with 2,4-
dimethylpyrrole.  Their UV spectra contain four quite intense bands in the 300 – 750 nm region, 
and do not resemble the sum of the spectra of tetraphenylporphyrin (TPP) and of BODIPY.  
Systems 212 and 214 emit respectively at 693 and 714 nm upon excitation over all the 240 – 
700 nm region with low quantum yields, and 213 did not show any significant  fluorescence.12 
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NN
Ph
Ph
Ph
Ph
NH
CHO
M
211  
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N N
NN
Ph
Ph
Ph
Ph
N N
F2
B
M
M = none
212
CH2Cl2, ! 0.04
"max abs 388, 413, 531, 640 nm
"max emiss 693 nm
 
 
M = Cu
213
CH2Cl2,  ! 0
"max abs 390, 412, 531, 675 nm
"max emiss 693 nm
M = Zn
214
CH2Cl2,  ! 0.053
"max abs 392, 415, 539, 676 nm
"max emiss 714 nm  
 
 
 
J. Aza-BODIPY Dyes 
1. Tetraaryl Systems 
Synthesis of the azadipyrromethene chromophore 215 (without boron, but with aryl 
substituents) was first described in the 1940s.229-231  This, as described below, is the framework 
for a very interesting set of dyes called the aza-BODIPYs.  Two general methods to prepare 
these compounds were developed.  In one, 2,4-diarylpyrroles were converted into their 5-nitroso 
derivatives, then condensed with a second molecule of pyrrole (Scheme 1.16a).  Scheme 1.16b 
shows the second method, in which Michael addition products D from chalcones and 
nitromethane,229 or cyanide E,230,231 were reacted with formamide (or other ammonia-sources) to 
give the core 215.  In the first instance, these reactions were performed neat, ie without solvent.   
Soon after, it was realized that use of alcohol solvents usually causes the azadipyrromethenes to 
precipitate from the reaction mixture, thus enhancing the ease of isolation and yields. The 
postulated mechanism for formation of the azadipyrromethene core from the nitromethane 
adducts is shown in Scheme 1.16c.  It proceeds via pyrrole 217, which is nitrosylated in situ to 
give 218 that then condenses with another molecule of the pyrrole.  
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5
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Ar Ar
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Scheme 1.16.  Formation of azapyrromethene from a. nitroso pyrrole; and b. 
nitrobutyrophenones D and keto-nitrile E; c.  postulated mechanism for the formation of 
azapyrromethene from nitrobutyrophenones D and, d. from keto-nitrile E. 
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Scheme 1.16.  Continued. 
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Scheme 1.16.  Continued. 
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It is also possible to prepare the azadipyrromethene chromophore from cyanide Michael 
addition products E as described in Scheme 1.16d.  Ammonium formate serves as a source of 
ammonia in the pyrrole-forming condensation step.  The 2-amino pyrrole intermediates 219 
readily convert to the azadipyrromethene core on heating in the air. Switching from acetate to 
formate in the dry melt process for the synthesis of 215 nearly doubled the yield to give 
approximately 50%.231  Formation of this chromophore seems to be most facile when there are 
four phenyl substituents, but it is possible to obtain the diphenyl products 222 (below) by slight 
modification of the reaction conditions.231  
The first reactions of azadipyrromethenes with boron electrophiles were reported in the 
early 90’s (Scheme 1.17).130,232 The aza-BODIPY 221 was made from the 3,5-tetraphenyl 
azapyrromethene 220 in that way.  It was reported that the less substituted aza-BODIPY 223 
could not be obtained after treatment of the corresponding aza-dipyrromethene 222 with boron 
trifluoride;232 however, this might have been an artifact of the particular conditions screened. 
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Scheme 1.17.  First syntheses of  aza-BODIPY dyes. 
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Ph Ph
Ph Ph
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Beginning with research largely from O’Shea’s group from 2002 onwards, there has been 
a resurgence of interest in aza-BODIPY dyes, and this has resulted in syntheses of dyes like 224 
- 227.233-235   In this latest era of the field, the azadipyrromethene skeletons are still prepared 
from nitromethane adducts to the corresponding chalcone according to the route described in 
Scheme 1.16c but butanol, rather than methanol or solvent-free conditions, was the preferred 
medium.234  The syntheses were completed by adding BF3•OEt2 at room temperature; the 
intermediate azadipyrromethanes precipitated out in high purities and were not purified beyond 
washing with ethanol.233,234   
UV absorption maxima of the tetraarylazadipyrromethene-BF2 chelates strongly depend on 
the Ar-substituents.  para-Electron donating groups on the 5-Ar substituents gives increased 
extinction coefficients and significant red-shifts in the λmax abs (149 nm for dimethylamino vs H, cf 
227 vs 221).235  para-Substitution with an electron donating group on the 3-aryl ring has less 
impact, but still gives a bathochromic shift (cf 224 vs 225).234 
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The UV absorption maxima of the aza-BODIPY dyes are relatively insensitive to solvent 
polarity; only small blue-shifts tend to be observed (6 – 9 nm) when switching solvents from 
toluene to ethanol.  Their absorptions are sharp, with a full width at half-maximum height (fwhm) 
varying from 51 to 67 nm in aqueous solution with an emulsifier called Cremophor EL, and 47 to 
57 nm in chloroform indicating that the dyes do not aggregate under those conditions.  The 
extinction coefficients range from 75,000 to 85,000 M-1 cm-1, which is much greater than 
substituted porphyrins (3000 – 5000 M-1 cm-1) for instance.  This strong absorbance is one of the 
factors that facilitate efficient singlet-oxygen generation, hence these molecules are potentially 
useful photosensitizers for photodynamic therapy.236-239  
Fluorescence emission spectra of the aza-BODIPY dyes reported to date are also 
relatively insensitive to the solvent polarity.  Compounds 221 and 224 to 226 have high 
fluorescence quantum yields.  In the case of 226 , there is a bromine atom attached to the 
phenyl substituent, but no significant decrease in the quantum yield was observed.234  On the 
other hand, introduction of bromine directly into the core of the dye eg compounds 228 to 230 
results in a significant decrease of the fluorescence quantum yields, indicating a larger heavy-
atom effect and an increased singlet oxygen production.234  A quantum yield was not reported for 
227, but the compound became much more fluorescent under acidic conditions due to variation 
in the internal charge transfer.235  Upon addition of acid, the absorption band at 799 nm 
disappears and a new band at 738 nm appears indicating the mono-protonated form.  The later 
disappears with addition of more acid, and a new band characteristic of the bis-protonated 
species appears at 643 nm. 
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Aza-BODIPY dyes mostly have been discussed in the context of agents for photodynamic 
therapy, but chemosensors have also been made from these compounds.  Compound 231 is 
highly selective for mercuric ions that become chelated between the 2’-pyridyl groups.240  
Mercuric ion complexation red-shifts both the UV-absorption and fluorescence emission maxima.  
The dissociation constant was determined to be 5.4 × 10-6 M, with a 1:1 binding stoichiometry.  
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Compound 232 and 233 are photoinduced electron transfer crown ether chemosensors 
featuring aza-BODIPY chromophore;241 they are used as visible sensors for the paralytic 
shellfish toxin Saxitoxin.  Saxitoxin contains guanidine groups, and it is these functional groups 
that interact with the crown ether part of these molecules.  In the absence of Saxitoxin, PET from 
the crown ether to the fluorophore quenches the fluorescence.  Upon complexation of the toxin, 
PET can no longer happen and fluorescence is turned on.  At 1:1 toxin/crown stoichiometry, the 
fluorescence enhancement was over 100% for compound 232.  The average binding constant 
for 232 to Saxitoxin, 6.2 × 105 M-1, was among the highest observed for any chemosensor of that 
100 
toxin.  Compound 233, which has a larger crown ether bound the toxin less strongly (1.4 × 104 M-
1) and gave insignificant fluorescence enhancement.  The putative PET mechanism in these 
systems involves π-stacking of one of the Saxitoxin’s guanidiniums to the fluorophore.   
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2. Extended Aza-BODIPY Systems 
Strongly electron-donating groups, rigidifying structural modifications, and embellishments 
to extend the conjugation of the BODIPY dyes tend to red-shift their fluorescence emissions.  
Predictably then, similar modifications can be used to push the emission spectra of aza-BODIPY 
systems into the near-IR.   
The “extended” aza-BODIPY systems 234 – 246 were synthesized from 2,4-diarylpyrroles.  
These starting materials were obtained in good overall yield over four steps from an alkene via 
(i) addition of iodo azide, (ii) dehydro-halogenation, (iii) pyrrolysis (azirine formation) and (iv) 
carbanion induced pyrrole formation as shown in Scheme 1.18.242,243 
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Scheme 1.18.  Synthesis of cyclized/restricted 2,4-diarylpyrroles. 
R
ICl, NaN3
CH3CN, 23 °C
R
I
N3
tBuOK
Et2O, 23 °C N3
R
 
CH2Cl2, 175 °C
N
R
R1
OR2
acyclic or cyclic ketone
NaH, DMSO, 23 °C N
H
R1
R2
R
 
R = Ph; 4-MeOC6H4, phenylethyl  
 
 
The conformationally restricted aza-BODIPY dyes were then prepared as shown in 
Scheme 1.19 via condensation of the pyrrole generated in Scheme 1.18 with a nitrosopyrrole 
generated in situ, followed by complexation with boron trifluoride.  Attempts to condense 2,4-
dimethylpyrrole with a nitrosated restricted 2,4-diarylpyrrole failed to give any product, 
suggesting that the 2-aryl substituent in the pyrrole is essential for the formation of these 
restricted aza-BODIPY dyes.   
 
 
Scheme 1.19.  Synthesis of a, symmetrical and b, asymmetrical conformationally 
restricted azaBODIPY dyes. 
a 
NH
MeO
Ph
(i) HOAc, Ac2O
NaNO2
(ii) Hunig's base
 BF3•OEt2
(CH2Cl)2
N
B
F2
N
N
MeO OMe
Ph Ph
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Scheme 1.19.  Continued. 
b 
 
(i) HOAc, NaNO2
(ii) aryl pyrrole
Ac2O / HOAc
(iii) Hunig's base
 BF3•OEt2
(CH2Cl)2
N
B
F2
N
N
Ar
MeO
Ph Ph
NH
MeO
Ph
 
 
 
 
All the conformationally restricted systems 234 – 246 absorb over 650 nm.  Dyes 234 – 
236 with both sides incorporated in carbocyclic rings have narrow, intense (high ε) absorption 
bands at long wavelengths.  In comparison to the “non-constrained” tetraaryl-azaBODIPY 224, 
there is a bathochromic shift of up to 52 nm and a concomitant halving of the fwhm  (27.1 nm for 
236 vs 52.0 nm for 224). The novel dyes were reported to possess excellent chemical and 
photostability.  Furthermore, the fluorescence is insensitive to solvent polarity.242,243 
There are also several details regarding the spectral properties of the dyes in this series.  
Substitution at the 3-position of the core does not affect the ε-value of the dyes (compare 234 – 
236).  Introduction of electron-donating groups results in a small blue-shift and a slightly higher 
fluorescence quantum yield (234 vs 235). Shorter λabs , lower ε, broader absorption band, and 
lower fluorescence quantum yield were associated with the sulfur-containing dye 237.  The 
dehydrogenated carbocyclic restricted ring in system 239 decreases its quantum yield relative to 
234.  Aza-BODIPYs with only one side restricted have much lower extinction coefficients (240 – 
246 vs 234). The quantum yields of non-symmetric aza-BODIPY dyes are highly dependent on 
the substituents on the aromatic ring.  Electron donating para-substituents give higher quantum 
yields (240 and 241), with shorter λabs indicating that the phenyl rings are twisted. ortho-Electron 
donating groups (eg in 242) result in short λabs, low ε, and broad absorption bands, indicating 
that the phenyl rings in 242 are twisted.  Unexpectedly shorter λabs, low ε, broader absorption 
bands and lower quantum yields were observed when two methoxy groups were present (243 
and 244).  The sharp and intense absorption, high quantum yield obtained in the special case of 
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245 wherein a 2-methoxy-1-naphthyl substituent is present indicates that the naphthyl ring is 
distorted so that electron transfer is suppressed.   
 
N
B
F2
N
N
MeO OMe
Ph Ph
N
B
F2
N
N
MeO OMe
MeO OMe
234  
CHCl3, ! 0.28
"max abs 740 nm
# 159000 M-1cm-1
"max emiss 752 nm
 235 
CHCl3, ! 0.29
"max abs 736 nm
# 157000 M-1cm-1
"max emiss 748 nm  
 
N
B
F2
N
N
MeO OMe
Ph Ph
236
CHCl3, ! 0.31
"max abs 721 nm
# 162000 M-1cm-1
"max emiss 732 nm
N
B
F2
N
N
S S
Ph Ph
237
CHCl3, ! 0.11
"max abs 706 nm
# 115000 M-1cm-1
"max emiss 730 nm  
 
N
B
F2
N
N
MeO
Ph Ph
N
B
F2
N
N
MeO
Ph Ph
238
CHCl3, ! 0.32
"max abs 723 nm
# 157000 M-1cm-1
"max emiss 734 nm
239
CHCl3, ! 0.11
"max abs 715 nm
# 141000 M-1cm-1
"max emiss 730 nm  
 
104 
N
B
F2
N
N
Ph
MeO
Ph Ph
N
B
F2
N
N
MeO
Ph Ph
OMe
240
CHCl3, ! 0.44
"max abs 688 nm
# 108000 M-1cm-1
"max emiss 710 nm
241
CHCl3, ! 0.38
"max abs 708 nm
# 96200 M-1cm-1
"max emiss 732 nm  
 
N
B
F2
N
N
MeO
Ph Ph
OMe
 242
CHCl3, ! 0.38
"max abs 678 nm
# 83900 M-1cm-1
"max emiss 713 nm
N
B
F2
N
N
MeO
Ph Ph
MeO
OMe
243
CHCl3, ! 0.24
"max abs 681 nm
# 66500 M-1cm-1
"max emiss 728 nm  
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N
N
MeO
Ph Ph
OMe
OMe
N
B
F2
N
N
MeO
Ph Ph
OMe
244
CHCl3, ! 0.18
"max abs 707 nm
# 78000 M-1cm-1
"max emiss 735 nm
245
CHCl3, ! 0.46
"max abs 668 nm
# 113000 M-1cm-1
"max emiss 692 nm  
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N
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Ph Ph
OMe
246
CHCl3, ! 0.05
"max abs 774 nm
# 70300 M-1cm-1
"max emiss 815 nm
224
CHCl3, ! 0.36
"max abs 688 nm
# 78500 M-1cm-1
"max emiss 715 nm  
 
 
Dyes Based On Benz[c,d]indole 
Synthesis of compound 248 involves refluxing 2-benz[c,d]indolamine hydroiodide with 2-
(methylthio)benz[c,d]indole-hydroiodide in 1,2-dichlorobenzene in presence of triethylamine 
gives the amine 247. Subsequent treatment with boron trifluoride etherate affords the desired 
product 248 (reaction 18).244 
While the benz[c,d]indole based BODIPY dye 210 displays a red-shifted absorption and 
fluorescence, the aza-BODIPY analog 248 shows a blue-shifted absorption at 540 nm.  
Unfortunately, no fluorescence properties have been reported.  
 
+
N
S
N
NH2
•HI •HI
o-C6H4Cl2
Et3N, reflux N HN
N
247  
N N
N-
B
F2
248
CH2Cl2,  ! na
"max abs 540 nm
"max emiss na
Et3N, BF3•OEt2, MePh
 
reaction 20 
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K. Other Analogs of the BODIPYs 
1. Biimidazol-2-yl-BF2 Complexes 
Biimidazol-2-yls difluoroborate complexes 249 have been obtained by: (i) reacting glyoxal 
bisulfite, 2,3-butanedione and concentrated aqueous NH3 (Scheme 1.20a)245,246; (ii) 
condensation of 1,2-cyclohexanedione with 40% aqueous glyoxal in ethanol saturated with dry 
ammonia gas;246  and, (iii) condensation of oxamide with o-phenylenediamine in refluxing 
ethylene glycol (Scheme 1.20c).247,248 It would seem logical that similar dyes of the type 250 and 
251 could be prepared, but attempts to do so have been reported as unsuccessful.249 
 
N
B
F2
N
N N
250
N
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F2
N
N N
251
N
N
R
249
R' B
F2
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H
N
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Scheme 1.20.  Synthesis of biimidazol-2-yls BF2 complexes. 
a 
249a
CH2Cl2, ! 0.93
"max abs 334 nm 
"max emiss 377 nm
N
N
B
F2
N
H
N
O
O
2 NaHSO3  H2O
O
O
+
(i) (NH4)2CO3
conc. aq. NH3
(ii) BF3•OEt2
 
 
 
b 
249b
CH2Cl2, ! 0.90
"max abs 339 nm
"max emiss 386 nm
N
N
B
F2
N
H
N
O
OO
O
+
(i) EtOH, NH3 gas
(ii) BF3•OEt2
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Scheme 1.20.  Continued. 
 
c 
249c
EtOH, ! 0.68
"max abs 355 nm  
"max emiss 417 nm
N
N
B
F2
N
H
N
+
(i) ethylene
 glycol,
reflux, 24 h
(ii) BF3•OEt2
NH2
NH2
O
OH2N
NH2
 
 
 
 
 
The parent, non-B-coordinated heterocyclic systems for molecules 249 are not significantly 
fluorescent, but the BF2 complexes display strong fluorescence as shown in the diagrams.  
Predictably, red shifts for both the absorption and emission maxima, and increased extinction 
coefficients are observed with increased conjugation and rigidity. 
 
2. Pyridine-based Systems 
The dipyridyl-2-yl-boron complexes 252 - 256 have been prepared from reactions of 
bipyridines with boron electrophiles.250.  They absorb between 302-322 nm, with the exception of 
the complex 255, which absorbs at 371 nm.  No fluorescence was detected for these complexes. 
 
N
B
F2
N N
B
Cl2
N N
B
Ph2
N
252 253 254  
 
108 
N
B
N N N
O O
B
255
256  
 
The pyridomethene-BF2 complex 257 was synthesized as shown in reaction 19 from the 
2,2’-dipyridylmethane by fusion with sodium borohydride.251  The product shows a strong 
absorption at 468 nm, with a extinction coefficient of 17,783 M-1cm-1 in chloroform, but does not 
fluoresce. 
 
N N
2 HBF4
NaBH4, 200 °C
N
B
F2
N
257  
reaction 21 
 
 
The 10-azapyridomethene-BF2 complex 258a was obtained via condensation between 
dipyrid-2-ylamine and boron trifluoride.232 Similarly, 10-Azapyridomethene-B(Et)2 258b was 
obtained by condensation with triethylboron (reaction 20). Complex 258a absorbs at 382 nm (log 
ε = 4.47) in ethanol, and strongly fluoresces at 422 nm (Φ = 0.81). 
 
N N
H
N
N
B
X2
N
N
BF3•OEt2 or BEt3
258
a  X = F
b  X = Et  
 
reaction 22 
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Treatment of dipyrid-2-ylamine with methyl iodide gives the methyldipyrid-2-ylamine, which 
can be converted to the 10-methyl-10-azapyridomethene-BF2 complex 259 by treatment with 
boron trifluoride. The homologous complex 260 was obtained by condensation between 2-
amino-6-methylpyridine and 2-chloro-6-methylpyridine, and subsequent treatment with boron 
trifluoride.  Both these complexes are fluorescent, but the neutral one, 260, fluoresces at longer 
wavelength. 
N
B
F2
N
N+
259
EtOH, ! 0.36
"max abs 325 nm
"max emiss 362 nm
N
B
F2
N
N
260
EtOH, ! 0.40
"max abs 396 nm
"max emiss 416 nm  
 
3. 2-Ketopyrrole Complexes 
The 2-ketopyrrole complexes 261 - 265 were isolated as minor by-products (less than 5%) 
in the synthesis of the corresponding BODIPY analogs.  The yield of 261 - 265 could be 
improved by increasing the amount of acid chloride used in the synthesis.  2-Ketopyrrole 
complexes are less conjugated than BODIPY dyes, hence their absorption, extinction 
coefficients and emission wavelengths are shorter/smaller.  The Stokes’ shifts for these 
compounds, however, are greater than for BODIPY systems (48 nm to 154 nm, cf approximately 
10-15 nm for BODIPY dyes).   
 
Br
N B
F2
O
I
N B
F2
O
I
N B
F2
O
261
CHCl3, ! na
"max abs 321 nm
 # 19 000
"max emiss 475 nm
262
CHCl3, ! na
"max abs 322 nm
 # 16 000
"max emiss 475 nm
263
CHCl3, ! 0.89
"max abs 468 nm
 # 48 000
"max emiss 516 nm  
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N
B
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264
CHCl3, ! 0.52
"max abs 488 nm
 # 43 000
"max emiss 544 nm
265
CHCl3, ! 0.58
"max abs 445 nm
 # 46 000
"max emiss 504 nm  
 
 
4. Azobenzene Derivatives 
Azobenzenes are the most common chromophores in commercial dyes and, because of 
photoinduced isomerization, they are used as photoresponsive molecular switches.  A 
consequence of facile photoisomerization is that quantum yields for these compounds are so low 
that fluorescence tends only to be observed in a rigid matrix at low temperature.  A recent 
innovation in this field, however, is fixation of the π-conjugate systems using boryl-entities to give 
the fluorescent compounds  266 – 268.252  
 
I
N
N
R
R = H, OMe
(i) n-BuLi, Et2O, - 112 °C
(ii) (C6F5)2BF•OEt2 or (C6H4-4-F)2BO
iPr
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N
N
B
C6F5
C6F5
266
hexanes; ! 0.23
"max abs 386 nm
"max emiss  503 nm
N
N
B
C6F5
C6F5
267
hexanes; ! 0.76
"max abs 439 nm
"max emiss  524 nm
OMe
N
N
B
C6H4-4-F
C6H4-4-F
268
no fluorescence  
reaction 23 
 
Azobenzene dyes 266 and 267 display a remarkable red shifted absorbance (386 nm and 
439 nm, respectively) relative to unsubstituted (E)-azobenzene (λ = 315 nm).  Irradiation of 266 
and 267 with a super-high-pressure mercury lamp did not cause photoisomerization.  The 
azobenzene derivative 268, bearing a fluorinated substituent on the boron atom, showed almost 
no fluorescence.  We speculate that this could be due to intramolecular charge transfer from the 
least electron rich aryl substituent into the excited state of the complexed azobenzene system. 
5. Miscellaneous N, N-Bidentate Diphenyl Boron Chelates 
Luminescent N,N-bidentate diphenylboron chelates 269 - 281253,254 have emission maxima 
that vary with the nature of the parent organic system.  Limited information was provided 
regarding the spectroscopic properties of these molecules, but the data presented are interesting 
because some of the dyes have high quantum yields and/or fluorescence emissions around 600 
nm.   These systems perhaps warrant further attention. 
  
N N N
B
Ph Ph
270
!max emiss  476 nm
" 0.61
N N
B
Ph Ph
269
!max emiss 516 nm
" 0.29  
112 
 
N N
B
Ph Ph
F
271
!max emiss 490 nm
" 0.33
N N
B
Ph Ph
Cl
272
!max emiss 487 nm
" 0.22  
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B
Ph Ph
F
F
274
!max emiss 481 nm
" 0.32
N N
B
Ph Ph
MeO
273
!max emiss 532 nm
" 0.036  
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B
Ph Ph
N N
B
Ph Ph
F
F
F
F
F
275
!max emiss 482 nm
" 0.31
276
!max emiss 469 nm
" 0.65  
 
N N
B
Ph Ph
F
N
N
N
F
F
F
B
Ph Ph
277
!max emiss  467 nm
" 0.60
278
!max emiss 445 nm
" 0.46  
 
N N
S
N
N
B
Ph Ph
BPh
Ph
279
!max emiss 470 nm
" 0.14
280
!max emiss 611 nm
" na  
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Ph
281
!max emiss 583 nm
" na  
 
 
A variety of methods were used to produce the parent heterocycles for the dyes shown 
above (Scheme 1.21).  The 2-(2'-pyridyl)indole and 2-(2'-thiazolyl)indole based ligands were 
synthesized by a two-step Fischer synthesis (Scheme 1.21a and b, respectively).  Scheme 1.21c 
illustrates how a Negishi coupling255 was used for the synthesis of the 2-(8'-quinolyl)indole or -
azaindole.  Treatment of the product heterocycles shown in Scheme 1.21 with triphenylboron 
(1:1 ratio) in toluene afforded the boron complexes 269 - 281 in good yields.  
 
Scheme 1.21.  Two-step Fischer synthesis of a 2-(2’-pyridyl)indole ; b 2-(2’-
thiazolyl)indole; c synthesis of 2-(8’-quinolyl)indole or aza-indole via  Negishi coupling. 
a 
N
O
+
NHNH2
R2
EtOH
R2
N
H
N
N
R1 R3
R4 R
3
R4
R1
 
R2
N
H
N
R1
R3
R4
PPA or HOAc
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Scheme 1.21.  Continued. 
b 
 
NH2
2-acetylthiazole, EtOH, AcOH
HN N N
S
 
 
AcOH, ZnCl2
N
H
N
S
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X N
H
PhSO2Cl, NaOH, NBu4Br
X N
SO2Ph  
 
(i) LDA, THF, 0 °C
(ii) ZnCl2, THF, 25 °C
X N
SO2Ph
ZnCl ArBr, Pd(PPh3)2Cl2
DIBAH, THF, reflux
 
 
X N
NPhSO2
NaOH, EtOH
X N
H
N
 
 
 
6. Boryl-substituted Thienylthiazoles 
Finally, there are compounds that are even less closely related to the BODIPY core, 
formed by intramolecular B-N coordination in N-heteroaromatic systems.  This new concept is 
illustrated for the development of new electronic materials.  The interaction between the Lewis 
acid (boron) and Lewis base (nitrogen) not only constrain the π-conjugated framework in a 
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coplanar fashion, but also lower the LUMO level (Figure 1.8).  Thus, (3-boryl-2-thienyl)-2-thiazole 
282 was synthesized from (3-bromo-2-thienyl)-2-thiazole as shown in Scheme 1.22.256  
Compound 282 can easily be functionalized to the tin 283 or iodo 284 derivatives via the lithiated 
intermediates.  Lithiation occurs regioselectively at the 5-position of the thiazole ring.  
 
 
N N
N N
B B
intramolecular 
B-N coordination
coplanar !-conjugated skeleton
lower LUMO level  
Figure 1.8.  Intramolecular B-N coordination of N-heteroaromatic systems. 
 
 
 
Scheme 1.22.  Synthesis of the dimesityl-boryl substituted thienylthiazole 282. 
S S
N
Br (i) nBuLi
Et2O, - 78 °C
(ii) Mes2BF S S
N
B
MesMes
282
THF, ! 0.09
"max abs 333 nm
"max emiss 452 nm
1 or 2 eq. nBuLi
Et2O, - 78 °C
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Scheme 1.22. Continued. 
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regioselective 
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at the 5-position 
of the 
thiazole ring
 
 
 
 
The corresponding tin and iodo derivatives can be used as building blocks in metal-
catalyzed coupling reactions to prepare extended π- electron systems such as the head-to-head 
(H-H), head-to-tail (H-T), and tail-to-tail (T-T) dimers 285 - 287 (Scheme 1.23).  The dimers 
display red-shifted absorption and emission relative to the monomer.  The boryl-substituted 
thienylthiazoles 282 and 285- 287 show weak fluorescence emission in the range 452 – 492 
nm.256 
 
Scheme 1.23.  Synthesis of a, head-to-head; b, head-to-tail, and c, tail-to-tail dimers. 
a 
 
SS
N
B
Mes Mes
H-H dimer
285
THF, ! 0.06
"max abs 443 nm
"max emiss 492 nm
S S
N
B
MesMes
I
S S
N
B
MesMes
[NiBr2(PPh3)2]
Zn, Et4NI
THF, 50 °C, 24 h
284
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Scheme 1.23.  Continued. 
b 
 
SS
N
B
Mes Mes
S S
N
B
MesMes
SnBu3I
+
[Pd2(dba)3]•CHCl3
P(furyl)3
THF, reflux, 15 h
284 283  
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B
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H-T dimer
286
THF, ! 0.07
"max abs 427 nm
"max emiss 486 nm
SS
N
B
Mes Mes
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S S
N
B
MesMes
Li
S S
N
B
MesMes
T-T dimer
287
THF, ! 0.09
"max abs 414 nm
"max emiss 472 nm
SS
N
B
Mes Mes
(i) nBuLi, THF
- 78 °C to 25 °C
(ii) CuCl2
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L. Conclusion 
Applications of BODIPY dyes outnumber, by far, studies of their fundamental chemistry 
and spectroscopic properties.  This is unfortunate because they are such powerful tools for 
imaging, chemosensors, lasing materials, etc.  There would be even more applications if some 
deficiencies in the area were addressed.  For instance, there are very few water-soluble BODIPY 
dyes.  In this review we mentioned compounds 53 – 56 and 69d.  The only other examples of 
water-soluble BODIPY dyes we found were lipophilic BODIPYs made water-soluble by activation 
with a sulfonated N-hydroxysuccinimide derivative. 
 
N N
R
B
F2
NaO3S SO3Na
R = Me, 53; Et, 54; H, 56
N N
B
F2
X
X = SO3Na, 55
CH=CHSO3H, 69d  
 
One conspicuous area for further research is the design and synthesis of BODIPY 
derivatives that emit further into the near-IR.  Steps towards this can be taken by attaching 
aromatic groups, preferably with electron-donating substituents (eg 87), rigidifying their structure 
(eg 202), or producing ring-fused systems like 172.  One of the most innovative synthetic 
procedures for doing this involves condensation of BODIPY methyl substituents to give dyes 
similar to ones that Invitrogen markets such as “BODIPY 630/650” and “BODIPY 650/665”. 
 
N N
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CHCl3
! max emiss 626 nm
MeO OMe
N N
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O O
202  
CHCl3
!max emiss 654 nm  
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CH2Cl2
!max emiss 780 nm  
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Another synthetic innovation is the chlorination of certain BODIPYs to give 3,5-dichloro-
derivatives.  These products may be functionalized via Pd-mediated couplings or SNAr reactions 
to give products that tend to fluoresce at longer wavelengths.  Compounds 65 and 110d are 
examples of the products that can be formed by this approach. 
 
N N
Ar
Cl N
B
F2
65
MeOH
!max emiss 562 nm
N
B
F2
N
110d
MeOH
!max emiss 622 nm
Ph Ph
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Many papers have been published on BODIPY-like systems in which fluorine atoms on the 
BODIPY dyes are replaced by a variety of C- or O-based nucleophiles to give products F.  These 
modifications have proven useful as a means to make energy transfer systems.  Substitutions of 
this kind may alter the quantum yields and fluorescence properties of the dyes, but they do not 
tend to shift their emissions to the red.  Conversely, incorporation of a cyanide group at the 
meso-position gives a dramatic shift towards the near-IR. 
N
B
N
X X
R
F
X = alkyne, aryl, alkyl
or alkoxide
no significant red shift
N
B
N
F F
R
G
pronounced red shift
CN
 
 
Substitution of the boron atom in BODIPY dyes gives fluorescent Zn, In, and Ga 
derivatives, but other metals tend to quench the fluorescence.  Quenching in such derivatives 
presumably occurs via electron-trasnfer mechanisms involving the dyes in their excited states. 
Replacement of C-8 in the BODIPY with a nitrogen gives the so-called “AzaBODIPYs”.  
These are an extremely interesting set of dyes because of their long fluorescence emissions 
wavelength.  No water-soluble derivatives of these have been prepared, and nearly all the 
substituted compounds feature aryl groups in the 3,5-positions.  
 
azaBODIPYs
N
B
F2
N
N
Ar Ar
Ar Ar
relatively
long
wavelength 
fluorescence
emissions
 
 
Overall, an abundance of relatively straightforward applications of BODIPY dyes have 
been reported.  Some of the most significant synthetic procedures tend to be written in cryptic 
styles that are so often seen in the patent literature, but there have been some recent milestones 
in this area.  The most important future developments with respect to applications in 
biotechnology will involve synthesis of water-soluble, easily functionalized systems, particularly 
those fluorescing above 600 nm. 
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CHAPTER II 
FUNCTIONALIZED AZA-BODIPY DYES 
 
A. Introduction 
  Most fluorescence detection strategies use visible fluorophores, fluorescein being one of 
the most popular.  However, autofluorescence from the cell can often be a problem when using 
visible fluorophores, and can result in both lower sensitivity and selectivity.  “Green” 
autofluorescence of the skin and viscera, especially the gallbladder, small intestine, and bladder, 
is high when excited with blue light.257  Tissue autofluorescence can be eliminated or reduced by 
use of NIR filter set.  Imaging live cells deep in tissue is also difficult to accomplish using light 
microscopy because light scatters as it travels through tissue.  There are two main type of 
scatters: Rayleigh scattering which is the scattering of light by particles much smaller than the 
wavelength of the light, and Mie scattering which can be describes as scattering by particles 
similar to or larger than a wavelength.257 Light scatter is dependent on the wavelength of 
detection by 1/λ4.258,259 Consequently, detection at 820 nm offers a sixfold reduction in scatter 
over detection at 500 nm.  Very few biological molecules possess intrinsic fluorescence in the 
near-infrared (NIR) region of the spectrum (650-1100 nm) (Figure 2.1).  Therefore, sensitivity 
and selectivity can significantly be improved by near-infrared laser induced fluorescence 
detection.  
 
200 400 600 800 1000
Biomolecules NIR dyes
Visible Fluorophores
 
Figure 2.1. Very few biological molecules possess intrinsic fluorescence in the near-IR.  
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Due to the aforementioned factors, there is considerable interest in preparing new fluorescent 
dyes that emit towards the near-IR region. 259-262 Unfortunately, there are a very limited number 
of organic molecules that emit in this range and could be adapted to form probes for 
biomolecules. The most commonly NIR probes used in cell imaging are cyanines (Figure 2.2),263-
267; whereas oxazines and squaraines have also been used.  However, all NIR cyanine dyes 
have poor photostability, and in most cases possess low fluorescence quantum yields.  The 
highest fluorescence quantum yield for NIR cyanine dyes in water was reported to be 0.28.  
Squaraines tend to be hydrophobic, causing aggregation and problems in bioconjugation.  Thus, 
identification of stable and effective NIR probes has become urgent.   
 
 
O
NN
+
+Na-O3S
+Na-O3S
SO3
-Na+
SO3
-Na+
CO2H
IR Dye 78-CA  
Figure 2.2.  A tetra-sulfonated indocyanine dye, with a carboxylic acid that can be used for 
conjugation to biomolecules. 
 
 
  Few NIR fluorophores have been developed, and designing new NIR probes is a very 
difficult task.  An ideal NIR probe should (i) fluoresce at 700-900 nm, (ii) have a high 
fluorescence quantum yield, (iii) have a narrow excitation/emission band, (iv) have high chemical 
and photo-stabilities, (v) have low cellular toxicity, and (vi) have excellent biocompatibility.   
  BODIPY (difluoroboradiaza-s-indacene) dyes H are highly fluorescent, stable, and 
insensitive to the solvents’ polarity and pH.  BODIPYs are unusual in that they are relatively non-
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polar and are electronically neutral.  They have found widespread applications as laser dyes, 
sensors, and molecular probes that emit in the region around 520 – 600 nm.268  Modifications to 
the BODIPY core can lead to dyes that emit above 600 nm.  Such modifications include 
appending strong electron-donating groups, rigidifying substituents around the core, and 
extending the conjugation of the system. The strategy of attaching electron-donating 
substituents, however, has limitations.  For instance, amine groups make the probes sensitive to 
quenching via electron transfer to the excited state, and the fluorescence becomes pH sensitive.   
  There is a subset of BODIPY dyes that are related to the parent systems by N-for-C 
substitution at the C8-position.  These are commonly called “aza-BODIPY” dyes, and most of the 
compounds reported to date have 3,3,5,5-aryl substituents, of which the tetraphenyl system I is 
the most widely studied.  The parent heterocycle without a boron atom has been known since 
1943,269-272 but it was not until 1994 that a B-derivative was mentioned in the literature and its 
remarkable fluorescent properties were noted.273  Specifically, the tetraphenyl compound I was 
shown to emit at 695 nm (in 1,2-Me2C6H4, Φ = 0.77), ie a marked red-shift relative to other 
BODIPY dyes.  
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 To date, there have been only two deliberate attempts to further extend the emission of 
aza-BODIPY dyes into the near IR-region.  In the first, Carreira and co-workers used extended 
heterocycles to prepare constrained systems such as J; this gave molecules that emitted up to 
815 nm with enhanced quantum yields.274,275  Second, work from our laboratory focused on 
using ortho-oxygens on the 3,3-aryl substituents to constrain them giving systems K; this 
approach also shifts the fluorescence emissions to the red and increased the quantum yields.276  
Finally, when designing pH sensitive probes, O’Shea found that when 4-N,N-
dimethylaminobenzene substituents were created at the 3,3-aza-BODIPY sites in molecule L, 
then an emission at 823 nm was observed under conditions where the amine groups were not 
protonated.277 This was reported while the work described in this manuscript was in progress.   
Compound L has limited value as a potential core-structure for biomolecular probes unless 
protonated, in which case the red-shift is not observed.  Nevertheless, that observation 
supported the hypothesis we were exploring, ie that strongly electron-withdrawing or -donating 
aryl-substituents could significantly shift the emissions of aza-BODIPY dyes.   A second goal of 
this study was to prepare aza-BODIPY systems with halide substituents that could be substituted 
with “donor” fragments that absorb considerably shorter UV radiation.  In the event, both these 
goals were realized, and the data are reported here.  Specifically, a series of aza-BODIPY dyes 
288a - g, having a range of different substituted-aryl groups were prepared.  One of these 
potential “acceptor” molecules, compound 288a was elaborated into the donor-acceptor 
cassette278-280 systems 289 and 290.  Important spectral parameters for all these dyes are 
reported here. 
 
 
N
B
F2
N
N
288
R2
R1 R
1
R2
R3 R
3
cpd          R1          R2          R3
a            OMe        I              H
b            Br            OMe       H
c            H             H            OMe
d            Br            H            OMe
e            I               H            OMe
f             Br           OMe        OMe
g            Br           NMe2       OMe
ha            Br            I              H
a compound 288h could not be obtained.  Compound 293h could however be obtained.  
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1. Multiplexing and Through-bond Energy Transfer Cassettes 
  It is often desirable to simultaneously observe several fluorescently tagged components in 
a biochemical mixture, ie multiplexing.  Our group has used the concept of through-bond energy 
transfer to design novel dye cassettes for multiplexing for DNA sequencing.281  Multiplexing with 
one excitation source is, however, difficult as the sensitivity dramatically decreases with dyes 
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emitting in the red.  This is because dyes that emit near the excitation source absorb the light 
most efficiently since they have a greatest absorption at that wavelength, while the dyes that 
have red-shifted absorption absorb less light and therefore fluoresce less at the excitation 
wavelength.  To alleviate this problem, combinations of dyes that maximize FRET have been 
designed.  The efficiency of the energy transfer in FRET systems is governed by the overlap 
integral between the donor emission and the acceptor absorption.  If the overlap of the emission 
of the donor dye with the absorption of the acceptor dye is small, then the energy transfer will be 
small.  Therefore, FRET is only a partial solution. 
  Through-bond energy transfer is mechanistically different from FRET.  Notably, there is no 
known requirement for overlap of the emission of the donor fragment with the absorption of the 
acceptor part.  Thus, in appropriately designed through-bond energy transfer cassettes, a donor 
part, or parts, could absorb photons at a convenient wavelength (eg 488 nm: excitation from an 
Ar-laser), transfer the energy rapidly through the conjugated linker to the acceptor fragment that 
emits at a far longer wavelength (Figure 2.3).  The overlap between the donor emission and the 
acceptor absorbance is no longer required in through bond energy transfer cassettes.  Thus, it is 
possible to design dyes that absorb strongly at a short wavelength and emit brightly with very 
similar intensities and excellent resolution.  Coupling more than one donor in the conjugated 
system can increase the intensity of the emission from the acceptor.  In summary, both the 
resolution and fluorescence intensities obtained from several probes excited at a single 
wavelength can be potentially increased by through bond energy transfer cassettes (Figure 2.4).  
 
 
n
hv
donor acceptor
hv'
energy transfer
 
Figure 2.3.  Through-bond energy transfer cassette 
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Figure 2.4. a Idealized fluorescence emissions  from dyes used in DNA sequencing. b  An 
approximate representation of data obtained from single dyes in DNA sequencing. c  Diminished 
fluorescence intensities of the red dyes can be attributed to their lower extinction coefficients at 
the excitation wavelength, relative to the blue dyes. 
 
 
A set of four through-bond energy transfer cassettes for use in automated fluorescence detected 
DNA sequencing has already been designed in our laboratories (Figure 2.5).282  The cassettes 
feature fluorescein as a donor, and rosamines as acceptor dyes.  They were shown to emit 
strongly, with highly efficient energy transfer.  Upon excitation at 488 nm, sole fluorescence 
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typical of the acceptor was observed, proving 100% energy transfer from the donor to the 
acceptor (Figure 2.6).  Furthermore, the four cassettes were considerably more stable to 
photobleaching than fluorescein, even though they each contain a fluorescein donor. 
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Figure 2.5.  First generation of through-bond energy transfer cassettes developed for DNA 
sequencing (top), and the corresponding acceptor rosamine fragments (bottom). 
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Figure 2.6.  Fluorescence emission of the cassettes upon excitation at 488 nm. 
 
  This first generation of ET cassettes were a milestone in our research, but they were not 
very suitable for applications in biotechnology eg cellular imaging due to their poor water-
solubility.  Furthermore, probes emitting in the near-infrared region (650-850 nm) are preferred 
for cell imaging to avoid background fluorescence from flavins and other components in cell, and 
the emissions of these cassettes occurred at somewhat shorter wavelengths.  We therefore 
decided to attempt preparations of water-soluble cassettes involving aza-BODIPY acceptors.   
 
B. Results and Discussion 
1.  Synthesis of Aza-BODIPYS 288a – g 
 Synthesis of dyes 288 began with diaryl α,β-unsaturated ketones 291 (chalcones; readily 
prepared by an aldol/dehydration reaction of the corresponding benzaldehyde and 
acetophenone derivatives).  O’Shea’s modification283 of an older Rogers’ procedure was then 
used.284  Thus, Michael addition of the anion from nitromethane to the chalcones 291 gave the 
1,3-diaryl-4-nitrobutan-1-ones 292 in essentially quantitative yields after aqueous work-up; these 
were then used without further purification.  Condensation with ammonium acetate in refluxing 
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butanol gave the azadipyrromethenes 293 via a cascade of events.  Finally, complexation of the 
azadipyrromethenes with boron trifluoride gave the azaBODIPYs 288 in excellent yields.  
 
 
Scheme 2.1.  Synthesis of azaBODIPYs 288. 
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+
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R1 R2
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  Using the procedure outlined in Scheme 1, dipyrromethene intermediate 293h was only 
obtained in low yield (8%, crude) and in an impure form, so other conditions were developed 
(Scheme 2).  Variations of solvent (butanol, pentanol, hexanol, neat), ammonia source (HCONH2 
instead of NH4OAc) and heating conditions (conventional heating or microwave radiation) to 
make the reaction viable were unsuccessful.  However, 293h•HCl was obtained from the γ-
ketonitrile 7 (made from the corresponding chalcone and acetone cyanohydrin) via condensation 
with hydroxylamine hydrochloride in methanol; this is one of the procedures developed by 
Rogers’ in 1944.270,285   Surprisingly, complexation of 293h with boron trifluoride etherate did not 
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give the desired product, but instead led to a compound with two BF2 units (19F); the structure of 
this adduct was tentatively assigned as 295.  Presumably steric and/or electronic interactions 
within 293h prevented formation of the desired aza-BODIPY 288h, an observation supported by 
the fact that when the iodo groups were substituted (via Sonogashira for example) prior to 
complexation, formation of the aza-BODIPY proceeds easily and in good to excellent yield (data 
not shown). 
 
Scheme 2.2.  Synthesis of 293h from γ-ketonitrile. 
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 Compounds 288a - g have good solubilities in most organic solvents (eg chloroform, 
toluene, tetrahydrofuran).   An X-ray structure of compound 288a is shown in Figure 2.7.   
Compound 288a crystallized in the triclinic space group P-1 with two molecules in the 
asymmetric unit.   The overall conjugated nature of the chromophore was confirmed from the 
analysis of the crystal structure with comparable bond lengths (Table 2.1). 
 
 
 
Figure 2.7. Thermal ellipsoid representation of 288a.   
 
 
 
Table 2.1.  Selected bond lengths and angles for 288a. 
Bond Length / Å angle Angle / ° 
C(1) – N(2) 1.362 F(1) – B(1) – F(2) 111.6 
C(1) – N(1) 1.353 F(1) – B(1) – N(1) 110.2 
C(1) – C(2) 1.474 F(2) – B(1) – N(1) 109.9 
C(2) – C(3) 1.36 F(1) – B(1) – N(3) 108.8 
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Table 2.1. Continued.    
C(3) – C(4) 1.39 F(2) – B(1) – N(3) 110.4 
C(4) – N(1) 1.404 N(1) – B(1) – N(3) 105.8 
N(1) – B(1) 1.56 N(1) – C(1) – N(2) 125.8 
B(1) – F(1) 1.379 N(1) – C(1) – C(2) 110.9 
C(5) – N(3) 1.390 N(2) – C(1) – C(2) 123.2 
C(5) – N(2) 1.327 C(3) – C(2) – C(1) 102.7 
C(5) – C(6) 1.452 C(3) – C(2) – C(9) 127.8 
C(6) – C(7) 1.39 C(1) – C(2) – C(9) 129.4 
C(7) – C(8) 1.42 C(2) – C(3) – C(4) 112.0 
C(8) – N(3) 1.375 C(3) – C(4) – N(1) 107.8 
N(3) – B(1) 1.58 C(3) – C(4) – C(29) 126.7 
B(1) – F(2) 1.387 N(1) – C(4) – C(29) 125.4 
  
2. Spectroscopic Properties of Aza-BODIPY Derivatives 288 a – g 
 Compounds 288 were prepared mainly to facilitate syntheses of more elaborate molecules 
containing donor groups (eg 289 and 290, vide infra), consequently most of them contain 
halogen atoms.  However, this series of compounds does provide some non-systematic basis for 
comparing absorption and fluorescence properties.   
 Absorption spectra of compounds 288 show strong S0→S1 transitions with absorbance 
maxima between 650 and 798 nm (Table 2.2 and Figure 2.8a).  Entry 1 and 2 in Table 2.2 are 
literature data283 for the tetra-aryl substituted aza-BODIPYs I and M. 
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   Using these as references, the data collected on compounds 288 indicate that introduction 
of electron-donating groups onto the aryl substituents results in significant bathochromic shifts.  
The largest red-shift in the series was observed for compound 288g (entry 9) which has two 
strongly electron donating groups attached to the 3-aryl substituents in ortho- and para-positions. 
This is consistent with the idea that the aza-BODIPY core is more conjugated with electron rich 
aryl substituents, presumably due to better orbital overlap.  Comparison of molecules 288c – e 
with the rest of those in the series implies that the presence of an ortho-methoxy group on the 3-
aryl substituent correlates with a blue-shift in the absorbance, but this may be overridden by a 
strongly electron donating group in the para-position of that same aromatic ring.  Throughout, the 
extinction coefficients for these new dyes are high, in the range of 55 000 to 109 000 M-1cm-1, 
characteristic of aza-BODIPY compounds.   
 Fluorescence properties of the new dyes are also shown in Table 2.2, and the spectra are 
shown in Figure 2.8b.  Their emission maxima range from 676 to 830 nm in toluene.  Quantum 
yields for compounds in this series range from 0.07 to 0.41 in toluene.  Interestingly, the 
fluorescence quantum yields of the bromoaryl-substituted derivatives were not significantly 
altered, while the fluorescence quantum yields of the iodoaryl-substituted derivatives show a 
significant decrease.  There has been a tendency to over-generalize on the influence of some 
substituents on fluorescence, and the so-called “heavy atom effect” is a prime example of this.  
For compounds 288, bromine-containing aryl-substituents do not reduce the quantum yields to 
trivial values (eg 288b, entry 4).  The only iodinated analogs in the series, 288a and 288e, also 
have reasonable quantum yields (0.18 and 0.10, respectively, entries 3 and 7).  Most probably, 
the origins of the heavy atom effect are electron donation or acceptance from excited states of 
the chromophore, which often, but not always, occurs when heavy atoms are present.  For the 
aza-BODIPY dyes 288 the halo-substituents are isolated from the chromophore by the aryl twist.  
Consequently, the main parameter influencing the fluoresence properties of the core is the 
oxidation potentials of those aryl substituents.  This more sophisticated argument, rather than 
generalizations about “heavy atom effects”, is one advocated in other situations in several 
papers by Nagano and co-workers.286-292 
 135 
 
 
 
 
Table 2.2.  Spectroscopic properties of the Aza-BODIPY derivatives 288 a - g. 
N
B
F2
N
N
1
R2
R1 R
1
R2
R3 R
3
substn of H
by OMe:
red shift
substn of H
by OMe:
blue shift
substn of H
by OMe:
large red shift
 
entry dye λabs (nm) ε (M-1cm-1) λem.  
(nm) 
fwhma 
(nm) 
Φb 
1 B 655 79 000  676 - 0.34  
2 F 693 85 000 717 - 0.36   
3 288a 680 109 000 711 47 0.18 ± 0.01 
4 288b 702 84 120 731 30 0.42 ± 0.03 
5 288c 640 73 850 688 47 0.07 ± 0.01 
6 288d 650 55 000 694 47 0.10 ± 0.01 
7 288e 653 71 600 701 35 0.10 ± 0.01  
8 288f 692 66 200 738 50 0.20 ± 0.01 
9 288g 798 68 610 830 30 0.07 ± 0.01 
aFull width at half maximum peak height. bMeasured in 1% pyridine/toluene, Zn-phthalocyanine standard 
(Φ = 0.30 in the same solvent).   
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Figure 2.8.  a Normalized absorption and b fluorescence spectra of compounds 288a – g in 
toluene at 5 µM. 
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3. Synthesis of Through-bond Energy Transfer Cassettes 289 and 290 
 Scheme 3 shows syntheses of molecules 289 and 290 that have donor fluorescein-
derived entities attached to BODIPY cores.  These molecules were made to test their efficacy as 
energy transfer cassettes.  The difference between compounds 289 and 290 is only a carboxylic 
acid linker in the acceptor part.   Throughout this donor fragment was derived from the ethynyl 
fluorescein diacetate 296280,293 which served as a Sonogashira294 coupling partner for the aza-
BODIPYs 288a or 297, respectively.  Compound 297 was obtained via a one-pot, two step 
procedure involving deprotection and alkylation of 288a.  In the synthesis of compound 297, 
demethylation of the aza-BODIPY 288a gave an intermediate with two phenolic-OH groups.  
This was unstable to air, hence it was alkylated without isolation at that stage.  The final step in 
both syntheses was removal of the acetate groups from the fluorescein parts (potassium 
carbonate or TMSOK295); in the synthesis of compound 290 this also hydrolyzed the methyl ester 
functionality.  Overall, the synthesis of cassette 289 was reasonably straightforward.  However, 
cassette 290 was practically more difficult to prepare because of the instability of the 
intermediate mentioned above, and the need to isolate the final product via RP-HPLC.  We were 
unable to fully and properly characterize compound 290 by NMR (1H and 13C) in most organic 
solvents, including CD3CO2D and D2O, because the compound aggregated.  However, 
compound 299 was fully characterized. Synthesis of compound 290 was supported by mass 
spectrometry analysis, and UV-fluorescence properties. 
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Scheme 2.3.  a. Synthesis of cassettes 289 and b. 290. 
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Scheme 2.3.  Continued 
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Scheme 2.3.  Continued 
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Scheme 2.3.  Continued 
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4. Spectroscopic Studies of Cassettes 289 and 290 
  The absorption and emission spectra of cassettes 289 and 290 are solvent and pH 
dependent, reflecting the characteristics of the fluorescein part.  This is consistent with the 
properties of fluorescein itself.85, 296-297 Fluorescein tends to close to its lactone form at pH values 
of somewhat less than 6.5, and it is not particularly fluorescent in that state (Figure 2.9).  Such 
pH-dependencies are undesirable if these cassettes were to be used as probes for imaging 
biomolecules. 
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Figure 2.9.  pH dependency of fluorescein fluorescence quantum yield. 
 
 Preliminary investigations of the spectroscopic properties of compound 289 showed little 
to no energy transfer from the donor to the acceptor in a 1:1 mixture of THF:buffer pH 7.4 
(Figure 2.10a) ie little to no fluorescence from the aza-BODIPY (eg at 730 nm) was observed, 
and only fluorescence emission from the fluorescein was seen upon excitation of the donors at 
488 nm,.  To test if aggregation was responsible for this poor energy transfer, a concentration 
study was performed.  No significant shift could be seen for both the absorption maxima of the 
donor and acceptor at 502 and 702 nm, respectively (Figure 2.10b).  Further, the relationship 
between fluorescence intensity and concentration was essentially linear (Figure 2.10c).  
However, increasing concentrations of the non-ionic detergent Triton X-100 had significant effect 
on the system.  The absorption peak of the fluorescein diminished with increased concentration 
of Triton X-100 (Figure 2.10d), and ultimately no peak was observed.  The fluorescence 
emission of the donor showed the same tendency; no emission was observed at high 
concentration of Triton X-100 (Figure 2.10e).  On the other hand, the fluorescence emission from 
the aza-BODIPY increased with increasing concentration of Triton X-100 (Figure 2.10f).  It 
appears that in presence of the non-ionic detergent Triton X-100, the fluorescein is converted to 
its non-fluorescent lactone form.  This change (from the quinoid to the lactone form) can occur 
due to the presence of the polyoxyethylene group in Triton X-100.  It is well established that 
fluorescein dye retains its lactone form in presence of solvents having oxygen groups.  
Compound 290 showed similar results. 
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Figure 2.10.  Spectra of: a UV absorption and fluorescence spectra (excitation at 488 and 702 
nm) of 289 in 1:1 THF:buffer pH 7.4; b UV absorption of 289 with increasing concentration of 
289 in 1:1 THF:buffer pH 7.4; c fluorescence intensities (at 530 and 730 nm) versus 
concentration of compound 289 in 1:1 THF:buffer pH 7.4; d UV absorption of compound 289 in 
1:1 THF:buffer pH 7.4 with increasing amount of Triton-X 100; e fluorescence intensity of 
compound 289 upon excitation at 488 nm with increasing amount of Triton-X 100; f fluorescence 
intensity of compound 289 upon excitation at 702 nm with increasing amount of Triton-X 100. 
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Figure 2.10. Continued. 
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Figure 2.10. Continued.
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C. Conclusions 
 
 These studies show that the fluorescence emissions observed from aza-BODIPY dyes 
can be manipulated by altering the aryl-substituents.  Red-shifts in the fluorescence tend to 
correspond to strongly electron donating para-groups, at least for the 3-aryl substituent.  A series 
of seven functionalized aza-BODIPY dyes were prepared.  Of these, compound 288a proved to 
be a useful starting material for attachment of alkyne-based donor entities.  In this study, the 
donor was a fluorescein-derived alkyne.  Cassette 289 prepared from this coupling procedure 
exhibited absorption and fluorescence characteristics that were highly dependent on pH and 
solvent media.  These observations correlate with equilibria at the fluorescein part corresponding 
to lactone formation, and to solvent polarity effects that seem to be influenced by the addition of 
a non-ionic detergent.  Overall, fluorescein is probably not a good donor for cassettes designed 
for applications around physiological pH values.  Aza-BODIPY dyes have great potential 
application as biomolecular probes if they can be modified to increase solubility in aqueous 
media thereby decreasing aggregation. 
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CHAPTER III 
RING CONSTRAINED NEAR-IR AZA-BODIPY DYES 
 
A. Introduction 
Surprisingly few fluorescent probes emit in the near-IR region with high quantum yields.298   
Such compounds are valuable for intracellular imaging because autofluorescence in cells tend to 
obscure emissions at wavelengths below approximately 550 nm, but this factor becomes less of 
an issue at much longer wavelengths.  Probes that emit in the 700 – 900 nm region are, 
therefore, relatively easy to visualize inside cells. 299    Cyanine dyes are currently the most 
widely used tags for visualization in this wavelength range, but they have relatively poor 
quantum yields. 300     Thus there is need for new fluorescent probes that emit efficiently above 
700 nm.  
BODIPY dyes are popular in biotechnology because they tend to have relatively sharp 
fluorescence emission characteristics, and high quantum yields.301    However, the emission 
wavelengths of most BODIPY dyes are in the 530 – 630 nm range, and this is sub-optimal for 
intracellular or tissue imaging (vide supra).  Previous work from our group explored two 
modification strategies for shifting BODIPY-fluorescence emissions to the red (Figure 3.1a).  The 
first was to prepare “ring extended” BODIPY dyes, eg N, from heterocycles having more 
conjugated aromatic systems.302  In the second, demethylation and intramolecular cyclization of 
the BODIPY O afforded a system P wherein non-radiative loss of energy via rotation around a C-
Ar bond was prevented by B-O bond formation.303  Comparison of data presented in Figure 3.1 
for O with that for N and P indicates both strategies were effective, but still the emission 
wavelength was less than 700 nm. 
Recent contributions from O’Shea and co-workers have elegantly demonstrated that 
tetraaryl-substituted aza-BODIPY dyes, like Q (Figure 3.1b), in solution fluoresesce at 
significantly high wavelenghts than typical BODIPY systems.304,305   In an exciting development, 
Carreira et al prepared the ring-extended azaBODPIY dye R and showed it fluoresced at well 
over 740 nm.306  We were therefore motivated to prepare compound 300 and study its 
fluorescence properties to complete this intriguing correlation of structure and fluorescence 
properties. 
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Figure 3.1. Comparison of fluorescence emission wavelength maxima and quantum yields 
(both in CHCl3) for: N a “ring-extended” BODPIY; O an aryl-substituted BODIPY; P a similar, but 
constrained, aryl substituted BODIPY; Q a tetraphenyl-substituted azaBODIPY; and R a “ring 
extended” aza-BODIPY.  Compound  300 is the focus of this research project. 
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B. Results and Discussion 
1. Synthesis 
Scheme 3.1 shows the synthesis of the target aza-BODIPY 300.  Compounds 300 are 
synthesized from the corresponding ortho-substituted aza-BODIPY dyes 288c and 288d by 
demethylation of the methoxide groups with boron tribromide.  We anticipated this would lead to 
spontaneous cyclization giving the target materials 300a - b.  However, in addition to these, 
compounds corresponding to bromination of the azaBODIPY framework, ie  300c - d were also 
observed.  This is somewhat surprising since this did not occur for synthesis of P, but it is also 
potentially useful if the compounds are to be modified further.  
 
 
 
Scheme 3.1.  Synthesis of target aza-BODIPY 300. 
N
B
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N
N
Ar1 Ar
1
288c - d
BBr3, CH2Cl2, 0 to 25 °C,12 h
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300a   61 %;  Ar1 = C6H5; X
1=X2 = H
300b   36 %; Ar1 = p-BrC6H4; X
1=X2 = H
300c   41 %; Ar1 = p-BrC6H4; X
1 = H, X2 = Br
300d   21 %; Ar1 = p-BrC6H4; X
1=X2= Br
 
 
 
2. Spectroscopic Properties 
Figure 3.2, figure 3.3 and Table 3.1 compare the electronic spectral characteristics of “less 
constrained” and  “constrained” compounds 288c, 288d and 300a - d.  The constraint caused by 
forming the B-O bonds in 300 gave bathochromic shifts in both the absorption and emission 
maxima, and as much as a seven fold increase in the quantum yields.  Introduction of bromine 
substituent in 300c and 300d did not result in a pronounced quenching of the fluorescence, 
contrary to some similar systems.304 
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Figure 3.2.  Absorption (5 µM in PhMe) spectra of 288c - d and 300a - d. 
 
 
Table 3.1.  Spectroscopic properties of 288c–d and 300a–d. 
 λmax/nm 
(abs)a 
λmax/nm 
(flu)a 
fwhm/nm Φb 
288c 642 688 43 0.07 ± 0.01 
300a 728 746 36 0.51 ± 0.02 
288d 650 699 45 0.10 ± 0.01 
300b 745 760 36 0.46 
300c 747 769 38 0.35 
300d 755 776 36 0.36 
  [a] a In PhMe  [b] In 1% pyridine in PhMe, ZnPtc was used as a standard (Φ= 0.30) 
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Figure 3.3.  Fluorescence  (5 µM in PhMe) spectra of 288c - d and 300a - d. 
 
 
3. Electrochemistry 
Electrochemical studies were performed for compounds 288a (Figure 3.4) and 300a 
(Figure 3.5) using dichloromethane as solvent and tetra-n-butylammonium tetrafluoroborate 
(TBA•BF4) as supporting electrolyte; the data are summarized in Table 3.2.  Both compounds 
displayed reversible oxidation waves, with half-wave potential of + 0.528 and + 0.934 V vs NHE 
(normal hydrogen electrode) for 288a and 300a, respectively.  Reversible reduction waves with 
half-wave potentials of – 0.291 and –0.105 V vs NHE were observed for 288a and 300a, 
respectively.  Compound 288a is easier to oxidize than 300a by 406 mV.  Reduction of 288a is 
more difficult (because the HOMO-LUMO gap is bigger, see above), with the corresponding half-
wave potential being decreased by 186 mV relative to 300a.  
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Table 3.2.  Electrochemcial properties of 288c  and 300a. 
 E1/2 V vs NHE 
 bodipy-•/bodipy bodipy Bodipy/+• 
288c 0.528 - 0.291 
300a 0.934 - 0.105 
[a] The redox potentials were measured by cyclic voltammetry in CH2Cl2 , containing 0.1 M 
TBA•BF4 with a scan rate of 0.2 V/s [b] Ferrocene was used as internal reference [c] A Ag/AgCl 
was used as reference electrode, and a platinum coil served as a counter electrode. 
 
 
 
 
Figure 3.4.  Cyclic voltamogram of compound 288c. 
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Figure 3.5.  Cyclic voltamogram of compound 300a. 
 
 
4. Frontier Orbitals Calculations 
B3LYP/6-31G* calculations on compounds 288c, 300a and 300d gave low energy 
conformers that have C2 symmetry axes passing through the B- and the bridging-N-atoms 
(Figure 3.6). The HOMO-LUMO energy gaps calculated were significantly less for compound 
300a and 300d relative to 288a, corresponding to a 2.19 to 2.11 and 2.05 eV drop on cyclization 
for 300a and 300d, respectively (Table 3.3).  The dihedral angles between the aryl substituents 
and the heterocycle are almost the same, aligning them in near parallel orientations (Table 3.4). 
A crystal structure for compound 300d (Figure 3.7) as a single crystal, and the structure in the 
solid state corresponded closely with those derived from the B3LYP calculations (Table 3.5).  
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288c HOMO        288c LUMO 
 
300a HOMO        300a LUMO 
 
Figure 3.6. HOMO and LUMO for compound 288c, 300a and 300d. 
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300d HOMO        300d LUMO 
 
Figure 3.6.  Continued. 
 
 
Table 3.3. Excitation energies from B3LYP calculations. 
Comp’d Excited 
state 
Transition character ΔE (eV) 
288a 1 HOMO → LUMO 2.197 
 2 HOMO -1 → LUMO 3.066 
 3 HOMO -2 → LUMO 3.07 
    
300a 1 HOMO → LUMO 2.111 
 2 HOMO -1 → LUMO 2.854 
 3 HOMO -2 → LUMO 3.122 
    
300d 1 HOMO → LUMO 2.047 
 2 HOMO -1 → LUMO 2.734 
 3 HOMO -2 → LUMO 2.886 
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Table 3.4.  Selected parameters for compounds 288c and 300a. 
N N
N
B
O O
N N
N
B
F2
MeO OMe
1
2 2
1
3 3
1 12 2
!1
!2
!3 !4
!1
!2
!3 !4
 
 288c 300a 
Bond lengths [Å]   
B – F 1.402 - 
B – O - 1.476 
B – N 1.569 1.519 
N2 – C1 1.398 1.392 
C1 – N1 1.322 1.329 
Cphenyl – O 1.365 1.347 
   
Valence angles [°]   
F – B – N 111.6 - 
O – B – N - 106.2 
B – N2 – C1 122.4 125.9 
F – B – F 110.9 - 
O – B – O - 106.9 
C2 – N1 – C1 120.4 118.5 
O – C – C 116.6 - 
C – O – B - 116.5 
   
Torsion angles [°]   
ϕ1 133.6 161.8 
ϕ2 133.6 161.8 
ϕ3 151.6 156.3 
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Figure 3.7.  X-Ray structure of compound 300d. 
 
 
 
Table 3.5.  Comparisons of some key parameters for 300d. 
bond lengths [Å] 300d (exp) 300d (theoretical from B3YLP 
calc.) 
   
B – O1 1.474 1.472 
B – O2 1.459 1.473 
B – N1 1.529 1.519 
N2 – C1 1.341 1.328 
C1 – N1 1.381 1.388 
C3 – N1 1.357 1.354 
C1 – C5 1.447 1.441 
C5 – C4 1.380 1.398 
C4 – C3 1.429 1.434 
C4 – Br1 1.880 1.877 
O2 – C10 1.364 1.348 
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Table 3.5. Continued. 
valence angles [°]   
O1  – B – O2 107.8 107.9 
O1  – B – N1 116.2 116.3 
O1  – B – N31 106.8 106.1 
C3 – N1 – C1 110.1 110.1 
C3 – N1 – B1 122.4 122.6 
C1 – N1 – B1 125.7 125.6 
C2 – N2 – C1 117.0 118.1 
C10 – O2 – B1 114.2 115.6 
N2 – C1 – N1 123.8 123.3 
N2 – C1 – C5 127.7 128.5 
N1 – C1 – C5 108.2 107.8 
N1 – C3 – C4 106.4 106.9 
N1 – C3 – C9 117.8 116.6 
 
 
 
C. Conclusion 
In conclusion, the constrained azaBODIPYs 300 emit at longer wavelengths and with a 
higher quantum yields than comparable tetraaryl-substituted azaBODIPY dyes.  Emission 
wavelengths of 746 - 776 nm are useful for applications in biotechnology.  The azaBODIPY 
systems reported here are relatively307 easy to prepare. 
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CHAPTER IV 
SYNTHESES AND SPECTROSCOPIC PROPERTIES OF ENERGY 
TRANSFER SYSTEMS BASED ON SQUARAINES DYES* 
 
A. Introduction 
1. Squaraine Dyes 
 Squaraines are a novel class of organic dyes that are largely used for applications such as 
imaging, biological labeling, photodynamic therapy and nonlinear optics.  They belong to the 
class of polymethyne dyes with resonance- stabilized zwitterionic structures (Figure 4.1). 
 
 
N
O
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Figure 4.1.  Resonance structures of squaraine dyes. 
 
 
 Reprinted with permission from “Syntheses and spectroscopic properties of energy 
transfer systems based on squaraines” by  Guan-Sheng Jiao, Aurore Loudet, Hong Boon Lee, 
Stanislav Kalinin, Lennart B.-Å. Johansson and Kevin Burgess, 2003. Tetrahedron, 59, 3109-
3116; copyright 2003, Elsevier Limited. 
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The first synthesis of squaraine dyes can be traced back to 1965 in the report of Triebs and 
Jacob, who were examining the action of pyrroles on squaric acid (Scheme 4.1).308  Pyrroles 
reacted in a 2:1 molar ratio with squaric acid and produced an intensely colored condensation 
product.  
 
 
Scheme 4.1.  First synthesis of squaraine dyes. 
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  Squaraines are generally prepared by condensation of electron-rich aromatic or 
heterocyclic compounds such as N,N-dialkylanilines, benzothiazoles, phenols, azulenes, and 
pyrroles with squaric acid.309-311  Access to a variety of electron-rich aromatic and heterocyclic 
systems, which react with squaric acid, facilitated the design of symmetrical and unsymmetrical 
squaraine dyes with tunable optical properties.   Furthermore, incorporating strong electron 
donors or extending the conjugation of the system allowed the synthesis of a large number of 
squaraines with near-IR absorption and emission. Because they emit in the near IR, and this 
region is far removed from the fluorescence of any biomolecules, squaraine are particularly 
attractive dyes for imaging, biological imaging.312 The intense absorption and emission 
characteristic of squaraine dyes are associated with the donor-acceptor-donor type charge-
transfer interaction. 
2. “Donor acceptor” Cassettes 
 “Donor acceptor cassettes” (compounds in which a moiety absorbs at low wavelength and 
another emits at higher wavelength) based on through-space fluorescence energy transfer are 
common in biotechnology.313-319 In such compounds, the ‘donor’, harvests energy from an 
excitation source and transmits it through space, via dipole–dipole coupling, to an ‘acceptor’ that 
then fluoresces. The donor and acceptor fragments in these cassettes are connected via a non-
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conjugated linker (Figure 4.2.a). The efficiency of energy transfer in these systems depends on 
the distance between the donor and acceptor. 
 “Donor acceptor cassettes” in which the donor and acceptor fragments are 
conjugated278,320 can have profound effects on the rates of energy transfer (ET) from the donor to 
the acceptor, and the ‘apparent Stokes’ shifts’ observed (Figure 4.2.b).321 Conjugated ET 
systems of this kind have been investigated extensively in material science.322,323 Such 
compounds can absorb at short wavelength and emit efficiently at much longer wavelengths, 
and can therefore be useful in applications that involve several multiplexed dyes, excited at one 
wavelength and observed at well dispersed longer wavelengths.   Syntheses and spectral 
investigations of novel through-bond ET cassettes in which donors are directly conjugated to a 
squaraine acceptor (Figure 4.2.c) were therefore undertaken. Carbazole and similar 
heterocycles were used as donors since these absorb in the UV region at around 300 nm. 
   
 
donor acceptor
h!
h!'
energy transfer
non-conjugated linker
current cassettes for biotechnology
use through-space energy transfer
a
 
 
donor acceptor
h!
h!'
conjugated linker
energy transfer
cassettes featuring
through-bond energy transfer
b
 
 
Figure 4.2.   a) Through-space ET cassettes, b) though-bond ET cassettes, c) the acceptor 
fragments used in this study. 
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Figure 4.2.  Continued.  
 
 
B. Results and Discussion 
1. Synthesis 
 Compounds like 301 in which the squaraine fragment was formed from resorcinol 
derivatives were previously prepared in our laboratories; however, the products had low 
quantum yields.  In retrospect, this is unsurprising because the 2,6-dihydroxyl substituents 
facilitate tautomerization processes, leading to radiationless decay.324  Cassettes of type 302 
were then prepared to avoid tautomerism problems.  Quantum yields were not markedly 
increased, however, because another unfavorable characteristic comes into play for 
unsymmetrical squaraines; specifically, rotation about the bond labeled ‘a’ is facile because 
resonance favors single bond character here relative to bond ‘b’. This effect makes electronic 
transmission through the squaraine system more difficult than it would otherwise be, depressing 
the quantum yield.  Consequently, we focused on the synthesis of symmetrical squaraines 303 
and 304 incorporating 3,3-dimethylindolenine and 2-methylbenzothiazole fragments, respectively 
(Figure 4.3). 
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Figure 4.3.  Donor-acceptor cassettes in this research. 
 
 
 Scheme 4.2 describes the syntheses of the cassettes 303b. After N-alkylation of the 
iodoindolenine to give 305b, copper-mediated couplings325 were used to introduce the carbazole 
unit giving compounds 306b in moderate yield (53%). Palladium-mediated couplings to achieve 
the same result were investigated briefly, but with little success.326 Compound 306b was 
condensed with squaric acid327 to give the desired product 303b as a blue metallic solid. The 
control compound 303a was prepared via an abbreviated version of this sequence.  
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Scheme 4.2.  Synthesis of cassette 303b. 
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 Attempt to synthesize 303c eg. with phenothiazine as donor failed.  We were unable to 
successfully couple the phenothiazine to the indolenine under the conditions developed for 
cassette 303b.  An alternative approach as shown in Scheme 4.3 was then undertaken to 
synthesize cassette 309c.  It started with the synthesis of 10-(4-ethynylphenyl)-10H-
phenothiazine 312 via Sonogashira coupling between phenothiazine and 323, and subsequent 
removal of the trimethyl silyl group in 311.  Compound 313c was then obtained via another 
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Sonogashira coupling reaction with the indolenine derivative 305b.  Finally, compound 313c was 
condensed with squaric acid to give the desired compound 309c as a blue metallic solid. 
 
 
Scheme 4.3.  Synthesis of cassettes 309c. 
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Scheme 4.3. Continued. 
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Cassettes 304b-d were prepared by a post-doctoral associate in our laboratories, Dr. 
Guansheng Jiao.  They were prepared via a similar procedure (Scheme 4.4) except that a 
palladium-mediated C–N coupling was used. The most notable difference between the two 
approaches is that the metal-catalyzed reactions gave higher yields in the second sequence 
(76–90%).329 
 
 
Scheme 4.4.  Synthesis of cassettes 304b-d. 
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Scheme 4.4. Continued. 
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2. Spectroscopic Studies 
 A series of spectroscopic measurements were undertaken to test if compounds 303b and 
304b–d behave as cassettes (rather than as simple conjugated molecules) and, if so, to 
quantitate their efficiencies. First, UV spectra of the molecules were recorded. If the UV 
spectrum of a particular system resembles that which would be obtained by superimposing UV 
spectra of the corresponding discrete donor and acceptor components, then the molecule is 
behaving as a cassette. Alternatively, if the UV is different, then the compound is behaving as a 
conjugated system.  The UV spectra of compound 303b overlaid with the spectrum of carbazole 
and 303a, i.e. the donor and acceptor components, respectively is shown in Figure 4.4a. The UV 
spectrum of 303b is very close to that which would be obtained by adding the donor (carbazole) 
and acceptor (303a) components. Consequently, this molecule behaves as a cassette with non-
planar donor and acceptor systems in the ground state. Similar data were obtained for 304b–d 
indicating they all function as cassettes (Figure 4.4). 
 Quenching of the donor fluorescence is one of the criteria that define a good cassette.  If 
this quenching is complete then the ET efficiency is 100%, where: 
ETefficiency={100×[1-(fluorescence intensity of donor in cassette) / (fluorescence intensity of free 
donor)]%} 
 In our systems, the fluorescence of the free carbazole donor was so weak that accurate 
ET efficiency measurements proved to be impossible. In practice, it was also difficult to 
accurately measure the fluorescence quantum yield when exciting the donor group of the 
cassettes studied here. Thus, two important characteristics of the cassettes, ET efficiencies and 
fluorescence quantum yields, could not be measured directly. 
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 ET efficiencies were therefore estimated using a different approach to circumvent the 
experimental difficulties outlined above; this involved the following line of reasoning:  
The efficiency of ET in a cassette must be close to 100% if the fluorescence quantum yield of the 
acceptor group is the same when excited at the donor, or at the acceptor absorption; 
If the ET efficiency is 1, then the ratio of the fluorescence excitation and the UV absorption 
spectra of the cassettes should be constant over the whole spectral region; 
Fluorescence lifetimes of the cassettes 303b and 304b-d were measured upon excitation in the 
donor and acceptor regions. If the timescale of ET is 100 ps or slower, we expect to observe 
negative components in the fluorescence decay. No such component was found. It is also true 
that the average lifetimes must be longer when the donor is excited directly.  
Table 4.1 summarizes the spectroscopic properties for 303b and 304b-d.  The quantum yields 
values (0.23–0.37) show moderate fluorescence efficiencies.  Rates of ET between the donor 
and the acceptor are likely to be fast relative to any thermal energy loss, so the quantum yields 
of the cassettes when irradiated in the donor region are likely to approximate to those of the 
acceptor components within them. 
The average lifetimes are shown in Table 4.2.  Fluorescence lifetime of the squaraine acceptor 
groups was very similar irrespectively of the excitation wavelength. 
 
Table 4.1.  Spectroscopic data for the compounds 303a,b and 304b-d 
Compound λmax abs (nm) 
below 350 nm 
λmax emiss (nm) 
 
Apparent Stokes’ 
shift (nm) 
ET (%)a Φb 
303a 279, 344 637 6c - 0.23 
303b 293, 340 659 366, 319 ~100 0.31 
304a 310, 350 679 10c - 0.33 
304b 292, 339 693 401, 354 ~100 0.37 
304c 257, 315 691 434, 376 ~100 0.33 
304d 319 688 369 ~100 0.36 
   a Determined indirectly, 
   b Excited at 590 nm for 303a, b and 630 nm for 304a-d, 
   c Actual Stokes’ shift for 303a and 304a. 
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Table 4.2.  The ratios of absorptions and fluorescence excitation spectra {A(λex)/F(λex)} and the 
aerage lifetimes of the acceptor group upon excitation of the donor and the acceptors of 
cassettes 303b and 304b-d 
Compound Average A(λex)/F(λex), 
λex = 300-400 nm 
Average lifetime (ns), 
λex = 300-350 nm 
Average lifetime (ns), 
λex = 630 nm 
304b 1.03 2.78 2.60 
304c 1.33 3.04 2.83 
304d 0.88 2.95 2.79 
303b 0.99 1.56 1.46 
 
 
 
 
 
a           b 
 
Figure 4.4. (a), (c), (e) and (g) Overlaid absorption spectra of the donor fragments, the acceptor 
fragments, and the complete cassettes; all in CHCl3 solution. (b), (d), (f) and (h) Fluorescence 
spectra of the cassettes; all excited at 300 nm or 590 (630) nm in CHCl3 solution. 
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c           d 
 
 
 
 
e           f 
 
 
Figure 4.4. Continued. 
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g           h 
 
Figure 4.4. Continued. 
 
 
C. Conclusions 
 In conclusion, several cassettes based on squaraine fragments acting as acceptors (303b 
and 304b–d) were prepared.  These cassettes transfer energy very efficiently to their acceptor 
parts when irradiated in the donor absorption region (ca. 300 nm).  With respect to fluorescence 
emission, the cassettes behave like dyes with a huge Stokes’ shift, absorbing around 300 nm 
and fluorescing in the near IR region (637–693 nm).  Emission at such long wavelengths is good 
for probing biological systems which do not fluoresce in this region, i.e. DNA, RNA, the majority 
of proteins, and many other biomolecular types.  The quantum yields of the acceptors in the 
cassettes are high, and we infer that they are also high for the cassettes when irradiated in the 
donor region.  Despite these attributes, cassettes 303b and 304b–d have some disadvantages 
with respect to tagging biological molecules.  First, the donor fragments do not absorb very 
strongly, hence they cannot supply the acceptor well.  Secondly, the molecules have poor water 
solubilities and this is likely to make their conjugation to biomolecules difficult.  Our current 
research on similar ET cassettes is focused on solving these problems. 
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CHAPTER V 
CORRELATIONS OF STRUCTURE AND RATES OF ENERGY 
TRANSFER FOR THROUGH-BOND ENERGY-TRANSFER CASSETTES* 
 
A. Introduction 
A common problem in biotechnology is encountered when several biological molecules 
labeled with different fluorescent dyes are to be observed by using a single excitation 
wavelength.  A typical example is in DNA sequencing, where termination by fluorescently labeled 
dideoxy-A, -T, -G, and -C bases must be differentiated.328,329  The dye that fluoresces at the 
shortest wavelength typically has an absorption maximum wavelength, λabs max, close to that of 
the exciting source, hence it absorbs strongly and emits brightly.   Conversely, λmax for 
absorption by the "red dyes" is not close to the excitation wavelength; therefore those dyes 
harvest fewer photons and fluoresce relatively weakly.  This problem can be partially alleviated 
by using two dyes arranged to maximize Förster energy transfer (FRET).330-332  However, the 
resolution/brightness of such FRET systems is constrained by overlap of the donor emission with 
the acceptor absorption, corresponding to the overlap integral described in Förster theory.333  
Our research focuses on donor-acceptor dye cassettes that are connected via a twisted, 
but otherwise conjugated, π-electron system.  In such systems, energy transfer may occur 
through bonds as well as through space.  If through-bond energy transfer is the dominant 
mechanism, then the resolution of multiplexed through-bond energy-transfer cassettes is not 
constrained by the spectral overlap integral.  Thus, it should be possible to design brighter and 
better-resolved systems for multiplexing in biological systems.  Through-bond energy transfer 
has been extensively investigated for development of optical materials,334-337 and for 
photosynthetic models338 but, prior to our work,339-341 not for applications in biotechnology.  
Indeed, the types of linkers used in the cassettes described here (diphenylethynyl units) are 
similar to those employed in work on through-bond energy transfer in porphyrin molecular 
arrays.338  
 
*Reproduced in part with permission from “Correlations of Structure and Rates of Energy 
Transfer for Through-Bond Energy-Transfer Cassettes” by T. G. Kim, J. C. Castro, A. Loudet, J. 
G.-S. Jiao, R. M. Hochstrasser, K. Burgess, and M. R. Topp, 2006. Journal of Physical 
Chemistry A, 110, 20-27; copyright 2005, American Chemical Society. 
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B. Results and Discussion 
In this collaborative work, we sought to explore the correlation between structures and 
rates of energy transfer and fluorescence polarization for a range of through-bond energy-
transfer cassettes.  To do this, we compare the anthracene-BODIPY (BODIPY = 4,4-difluoro-
1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene) systems 314 - 322,339 for which some data 
were reported previously, with the new fluorescein-rosamine cassettes 323 - 330340. An 
important through-space energy-transfer cassette 344 was also studied for comparison.  The 
compounds 314 - 330 were prepared in our laboratories by several students.  The spectroscopic 
studies were realized in Prof. Hochstrasser’s laboratories at the University of Pennsylvania. 
1. Synthesis 
Cassettes 314 - 329 were previously prepared by others group members over the past 
years.339,340.  Cassette 330 and 331 (not studied) featuring the shortest linker between the donor 
and acceptor were prepared for this study.   
 
 
O
CO2H
OHO
ON N+
O
CO2H
OHO
ON N+
331330  
 
 
Donor Synthesis 
Fluorescein was chosen as the donor due to its favorable water-solubility, absorption 
spectrum, and high quantum yield.  5-Carboxaldehyde fluorescein diacetate 332 was used as a 
starting block in the synthesis of these “short” cassette where a phenyl group only separates the 
donor and acceptor.  Compound 332 was obtained in 4 steps from resorcinol and phthalic 
anhydride (Scheme 5.1).  First, resorcinol and phthalic anhydride were condensed in methane 
sulfonic acid to give a mixture of both isomers, 5- and 6-carboxyfluorescein 333.   The crude 
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mixture was treated with acetic anhydride to give the 5- and 6-carboxyfluorescein diacetates 
334.  The isomers were subsequently separated after reduction with sodium borohydride to the 
corresponding 5- and 6-(hydroxymethyl)fluorescein diacetate 335.  Finaly, oxidation of the 5-
isomer with PCC gave the desired 5-carboxaldehyde fluorescein diacetate 332. 
 
 
Scheme 5.1.  Synthesis of 5-carboxaldehyde fluorescein diacetate 332. 
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Synthesis of the Energy Transfer Cassettes 
The “short” cassettes were prepared by condensation of the 5-carboxaldehyde fluorescein 
diacetate 332 and the appropriate aminophenol in presence of trifluoromethane sulfonic acid, 
followed by oxidation with chloranil (Scheme 5.2 and 5.3). 8-Hydroxyjulodinone and 3-
dimethylaminophenol were thus successfully condensed to produce 330 and 331, respectively.  
Condensation of 3-aminophenol under several different conditions revealed unsuccessful (data 
not shown).  Condensation of protected 3-aminophenol derivatives was also attempted, but 
failed. 
 
 
 
Scheme 5.2.  Synthesis of cassettes 330. 
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Scheme 5.3.  Synthesis of cassette 331. 
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2. Transition Moments 
Cassettes 314 - 330 have donor and acceptor fragments linked by rigid, π-conjugated 
systems.  They are designed to have a common absorbing chromophore matched to the exciting 
laser, but different emitters.  Energy-transfer cassettes featuring fluorescein as the common 
donor and rhodamines as acceptors are commonly used in DNA sequencing.  The 
fluoresecence emission of the acceptor moieties ranges from 550 to 650 nm.  Thus, different 
DNA bases excited by the same laser can be distinguished via the visible fluorescence of 
different attached labeling agents. 
Usually, energy-transfer cassettes are selected for properties such as distinguishable 
emission (i.e., relatively narrow band) spectra, high-fluorescence quantum yields, relative ease 
of attachment to DNA strands, and not least, good photostability.  In newer applications of 
labeling cassettes, which may involve experiments in single-molecule environments such as 
probe studies of single protein molecules, molecular orientation and fluorescence polarization 
also become important.  Molecular motion and/or orientation of a probe can be sensed through 
time-resolved fluorescence polarization measurements.   
The molecules examined in this study can be divided into three groups.  In the first (Figure 
5.1), compounds 314 - 318 have a 9- or 9,10-substituted anthracene donor species, excited near 
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405 nm, which transfers energy to a fluorescent BODIPY acceptor moiety.  Most of the variation 
in this sequence involved tuning the emission of the BODIPY emitter via symmetrical structure 
modification. 
 
 
N
B
F2
N N
B
F2
N N
B
F2
N N
B
F2
N N
B
F2
N
Br Br Br Br
MeO OMe
318317316315314  
Figure 5.1.  Sequence of anthracene-BODIPY cassettes having perpendicular donor and 
acceptor transition moments. 
 
 
The S1 ↔ S0 transition moments of the two chromophores are indicated in Figure 5.2.  
The anthracene S1 ↔ S0 transition moment is directed along the axis of the phenylacetylene 
linker and perpendicular to the transition moment of the BODIPY acceptor.  These transition 
moments are, therefore, mutually perpendicular, independently of the twist angle about the linker 
axis. Rate of energy-transfer in the range of 0.42 ± 0.12 ps were found for those compounds.339 
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-O2C
aligned with the linker, 
perpendicular to each other
rate ET = 0.42 ± 0.12 ps
aligned with the linker, coaxial
rate ET ~ 200 fs
perpendicular to the linker, parallel
to each other  
Figure 5.2.  Indications of the S1 ↔ S0 transition moments in the different energy-transfer 
cassettes. 
 
 
 
The second set of molecules (compounds 319 - 322; Figure 5.3) features the same donor 
and acceptor species, except that the long axis of BODIPY is aligned with the linker.  This 
causes the transition moments (see Figure 5.2) to be mutually coaxial with the linker, again, 
independently of rotation about the linker axis.  The length of the linker was also varied in this 
sequence to investigate the effects on energy-transfer rates, but the transfer rate for this set of 
compounds was found to be too fast to be measured accurately (~200 fs). 339 
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N N
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N
319 320  
Figure 5.3.  Sequence of anthracene-BODIPY cassettes having parallel donor and 
acceptor transition moments.  
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Figure 5.3.  Continued.  
 
 
 
The third set of compounds (323 - 330), shown in Figures 5.4 and 5.5, has fluorescein 
donors and rosamine derivatives as acceptor (the difference between rhodamine and rosamine 
lies in the presence or absence of an o-carboxyl substituent on the phenyl ring).  Most of the 
cassettes in the third set, shown in Figure 5.4, have a diphenylacetylene linker, which maintains 
the spatial relationship of the donor and acceptor species and gives rise to polarized emission 
from the acceptor.  The energy-transfer times were much longer than those for compounds 314 - 
322.  Compounds 323 - 330 have in common that the donor and acceptor transition moments 
are close to mutually parallel and are perpendicular to the axis of the linker, as Figure 5.2 
indicates.  
Those compounds 323 – 327, which were designed to have a steady evolution in the 
donor-acceptor energy gap, showed an unusually similar set of donor relaxation times, in pure 
ethanol, of 6.2 ± 0.4 ps.  
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BARF-
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327  
Figure 5.4.  Sequence of fluorescein-rosamine cassettes.  All have parallel donor and 
acceptor transition moments. 
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Compounds 328 – 330, shown in Figure 5.5, were designed to investigate the effect of 
varying the length and type of the linker on energy-transfer time and polarization anisotropy.  
They showed a much greater variation in transfer time, with the most noticeable difference being 
for compound 330.  Despite having the shortest linker and parallel transition moments, 
compound 330 had a relaxation time 3 times longer than any of the other cassettes.  Compound 
331 (data not shown) showed the same behavior.  Clearly, a less efficient energy-transfer 
mechanism exists for those two compounds. 
 
 
O
OHO O
HO2C
Me2N N
+Me2
BARF-
O
OHO O
-O3S
N N+
328 329  
O
O
HO2C
HO O
N N+
CF3CO2
-
330  
Figure 5.5.  Sequence of fluorescein-rosamine cassettes with shorter linker.  All also have 
parallel donor and acceptor transition moments. 
 
 
Finally, the compounds shown above were compared to a commercial labeling cassette, 
"Big-ROX" (336, obtained from ABI), which is shown in Figure 5.6.  Although having almost the 
same donor and similar acceptor species (rhodamine vs rosamine) to the other cassettes, the 
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two components are unsymmetrically linked by a flexible, partially saturated chain.   A molecule 
of this type allows one to examine the dynamical consequences of removing the rigid linker.  
Compound 336showed by far the longest transfer time (35 ps), suggesting that this is limited by 
FRET. 
 
 
O N+N
CO2H
NH
O
O N
H
O CO2H
CO2H
O
HO
Big ROX
336  
Figure 5.6.  Commercial energy-transfer cassette Big ROX, obtained from ABI. 
 
 
3. Relaxation Times 
Time-resolved emission spectra for compound 326 could be obtained by scanning the 
gated spectrum at different delay times after irradiation.  A clear decay of the donor emission 
near 530 nm (after excitation at 405 nm) and a complementary growth of the acceptor emission 
at 640 nm was observed on the time scale of 10 ps (Figure 5.7).  Time profiles for both the donor 
and acceptor for compound 326 were also obtained by setting the detector at a particular 
wavelength while scanning the optical delay (Figure 5.8).  The donor signal decayed with a time 
constant of ~5.8 ps.   
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Figure 5.7. Sequence of gated emission spectra for compound 326 (in EtOH) following 
ultrashort-pulsed excitation at 405 nm. 
 
 
 
Figure 5.8.  Gated fluorescence time profiles at 550 nm (donor) and 610 nm (acceptor) 
following ultrashort-pulsed excitation of compound 326. 
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Table 5.1.  Emission characteristics of rigidly linked donor-acceptor cassettes (solvent 
CHCl3 for compounds 314 - 322 and ethanol for 323 - 330, unless otherwise indicated) 
Cpd no. Acceptor 
emission 
maximum (nm) 
Energy-
transfer 
time (ps) 
Acceptor 
emission 
Anisotropy r(t) 
314 515 0.4 - 0.1 
315 520 0.49 n/m 
316 545 0.55 n/m 
317 660 0.33 -  0.1 
318 690 0.47 - 0.09 
319 615 <0.2 + 0.23 
320 650 <0.2 + 0.31 
321 570 <0.2 n/m 
322 590 <0.2 + 0.22 
323 535 6 n/m 
324 580 6.8 + 0.27 
325 605 6.3 + 0.25 
326 620 5.8; 3.4 (basic 
EtOH) 
+ 0.20 
327 580 ~6 + 0.20 
328 575 4.3 + 0.19 
329 600 2.5 + 0.25 
330 600 20 + 0.20 
Big ROX 
(336) 
590 35 0 
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4. Anisotropy Measurements 
Fluorescence anisotropy allows one to correlate the energy-transfer rates between the two 
chromophores with their relative transition moment orientations.  Fluorescence anisotropy, r, can 
be found from: 
r = (I// - I⊥) / (I// + 2I⊥) 
where I// - I⊥ indicate intensity measurements parallel and perpendicular to the incident 
polarization, respectively. Ideal values of r are +0.4 for parallel and -0.2 for perpendicular. 
Of all the samples studied (14 out of 18), only the commercial sample, compound 336 
where the donor and acceptor chromophores are linked by a long flexible chain, showed 
unpolarized acceptor emission despite strong polarization of the donor moiety (Table 5.1).   
The behavior of the anthracene-BODIPY cassettes, for which the sequence 314 - 318 
show perpendicular polarizations and sequence 319 - 322 show parallel polarizations, has 
already been reviewed.  We report here for the first time that all of compounds 323 - 330 also 
show parallel polarizations.  Figure 5.9 shows the situation for compound 314.  During the rapid 
transfer process, the anisotropy quickly adopts a value of r(t) near -0.1, which remains constant 
during the 5-ps time scale of the scan.  The negative anisotropy indicated a perpendicular 
orientation of the donor and acceptor transition moments.  
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Figure 5.9.  Polarized time profiles of compound 314 in chloroform following excitation at 
405 nm.  Signals monitored at 550 nm, on the BODIPY fluorescence. 
 
 
 
The time profile of compound 325 monitored at 610 nm is shown in Figure 5.10.  The 
fluorescence shows a positive anisotropy, decaying from the vicinity of + 0.33 (overlapping donor 
emission) to ~ +0.20, indicating a parallel orientation of the transition moments.  
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Figure 5.10.  Polarized time profiles of compound 325 in ethanol following excitation at 
495 nm.  Signals monitored at 610 nm, on the rosamine fluorescence. 
 
 
 
For reference, measurements following direct excitation of the acceptor species in 
compound 325 (exc ~ 530 nm) (Figure 5.10) showed a relatively slow depolarization, consistent 
with a diffusion-limited relaxation time (by extrapolation) on the order of 150-250 ps. Thus, any 
time-dependent change in the anisotropy on the time scale <20 ps, following donor excitation, is 
due to donor-acceptor energy transfer.  
 
C. Conclusions 
Comparison of the series 314 - 318 and 323 - 327 shows no systematic correlation of the 
transfer rate with the nature of the acceptor, despite the differences in donor-acceptor energy 
gap.  This also argues against the Förster mechanism, which depends somewhat critically on the 
overlap integral of the donor emission and acceptor absorption spectra, given by the above 
equation. 
Experiments with cassettes having reduced donor-acceptor distances (327, 328, 330) also 
showed no significant increase in transfer rates, as would be predicted from Förster theory.  On 
the contrary, results obtained for compound 330 showed that, when the linker is reduced to a 
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single carboxylated phenyl group, the transfer rate is much reduced.  This indicates a significant 
reduction in the amount of coupling of the two chromophores, despite their continued parallel 
arrangement, which is currently unexplained.  Similar variation of the donor-acceptor transfer 
distances in compounds 319 - 322 also did not reveal any correlations between the rates and the 
separation.  In those cases, the transfer rates were faster than the experiments could reliably 
resolve (i.e., more than 30× faster than that for the similar fluorescein-rhodamine cases) and, 
again, not predicted by Förster theory.  The donor and acceptor transition moments are both 
aligned with the linker axis, which is the case that clearly optimizes the transfer rates. 
Fragment compounds were also synthesized, such as a fluorescein type of donor and 
several acceptors of the type seen in cassettes 323 - 327. Calculations of the spectral overlap 
integrals between a given donor and several different acceptors show a variation of up to a 
factor of >2 for different cassettes, the maximum overlap being achieved for cassette 324. If 
Förster transfer were significant, one would expect a similar variation in the transfer rates, which 
was not actually observed. Also, given the r-6 dependence of the Förster integral, one could 
expect a strong dependence on the separation of the two chromophores, which again, we do not 
see.  Therefore, we conclude that Förster transfer is unlikely to represent the main mechanism 
for energy transfer in most of the cassettes shown here.  Of all the synthetic cassettes in this 
study, just one, compound 330, shows a slow energy transfer more consistent with a Förster 
type of mechanism. 
The decay times of 328 and 329 were somewhat shorter than those of 323 - 327, but 
within the variation observed in different solvents.  Also, fluorescence polarization 
measurements clearly showed that the transition moment of the acceptor rosamine species 
remained parallel to that of the donor, indicating a canceling twist induced by the biphenyl linker.  
The surprise was with compound 330 (and a similar compound 331 not shown here), where the 
energy-transfer time increased to around 20 ps (i.e., nearly an order of magnitude slower than 
328 and 329). Note that, in compound 330, the donor-acceptor separation is the closest for this 
entire family of molecules (323 - 330), and the polarization experiments again showed that the 
transition moments remain parallel.  Despite the reduction in the physical distance between the 
chromophores, the coupling is significantly weaker. This behavior is consistent with through-
bond energy transfer, which is influenced by the nature of the linker bonds intermediate between 
the donor and acceptor moieties.338,342 
Finally, compound 336, the commercial sample "Big-ROX", which contains flexibly linked 
fluorescein and rhodamine chromophores, shows a relaxation time nearly an order of magnitude 
longer than that for the other cassettes 323 - 329.  This is a case that more clearly reflects 
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through-space (FRET) as opposed to through-bond transfer.  This is different behavior from 
compound 330, which also shows slow energy transfer, but both the donor and acceptor 
emissions are polarized. 
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CHAPTER VI 
DESIGN AND SYNTHESIS OF FLUORESCENT CASSETTES BASED 
ON DIKETOPYRROLOPYRROLE 
 
A. Introduction 
1. DNA Sequencing: The State of The Art 
In 1975, Maxam and Gilbert devised the first method for sequencing DNA fragments.343 
This method is reliable for sequencing up to ~250-300 nucleotides at a time; both single-
stranded (ss) and double-stranded (ds) DNA can be sequenced. This technique involves the 
chemical cleavage of four samples of an end-labeled DNA restriction fragment at different 
specific nucleotides. The resulting fragments are separated by gel electrophoresis and the 
labeled fragments are detected by autoradiography. 
In 1977, Sanger and his colleagues developed a second sequencing method, which now 
is more widely used.344  The Sanger method or “dideoxy sequencing”, involves use of 2,3-
dideoxynucleotidetriphosphates (ddNTPs). It is based on the ability of ddNTPs to terminate 
primer extension reactions catalyzed by a DNA polymerase due to their lack of 3-hydroxyl 
groups. 
In a typical experiment, four separate reactions are performed, each containing primer, 
DNA template, polymerase, and the four deoxynucleotides (dNTPs). Addition of a different 
ddNTP to each reaction produces a nested set of oligonucleotides, each terminating with the 
specific ddNTP present in the reaction, that are then analyzed by gel electrophoresis (5’ end-
labelled with 32P or [α35S]dATP are commonly used). Further elaboration of the Sanger method 
came with the replacement of radioactive nucleotides by fluorescent dyes, which can either be 
attached to the primer or to the terminating fragments.345,346  In the dye-primer technology, four 
reactions can be set up and run in adjacent lanes, the sequencing primer having a fluorescent 
label. In the dye terminator chemistry, each of the ddNTPs has a different fluorescent label so 
that all four can be run in the same lane and distinguished by the wavelength at which they 
fluorescense. Four-color sequencing requires distinct emission maxima of the fluorophores, 
criterion that is met by the dyes (FAM, 5-carboxyfluorescein; JOE, 2’,7’-dimethoxy-4’,5’-dichloro-
6-carboxyfluorescein; TAMRA, N,N,N’,N’-tetramethyl-6-carboxyrhodamine; ROX, 6-carboxy-X-
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rhodamine) currently used. Unfortunately these dyes do not have equal absorbance at any 
wavelength; rhodamine dye-labeled primers exhibit weaker signals than those labeled with 
fluorescein (Figure 6.1). To compensate this difference, more DNA template or multiple lasers 
must be used in the reactions run with rhodamine dye-labeled primers. 
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Figure 6.1. Fluorescence intensities of JOE, ROX, FAM and TAMRA excited at 488 nm. 
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In 1995, Ju et al. introduced energy transfer (ET) primers, which are far superior labels for 
DNA sequencing.347  They have strong absorption at a common laser wavelength, high acceptor 
fluorescence emission at distinctive wavelength, and same relative electrophoretic mobility shift 
of the DNA fragments. Commonly, These primers carry a fluorescein derivative at the 5’ end as 
a donor, and other fluorescein and rhodamine derivatives as acceptors within the primer 
sequence, on a thymidine residue. Energy (from an excitation source) is transmitted through 
space, via dipole-dipole coupling, from the donor to the acceptor that then fluoresces. Energy 
transfer from the donor (fluorescein) to the acceptor (rhodamine) leads to a more efficient 
excitation of the acceptor dyes than direct excitation by the laser, resulting in exceptional 
sensitivity and signal strengths several fold greater than those obtained with conventional single-
dye labeled molecules. In these cassettes, the donor and acceptor are connected via a non-
conjugated linker (Figure 6.2). 
 
 
donor acceptor
non-conjugated linker
h!
h!'
energy transfer
 
 
donor acceptor
conjugated linker
h!
h!'
energy transfer
n
 
 
Figure 6.2.  Through-space energy transfer cassettes (top), through-bond energy 
transfer cassettes (bottom) 
 
 
However, through-space fluorescence ET does not solve the problem of resolution and 
intensity because the emission spectra of the donor dye must overlap with the absorption 
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spectra of the acceptor dye for ET to occur. However through-bond energy transfer (Figure 6.2) 
should allow for better resolution and intensities as demonstrated in Figure 6.3 since overlap of 
the donor fluorescence with the acceptor absorption is not required for ET.  
 
 
 
Figure 6.3.  Fluorescence intensities of ideal sequencing dyes: resolved and intense. 
 
 
2. Diketopyrrolopyrrole (DPP) Dyes348  
DPP as Pigments 
1,4-Diketo-3,6-diarylpyrrolo[3,4-c]pyrroles, also called DPP is one of the most recent 
addition to the class of high performance pigments.  The first synthesis of the DPP chromophore 
was reported in 1974 by Farnum, who while attempting to synthesize 2-azetinones 338 isolated 
a small amount of the diphenyl DPP derivative 337 (Scheme 6.1).348  The underlying DPP 
chromophoric system bears strong structural resemblance to many well-known pigments, such 
as indigos, isoindolinones, epindolindione and quinacridones (Figure 6.4). 
Despite their low molecular masses, the diaryl DPP pigments are highly insoluble and 
remarkably resistant to chemicals and heat.  These properties can be attributed to the presence 
of strong intermolecular bonding forces e.g., H-bonding, van der Waal’s contact, π - π 
interactions between molecular planes. 
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Scheme 6.1.   First report of DPP. 
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Figure 6.4. Structural analogy of DPP with commercial pigments. 
 
 
 
Syntheses, Mechanism of Formation and Reactivity of the DPP Chromophoric System 
In the original publication, Farnum postulated that the formation of the DPP 337 
proceeded via an oxidative dimerization.  In 1988, Iqbal and coworkers carefully reinvestigated 
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the Reformatsky route: synthesis of crucial intermediates and crossing experiments using two 
different benzonitriles strongly supported the formation of an intermediate lactam, and a new 
mechanism involving a pyrrolinone ester as the crucial intermediate was postulated.349  
However, the commercial viability of this process was hampered by the low yields of DPP 
formation (<30%).  Continued search for alternative approaches to the DPP system led to the 
discovery of the elegant synthesis shown in Scheme 6.2.349  Symmetrical DPP derivatives e.g. 
compounds bearing identical substituents at the 3- and 6- positions are obtained by 
condensation of succinic ester with 2 molar equivalents of nitriles in the presence of a strong and 
sterically hindered base.350  The first step in the process presumably lead to the formation of the 
pyrroline-carboxylate ester 3, which after deprotonation, reacts with a second equivalent of nitrile 
to give the final product. 
 
 
 
Scheme 6.2.  Synthesis of symmetrical DPP via the succinic route  
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Asymmetrically substituted DPPs can be obtained from the pyrrolinone ester 340 with 
another benzonitrile in presence of a strong base such as sodium tert-butoxide as shown in 
Scheme 6.3.350-353   
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Scheme 6.3.  Synthesis of unsymmetrical DPP  
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Although a number of modified methods have been reported, most of them suffer from low 
yield, high temperature and very long reaction times.  Very recently, microwave assisted 
synthesis of DPPs was elaborated and allowed preparation of the compounds in higher yields 
and much shorter reaction times (10 min only).354  The experimental procedure simply called for 
grinding and mixing ethyl bromoacetate, benzonitrile and zinc-copper couple.  The reaction 
proceeded efficiently for moderate electron-donating substituted benzonitriles, but did not work 
for electron-withdrawing or strong electron-donating substituted benzonitriles. 
  
 
 
197 
 
HN
NH
O
O
EFG
X
NFG
E+
Nu-
 
Figure 6.5.  Centres of potential chemical reactivity. 
 
 
There are several centres of reactivity in the DPP chromophoric system (Figure 6.5).355 
Appropriately substituted aryl groups could undergo diverse electrophilic and nucleophilic 
reactions.  The bicyclic lactam chromophore which incorporates three different functional groups, 
is also susceptible to chemical transformations.  Synthetic efforts have focused essentially on 
electrophilic aromatic substitution, N-substitution and nucleophilic transformations of the 
carbonyl group without incurring concomitant rupture of the heterocyclic nucleus (Scheme 6.4). 
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Scheme 6.4.  Examples of product that can be obtained by direct chemical 
transformations of diphenyl DPP. 
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N, N’- Unsubstituted DPP find commercial application as red pigments because of their 
low solubility in most common solvents. N, N’- disubstitution prevents the formation of 
intermolecular hydrogen-bonding, and thus increases the solubility of DPP derivatives in organic 
solvents. N, N’- disubstituted DPP derivatives can be prepared by condensation of 
diketofurofurane with anilines (Scheme 6.5a), by oxidative dimerization of β-ketoamides 
(Scheme 6.5b) or by direct N-arylation or N-alkylation of the amide (Scheme 6.5c).  In contrat to 
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N-alkylation, N-arylation of amides required highly electron deficient aryl electrophiles such as 1-
fluoro-2,4-dinitrobenzene, and necessitates reaction times of several days.  2,3,6-Triaryl-DPPs 
can be obtained from acylation of ethyl 2-aryl-4,5-dihydro-5-oxopyrrole-3-carboxylates with N-
arylbenzimidoyl chlorides in the presence of a strong base (Scheme 6a) or by reaction of 
benzonitrile under basic conditions with 1,2-diaryl-4,5- dihydro-5-oxopyrrole-3-carboxylates 
(Scheme 6.6b).356 
 
 
Scheme 6.5.  Synthesis of N,N’-disubstituted DPP dyes. 
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Scheme 6.6.  Synthesis of trisubstituted DPP dyes. 
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Spectral Properties 
The characteristic physical properties of DPP 337 are the high melting point (> 350°C), 
low solubility (< 110 mgL-1 in DMF at 25°C) and an absorption in the visible region with a molar 
extinction coefficient of 33,000.  In solution, DPP 337 gives a yellow fluorescing solution, 
whereas in the solid state it is a vivid red. Table 6.1 shows the absorption maxima (λmax) and 
the ε values of differently substituted DPPs measured in solution, as well as the absorption 
maxima in the solid state. All aryl DPP pigments investigated exhibited a bathochromic shift (shift 
to longer wavelength) of the maximum absorption in solution. In the solid state, however, the 
absorption maxima depend strongly on the substituents and their position on the aromatic rings. 
Meta- substituted DPPs often show a blue shift (entries 1,2 vs. 3), while para- substituted DPPs 
experience a red shift of the wavelength of maximum absorption (entries 4,5 vs. 3). The large 
bathochromic shift of the λmax in the solid state compared to that in solution is due to the strong 
intermolecular interactions, i.e. the hydrogen bonding, π-stacking and van der Waals interactions 
in the solid state.  
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Table 6.1.  Physical properties of some DPP pigments. 
 
 
 
 
 
Entry R Shade λmax (nm) 
in solution 
λmax (nm) 
in solid 
state 
Δλmax εmax 
1 m-CF3 Orange-
yellow 
509 518 9 21500 
2 m-Cl Orange 512 528 16 27000 
3 H Yellow-red 504 538 34 33000 
4 p-Br Blue-red 515 555 40 35000 
5 p-NMe2 Violet-blue 554 603 51 81500 
 
 
 
DPP pigments fluoresce in solution.  The Stokes shifts are in the range 10-15 nm and the 
fluorescence quantum yields ca. 60%.  Through N- substitution, both the solubility and the 
Stokes shift can be increased  
 
R'
N
N
R'
O
O
R
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R = H; Me
R' = H; 4-tBu; 3,5-tBu; 2-Me
!max flu = 509-528 nm
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B. Results and Discussion 
 DPP belong to the most recently developed classes of technical pigments. Its major 
application is in the painting and plastic industry.  To date, only three “water-soluble” DPPs have 
been made, but no UV and fluorescence studies have been realized on these compounds.  
However, the spectroscopic data reported on the pigment make this compound attractive for the 
purpose of our research project. We propose here to turn this pigment into a dye and to use it for 
fluorescence applications. In particular, DPP could be used as a donor in the cassette for DNA 
sequencing due to its absorption around 500 nm.  Our strategy toward this challenging objective 
is to introduce water-solubilizing group on the nitrogen of the pyrrolinone or on the aromatic 
rings.  N-Alkylation will also contribute to increase the solubility of these compounds by 
preventing the formation of intermolecular hydrogen bonds.  
1. Synthesis of N-alkylated DPP 
Synthesis of DPPs Derivatives 
A short series of DPPs 342a - c was synthesized from benzonitriles and diethyl succinate 
in presence of potassium tert-butoxide in tert-butanol (Scheme 6.7).  In a first time, the 
benzonitrile derivatives were treated with the base in freshly distilled tert-butanol, and heated to 
reflux.  Then, to this solution diethyl succinate was added dropwise.  The products, isolated by 
filtration, were obtained in poor yields (4 – 11 %).   
 
 
 
Scheme 6.7.  Synthesis of DPPs derivatives. 
R
CN
CO2Et
EtO2C
+
KOtBu, tBuOH
reflux,
R
HN NH
R
O
O
342
R = H,a;  Cl,b; Br, c
4 - 11 %  
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N,N-Dialkylation of DPPs 
Several attempts to alkylate DPP 342a or 342c were made, but none revealed successful.  
Alternative approaches were therefore undertaken.  These involved condensation of an amine 
with β-diketones or diketofurofurane as outlined in Scheme 6.5a and b.  The synthesis of the 
corresponding β-diketones and diketofurofuran are described in Scheme 6.8 and 6.9, 
respectively. β-Ketoesters 343 were obtained by reaction of ethyl acetate and benzoyl chlorides 
in presence of LDA in ether and base.  Next, a modified procedure of the Knorr oxidative 
coupling of the β-ketoesters,357 using NaOEt and iodine, afforded the 1,4-diketones 344 
(Scheme 6.8).  Diketofurofurans 345 were obtained by refluxing the corresponding 1,4-diketones 
in tert-butanol in presence of potassium tert-butoxide (Scheme 6.9). 
 
 
 
Scheme 6.8.  Synthesis of β-diketones 
Ar Cl
O
+
O
O LDA
THF, -78 °C Ar OEt
O O
343  
Ar OEt
O O
(i) Na, EtOH
(ii) I2, Et2O, THF
Ar OEt
O O
EtO
O
Ar
O
344
Ar =  p-BrC6H4  
 
 
 
Scheme 6.9.  Synthesis of diketofurofuranes.  
Ar OEt
O O
EtO
O
Ar
O
KOtBu, tBuOH
O O
Ar
ArO
O
345
Ar = p-BrC6H4  
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Finally, condensation of amines (alkyl or aryl) with either 344 or 345 should have given the 
corresponding DPP derivatives.  However, no product could be obtained although several 
conditions were attempted.  The fact that no product was obtained was most likely due to a bad 
choice of amines; the latter used not being reactive enough.  Also, it has been shown that this 
kind of reaction requires very long reaction time and maybe the reactions were not run for long 
enough at that time. 
In situ Synthesis of N,N’-Disubtituted Symmetrical DPPs 
 While the methodology described for the synthesis of N-alkylated DPP uses harsh 
conditions, we have elaborated a new route, easier and more convenient, toward the synthesis 
of N-alkylated DPP.  
As shown in Scheme 6.10, the synthesis of symmetrical DPP 347 started with 
condensation of 4-bromobenzonitrile with diethyl succinate in presence of sodium tert-butoxide, 
followed by alkylation in situ with tert-butyl bromoacetate to yield the DPP 346. Subsequent 
deprotection of the tert-butyl ester groups delivered the targeted compound 347 in clean manner 
with good overall yield.  
 
 
 
Scheme 6.10. Synthesis of symmetrical DPP 347. 
CN
Br
EtO2C
CO2Et Br CO2tBu
+
(i) Na, tBuOH, 2h, 100 °C
, 45 min, 100 °C(ii)
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Scheme 6.10. Continued.  
N N
CO2tBu
tBuO2C
O
O
Br
Br
95% TFA, 2.5% (iPr)3SiH
2.5% H2O, 25 °C, 1h
346  
N N
CO2H
HO2C
O
O
Br
Br
347  
 
   
 
 
Unsymmetrical DPP 
Unsymmetrical DPP could also be obtained with the same procedure; only 2 different 
benzonitriles were mixed with diethyl succinate. However this method leads to a mixture of 
symmetrical and unsymmetrical DPPs.  
On the other hand, reaction of a pyrrolinone moiety 349 (obtained by condensation of 
diethyl benzoylsuccinate with ammonium acetate) with a benzonitrile derivative (Scheme 6.11), 
represents a clean access to unsymmetrical DPP. 
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Scheme 6.11. Synthesis of the pyrrolinone 349. 
O
CO2Et
Br CO2Et
O
CO2Et
CO2Et
K2CO3, NaI
2 h,  65 °C
80-90%
+
348  
 
HN
O
CO2Et
NH3.CH3COOH, glacial acetic acid
reflux, 16 h, 70%
349  
 
 
 
Subsequent reaction of the pyrrolinone 349 with 4-bromobenzonitrile in presence of 
sodium tert-butoxide, followed by aklylation in situ with tert-butyl bromoacetate afforded the 
unsymmetrical DPP 350 in a good yield (Scheme 6.12). Subsequent Sonogashira coupling with 
Boc protected propargyl amine, followed by removal of the tert-butyl ester and Boc groups finally 
afforded the unsymmetrical DPP 352 (Scheme 6.12).  
 
 
 
Scheme 6.12. Synthesis of unsymmetrical DPP 352. 
HN
O
CO2Et
CN
Br
+
(i) Na, tBuOH, 1h, 100 °C
(ii) BrCH2CO2tBu, 45 min, 100 °C
70 %
349  
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Scheme 6.12. Continued. 
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2. UV and Fluorescence Studies  
Table 6.2, Figure 6.6 and Figure 6.7 show UV and fluorescence data for the symmetrical 
DPP 347, and the unsymmetrical DPPs 352, and 353 in aqueous sodium bicarbonate solution.  
Compound 353  was obtained by cleavage of the tert-butyl group in compound 350. 
 
 
 
Table 6. 2.  Spectroscopic data for the compounds 347, 352, and 353. 
compound 
λmax 
abs (nm) 
λmax emis (nm) (excited at 
the λmax abs )  
347 466 528 
352 466 531 
353 462 519 
 
 
 
 
Figure 6.6.  Normalized UV Absorption of DPP 347, 351 and 352 in NaHCO3. 
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Figure 6.7.  Normalized Fluorescence Emission of DPP 347, 352 and 353 in NaHCO3. 
 
 
 
From these results, we concluded than DPP dyes could act as a donor in cassette for 
DNA sequencing, due to its absorption close to the wavelength used in argon laser (488 nm). 
Introduction of the propargyl amine moiety in an attempt to extent the conjugation (352) and thus 
displace the maximum absorption wavelength toward longer wavelength only gave a small red 
shift suggesting that the diketopyrrolopyrrole core is the component to be modified in the dye in 
order to change its physical properties.   
Thus, the properties of the DPP derived dyes could be tuned to longer wavelengths by 
introducing a more constraint, rigid system.  Polycyclic systems such as S, T and U from 2-
cyano-benzoic methyl ester and 2-nitro benzonitrile could be near – IR derivatives of DPPs. We 
have also considered the synthesis of aza-DPP V but condensation of the corresponding oxo-
dihydro-pyrazole with 4-bromobenzonitrile failed to produce the pyrazolone V due to the lower 
reactivity of the pyrazole toward nucleophilic attack. 
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3. DPP-based Cassettes 
Synthesis of DPP based cassettes was undertaken in order to improve the λ maximum 
absorption (from 466 nm to 488 nm) and the molar extinction coefficient ε of DPP.  Fluorescein 
and naphthofluorescein were chosen as acceptor due to their relatively high absorptivity, and 
good water solubility. 
Dibromo-DPP was first synthesized following the previously described procedure.  
Subsequent Sonogashira coupling with trimethylsilylacetylene, followed by TBAF removal of the 
TMS group yielded diacetylene derivative DPP 355. Attachment of the acceptor, 5-
bromofluorescein diacetate and 5-bromonaphtofluorescein diacetate, was accomplished using 
Sonogashira coupling (Scheme 6.13). 
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O
Br
HO O
CO2H
5-bromo naphtofluorescein
!abs  602 nm
!flu  666 nm
O
Br
OHO
CO2H
5-bromofluorescein
!abs  492 nm
!flu  518 nm  
 
 
 
Scheme 6.13. Synthesis of bis-ethynyl DPP 355. 
N N
Br
CO2tBu
tBuO2C
Br
O
O H
TMS
Pd(PPh3)4
CuI, Et3N
MePH, 85 °C, 3h
+
346  
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Scheme 6.13. Continued.  
N N
CO2tBu
tBuO2C
O
O
TMS
TMS
(i) TBAF, CH2Cl2, -78 °C, 5 min
(ii) AcOH
354  
 
NN
tBuO2C
CO2tBu
O
O
H
H
355  
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Scheme 6.14.  Synthesis of bis-fluoresceindiacetate-DPP cassette 356. 
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Scheme 6.15.  Synthesis of bis-naphthofluoresceindiactetate-DPP cassette 357. 
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 The final cassettes could be obtained by simultaneous removal of the acetate and the tert-
butyl groups.     
 
C. Conclusion 
An efficient route (two steps, one pot reaction) to N,N-disubstituted DPP was designed 
and used to produce compound 346 on a large scale. N-Alkylation not only increased the 
solubility of the DPP derivatives prepared, but also provided an easy access to a linker for 
attachment to biomolecules by deprotection of the tert-butyl functionality.  Unsymmetrical DPPs 
352 and 353 were also prepared and studied.  DPPs 347, 352 and 353 represent some of the 
few water-soluble DPPs.  As illustrated with the preparation of cassettes 356 and 357, 
compound 346 is a useful synthon for the preparation of through-bond energy-transfer cassette 
via Palladium mediated cross-coupling. However, because of their low extinction coefficient and 
low fluorescence intensity in aqueous media, we decided to stop this project and focus on 
different dyes more suitable for DNA sequencing and/or cell imaging.  
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CHAPTER VII 
OUTLOOK AND CONCLUSION 
 
A. Outlook 
   
Designing new near-IR dyes consists of a lot of trial-error and is a very challenging task as 
it is hard to predict their quantum yields and extinction coefficients.  Aza-BODIPYs have 
potential as biomolecular probes since they emit around 700 nm and above.  However, as 
illustrated in Chapter II, a lot remains to be done to increase their water-solubilities, and reduce 
their overall hydrophobicity. There is therefore a need to design new water-soluble near-IR 
dyes.  Cyanines dyes are the most common near-IR, but their have low quantum yield in water, 
and they are not ideal for single molecule detection.  
 
1. Water-soluble Near-IR Dyes Based on Diketopyrrolopyrroles (DPP) Dyes 
Although our first attempt to use DPPs in through-bond energy transfer cassettes failed, a 
recent report on near-IR DPPs358 prompted our interest again. DPPs, as mentioned in the 
previous chapter, are highly insoluble in most organic solvents due to the network of hydrogen 
bonds they form with each other.  By N-alkylation, their solubility can significantly be increased 
by suppressing the formation of these hydrogen bonds.  Similarly, activation of the carbonyl 
groups, followed by reaction with nucleophile can be used to increase the solubilities of DPPs, 
but often, this only led to monosubstitution or to ring opening. 359,360   Daltrozzo and coworkers, 
have, however, recently reported the synthesis of disubstituted near-IR DPP dyes, by 
condensation of DPP with heteroarylacetonitriles in an excess of POCl3, followed by 
complexation with BF3•OEt2 or BPh2Cl.360  The new dyes thus formed emitted at 773 and 831 
nm, with high quantum yield ( 0.59 and 0.53) and high extinction coefficient.  Inspired by this 
work, we want to investigate the ability of these new dyes to act as acceptor in through-bond 
energy transfer cassettes.  To be used as bio-molecular probes, cassettes must be water-
soluble, and have a handle to attach to biomolecules.  The absorption and fluorescence 
emission of fluorescein being pH dependent, we propose to use a BODIPY dye as donor.  Our 
group has recently developed a methodology to synthesize sulfonated BODIPY dyes; however, it 
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appears that those dyes are not very stable.  Therefore, we need to design new water-soluble 
dyes.  
Triton X-100, the surfactant used to increase the solubility of our cassettes and/or dyes, is 
nothing else than a phenyl polyethylene glycol derivative.  Therefore, we envisage use of the 
polyethylene glycol motif as our solubilizing group. In addition to increasing water-solubilities of 
our dyes, introducing triethylene glycol chains instead of sulfonic acids should greatly increase 
the ease of purification. 
 There are several ways to introduce a polyethylene glycol chain onto a BODIPY core.  
The first one is the substitution of the F-atoms with polyethylene glycol (Scheme 7.1).  The 
second way is nucleophilic substitution onto 3,5-dichloroBODIPY.  Scheme 7.1 describes the 
synthesis of B-alkoxides derivatives 358 from triethylene glycol (358a) or allyl alcohol (358b).  
Allyl alcohol is chosen because a handle to attach to biomolecules could be easily obtained via 
ozonolysis. The thio-ether BODIPY could be obtained following the procedure developed by 
Biellmann and co-workers.361 
 
 
 
Scheme 7.1.  Synthesis of a, a water-soluble donor; and b, a donor bearing a handle. 
NH
(i) Et2O
(ii) CSCl2 in MePh, 0 °C, 10 min
(iii) 10 % aq. MeOH, 25 °C, 30 min NH HN
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N N
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 Scheme 7.2 shows the synthesis of an alternative water-soluble donor 360 bearing both 
a handle and a triethylene glycol motif.  It could be synthesized via nucleophilic substitution at 
the 3- and 5-positions of the dichloro-BODIPY 360.  A meso-thio-ether BODIPY is illustrated in 
this scheme to be later used in a Liebeskind cross-coupling, but a functionalized aryl group at 
the meso position could also be used.  Similarly, the symmetrical BODIPYs 361 could be 
obtained by nucleophilic substitution with 2-mercaptoacetic acid as shown in Scheme 7.3. 
Further treatment of 361 with 2-amino-2-(hydroxymethyl)propane-1,3-diol could provide the poly-
ol 362 (Scheme 7.3).  The Liebeskind cross-coupling involves the coupling of a boronic acid with 
a thioether under neutral conditions to form a new C-C bond (Scheme 7.4).   
 
 
 
 
Scheme 7.2.  Alternative route to a water-soluble donor bearing a handle.  
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Scheme 7.3.  Synthesis of a poly-ol BODIPY.  
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Scheme 7.4.  The Liebeskind-Srögl cross-coupling. 
R1 SR' + R2 B(OH)2
Cu(I)OCOR
cat. Pd
R1 R2 + Cu SR' +
R
O
B(OH)2
O
 
 
 
 
 
Synthesis of the cassette 
Synthesis of our first target is described in Scheme 7.5. In the first step, the dibromo-DPP 
has to be prepared.  This will be achieved by condensation of 4-bromobenzonitrile with diethyl 
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succinate in presence of a strong base.  Next, condensation of 2-(pyridin-2-yl)acetonitrile in 
presence of POCl3 with 363 will provide compound 364.  The latter can then be converted to the 
boronic acid 365 and coupled to any donor described above via the Liebeskind-Srögl cross-
coupling to form 366 which upon complexation with BF3•OEt2 will afford the target compound 
367.362-365  Upon excitation at 498 nm, emission at around 780 nm should be observed.  
Compound 367 is an illustrative example of cassettes that could be obtained via this route. 
 
 
 
 
 
Scheme 7.5.  Synthesis of a near-IR DPP-BODIPY based cassette. 
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Scheme 7.5. Continued. 
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2. Water-soluble cassettes based on aza-BODIPY 
As mentioned earlier, aza-BODIPY dyes tend to aggregate in aqueous solution or polar 
solvents in general.  Therefore, there is a need to increases their solubility while trying to 
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maintain their interesting properties,e.g. NIR absorption and emission, good quantum yields.  In 
his latest work, Carreira reported that aryl groups at the 3,3-positions were required to form the 
dye, without them, no product could be obtained.  The 5-position could however be altered.  
Thus, a 3,3-diaryl-5,5-dialky azaBODIPY dye 234 was synthesized.  Introduction of alkyls groups 
resulted only in a small blue shift of both the absorption and emission relative to 236. 
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"max emiss 752 nm  
 
 
 
Therefore, we propose to synthesize the furan-based aza-BODIPY dye 368.  Compound 
368 is particularly interesting as it easily allows introduction of carboxylic acid group onto the 
aza-BODIPY core via ozonolysis.  Compound 368 could be prepared via the classical route from 
2-furaldehyde and 4-iodoacetophenone.  Compound 369 is an example of near-IR cassette that 
could be prepared from 368 via the Liebeskind cross-coupling.  A bis-sulfonated BODIPY is 
shown in this case as a donor, but any of the BODIPYs mentioned above could be used as well.  
The synthesis of the cassette is shown in Scheme 7.6.  
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Scheme 7.6.  Synthesis of a cassette via the Liebeskind- Srögl cross-coupling reaction. 
N
B
F2
N
N
I I
O O
N
B
F2
N
N
(HO)2B B(OH)2
O O
 
 
+
N
B
F2
N
N
(HO)2B B(OH)2
O O
N N
SMe
B
F2
HO3S SO3H
Pd2(dba)3
TFP, CuTC
THF, 55 °C
 
 
 
 
 224 
 
 
Scheme 7.6. Continued. 
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B. Conclusion 
 
A series of near-infrared aza-BODIPY dyes have been synthesized, and their 
spectroscopic properties measured.  Through-bond energy transfer cassettes featuring two 
fluorescein units as donor, and an aza-BODIPY dye as acceptor, were then synthesized and 
their preliminary spectroscopic properties examined.  For both cassettes, little to no energy 
transfer was observed in buffer pH 7.4.  Addition of the non-ionic surfactant Triton X-100 (5%) to 
buffer pH 7.4 resulted in an increased energy transfer from the donor to the acceptor upon 
excitation at 488 nm.  Cassettes 289 and 290, although emitting near-IR are really not ideal for 
cell imaging.  The combination of a fluorescein moiety as a donor with an aza-BODIPY as the 
acceptor, appeared to be a poor choice as they are of opposite nature (hydrophobic acceptor 
and hydrophilic, pH dependent donor).  A lot remain to be done to make aza-BODIPY dyes 
useful for cell imaging. 
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Novels near-infrared aza-BODIPYs 300 were synthesized via a one-pot, two steps 
reaction. Upon demethylation, and intermolecular cyclization onto the B-atom, a ~ 100 nm red-
shift of both the absorption and fluorescence emission maxima could be observed.  Furthermore, 
as much as a seven fold increase in the fluorescence quantum yield was obtained upon 
cyclization. Electrochemical studies were realized for the first time on aza-BODIPY 288a and 
300a.  Both compounds displayed a reversible oxidation and reduction waves. 
Through-bond energy transfer cassettes 303 and 304 featuring a squaraine as the 
acceptor have been synthesized and their spectroscopic properties studied.  Efficient energy 
transfer was observed for those cassettes upon excitation of the donor (ca. 300 nm).  Although 
compounds 303 and 304 fluoresced brightly in the near-IR region, their lack of handle to attach 
to biomolecules and their poor water-solubilities made them unsuitable for cell imaging.  
In Chapter III, our collaborative work with Dr Hochstraser found no systematic correlation 
of the transfer rate with the nature of the acceptor.  No correlation was found either between the 
rates and the distance separating the donor and acceptor. Looking at the transition moments of 
the donor and acceptor,a general trend was observed for each series.  When the transition 
moments of the donor and acceptor were aligned with the linker, and coaxial, fast energy 
transfer was observed (~ 200 fs).  When the transition moments were aligned with the linker, but 
perpendicular, the observed rate of energy transfer was 0.42 ps.  For parallel transition 
moments, perpendicular to the linker, the rate of energy transfer was around 6 ps with the 
exception of compound 330 for which the transfer rate was much reduced (20 ps).  
Finally, we investigated the use of DPP (diketo-pyrrolopyrolle) pigment as a potential 
donor for through-bond energy transfer cassette. A convenient route to N,N-alkylated DPP was 
designed and allowed preparation of compund 346  in good yield on a large scale.  This 
compund was a useful synthon for the preparation of cassette 356 and 357.  Three water-soluble 
DPPs, whom two of them were unsymmetrical were also prepared.  The new DPP dyes thus 
prepared showed weak fluorescence emission and poor extinction coefficient.  For these 
reasons, this project was stopped. 
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APPENDIX A 
EXPERIMENTAL DATA FOR CHAPTER II 
 
General Experimental Procedures.   
All chemicals were obtained from commercial suppliers and used without further purification.  
Thin layer chromatography was performed using silica gel 60F254 flash. Chromatography on 
silica gel was performed using a forced flow of the indicated solvent on EM reagents silica gel 60 
(230-400 mesh).  The solvents were dried/degassed by passing them down an alumina column.  
1H and 13C NMR spectra were recorded on an Inova Instrument at 500 MHz (1H), 125 MHz (13C).  
11B and 19F NMR spectra were recorded on a Inova 400 Broad Band instrument at 128 MHz 
(11B) and 376 MHz (19F).  NMR chemical shifts are expressed in ppm relative to internal solvent 
peaks (CDCl3: 7.27 ppm for 1H and 77.0 ppm for 13C; DMSO-d6: 2.50 ppm for 1H and 39.5 ppm 
for 13C; CD3OD: 3.30 ppm for 1H and 49.0 ppm for 13C) and coupling constants were measured 
in Hz.  For 11B NMR, BF3.OEt2 has been used as an external reference; similarly, CFCl3 was 
used as an external standard for the 19F spectra. 
UV spectra were recorded in 1 cm path length quartz cuvettes on a Cary 100 Bio UV-Visible 
spectrophotometer at 5 µM.  Fluorescence emission spectra were recorded in 1 cm path length 
quartz cuvettes on a Photon Counting Spectrofluorometer PC1 SSI instrument equipped with an 
R928P photomultiplier tube which is sensitive up to ~ 850-900 nm.  Fluorescence spectra were 
recorded at concentrations between 1 and 5 µM.  Fluorescence quantum yield measurements 
were performed on the same instrument.  The slit width was 0.5 nm for both excitation and 
emission.  Relative quantum efficiencies of fluorescence of BODIPY derivatives were obtained 
by comparing the areas under the corrected emission spectrum of the test sample in 1% pyridine 
in toluene with that of a solution of zinc phthalocyanine, which has a quantum efficiency of 0.30 
according to the literature.1  Non-degassed, spectroscopic grade toluene and a 10 mm quartz 
cuvette were used.  Dilute solutions (0.01<A<0.05) were used to minimize reabsorption effects.  
The excitation wavelength was 671 nm for both compound 4 and 1, and the reference. 
Quantum yields were determined using the equation (1):2 
 
equation (1)  ΦX = Φst (IX/Ist) (Ast/AX)(ηX2/ηst2) 
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Where Φst is the reported quantum yield of the standard, I is the integrated emission spectra, 
A is the absorbance at the excitation wavelength and η is the refractive index of the solvent used 
(η=1 if same solvent). X subscript denotes unknown, and st denotes standard. 
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1-(4-Iodophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one (291a). 3,4 
 
 
 
 
 
4-Methoxybenzaldehyde (5.53 g, 0.04 mol), 4-iodoacetophenone (10.00 g, 0.04 mol) and 
potassium hydroxide (0.16 g, 4.06 mmol) were dissolved in methanol / H2O (1:1 v/v, 120 mL) 
and stirred under reflux for 12 h. During the course of the reaction, the product precipitated from 
the reaction mixture.  After cooling, the reaction mixture was filtered and washed with methanol 
to give the product as a white solid (11.35 g, 77%), m.p. (non corrected) 162.2-163.3 °C.  δH (500 
MHz, CDCl3): 7.84 (d, J= 8.1 Hz, 2H), 7.78 (d, J= 15.6 Hz, 1H), 7.71 (d, J= 8.1 Hz, 2H), 7.59 (d, 
J= 8.3 Hz, 2H), 7.33 (d, J= 15.6 Hz, 1H), 6.93 (d, J= 8.3 Hz, 2H), 3.85 (s, 3H);  δC (125 MHz, 
CDCl3): 189.6, 161.8, 145.2, 137.8, 137.7, 130.3, 129.8, 127.3, 118.9, 114.4, 100.3, 55.4;  m/z 
(ESI): theoretical mass (M+H)+: 365.00; found : 365.01. 
 
 
 
 
 
 
 
 
O
MeO I
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1H NMR for compound 291a (500 MHz, CDCl3) 
 
 
 
 
13C NMR for compound 291a (125 MHz, CDCl3) 
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3-(4-Bromophenyl)-1-(4-methoxyphenyl)prop-2-en-1-one (291b). 5 
 
 
 
 
 
4-Bromobenzaldehyde (5.00 g, 0.027 mol), 4-methoxyacetophenone (3.22 g, 0.027 mol) and 
potassium hydroxide (0.108 g, 2.7 mmol) were dissolved in ethanol (30 mL) and stirred at room 
temperature for 12 h.  The product which precipitated upon formation was filtered and washed 
with ethanol and water.  The titled product was obtained as a white solid (7.3 g, 85 %), m.p. (non 
corrected) 149-150 ° C.  δH (500 MHz, CDCl3): 8.04 (d, J= 8.8 Hz, 2H), 7.73 (d, J= 15.6 Hz, 1H), 
7.49-7.55 (m, 5 H), 6.99 (d, J= 8.8 Hz, 2H), 3.89 (s, 3H);  δC (125 MHz, CDCl3): 188.3, 163.5, 
142.4, 133.9, 132.1, 130.8, 130.7, 129.7, 124.5, 122.3, 113.8, 55.5;  m/z (ESI): theoretical mass 
(M+H)+: 317.01; found : 317.02-319.02 (Br isotope). 
 
 
 
 
 
 
 
 
 
 
 
O
Br OMe
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1H NMR for compound 291b (500 MHz, CDCl3) 
 
 
 
 
 
13C NMR for compound 291b (125 MHz, CDCl3) 
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(E)-1-(2-Methoxyphenyl)-3-phenylprop-2-en-1-one (291c). 6-8 
 
 
 
 
 
1-(2-Methoxyphenyl)-3-phenyl-2-propene-1-one was prepared according to the reported 
procedure.  The chalcone was obtained as a yellow oil (2.9 g, 60% yield). δH (500 MHz, CDCl3): 
3.89 (s, 3H), 6.99 (d, J= 8.3 Hz, 1H ), 7.04 (td, J= 7.6 Hz. J= 0.9 Hz, 1H), 7.38-7.42 (m, 5H), 7.47 
(td, J= 7.3 Hz, J= 1.7 Hz, 1H), 7.57-7.59 (m, 2H), 7.63-7.66 (m. 2H); δC (125 MHz, CDCl3): 192.7, 
157.9, 142.9, 134.9, 132.7, 130.1, 130.1, 129.0, 128.7, 128.2, 126.8, 120.5, 111.4, 55.5; m/z 
(ESI): theoretical mass (M+H)+: 239.1072; found : 239.1139 
 
 
 
 
 
 
 
 
 
 
 
 
O OMe
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1H NMR for compound 291c (500 MHz, CDCl3). 
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13C NMR for compound 291c (500 MHz, CDCl3) 
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3-(4-Bromophenyl)-1-(2-methoxyphenyl)prop-2-en-1-one (291d). 
 
  
 
 
A solution of acetophenone (3.20 g, 0.027 mol) in ethanol (27 mL) was added gradually to 
an aqueous solution of 10% KOH (80 mL) at 0 °C.  After stirring for 30 min, 4-
bromobenzaldehyde (5.00 g, 0.027 mol) was added to the solution and stirred at 0 °C for an 
additional 15 min.  The reaction mixture was then allowed to warm up to room temperature and 
stirred for 12h.  The product precipitated from the reaction mixture over the course of the 
reaction.  It was filtered and washed with water to afford the desired product as a white solid 
(8.05 g, 94 %).  Both isomers (E) and (Z) were obtained.  δH (500 MHz, CDCl3): 7.64 (dd, J= 7.6 
Hz, J= 1.9 Hz, 1H), 7.58-7.45 (m, 6H), 7.38 (d, J= 15.8 Hz, 1H), 7.05 (td, J= 7.6 Hz. J= 0.9 Hz, 
1H), 7.01 (d, J= 8.3 Hz, 1H), 3.91 (s, 3H);  δC (125 MHz, CDCl3): 192.6, 158.1, 142.1, 141.6, 
134.1, 133.1, 132.2, 132.1, 130.4, 129.7, 129.0, 127.5, 125.7, 124.4, 120.8, 111.6, 55.57;  m/z 
(HR-ESI): theoretical mass (M+H)+: 317.0099; found : 317.0231-319.0198 (Br isotope).  
O OMe
Br
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1H NMR for compound 291d (500 MHz, CDCl3) 
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13C NMR for compound 291d (125 MHz, CDCl3) 
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(E)-3-(4-iodophenyl)-1-(2-methoxyphenyl)prop-2-en-1-one (291e). 
 
 
 
 
 
A solution of 2-methoxyacetophenone (1.43 g, 0.011 mol) in ethanol (11 mL) was added 
gradually to an aqueous solution of 10% KOH (32 mL) at 0 °C.  After stirring for 30 min, 4-
iodobenzaldehyde (2.0 g, 0.009 mol) was added to the solution and stirred at 0 °C for an 
additional 15 min.  The reaction mixture was then allowed to warm up to room temperature and 
stirred for 12h.  The product precipitated from the reaction mixture over the course of the 
reaction.  It was filtered and washed with water to afford the desired product as a white solid (2.8 
g, 85%). δH (500MHz, CDCl3): 7.74 (d, J = 8.3 Hz, 2H), 7.64 (dd, J = 7.6 Hz, J = 1.7 Hz, 1H), 
7.56 – 7.37 (m, 3H), 7.32 (d, J = 8.3 Hz, 2H ), 7.05 (td, J = 7.6 Hz, J = 1 Hz, 1H ), 7.01 (d, J = 8.3 
Hz, 1H), 3.91 (s, 3H);  δC (125MHz, CDCl3): 192.5, 158.1, 141.6, 138.0, 134.6, 133.1, 130.4, 
129.8, 129.0, 127.8, 120.8, 111.6, 96.4, 55.7. 
O OMe
I
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1H NMR for compound 291e (500 MHz, CDCl3) 
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13C NMR for compound 291e (125 MHz, CDCl3) 
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3-(4-Bromophenyl)-1-(2,4-dimethoxyphenyl)prop-2-en-1-one (291f). 9,10 
 
 
 
 
 
A solution of 2,4-dimethoxyacetophenone (1.95 g, 0.011 mol) in ethanol (11 mL) was added 
gradually to an aqueous solution of 10% KOH (32 mL) at 0 °C.  After stirring for 30 min, 4-
bromobenzaldehyde (2.00 g, 0.011 mol) was added to the solution and stirred at 0 °C for an 
additional 15 min.  The reaction mixture was then allowed to warm up to room temperature and 
stirred for 12h.  The product precipitated from the reaction mixture over the course of the 
reaction.  It was filtered and washed with water to afford the desired product as a white solid (2.8 
g, 73%).  δH (500 MHz, CDCl3): 7.77 (d, J= 8.8 Hz, 1H), 7.44-7.62 (m, 6H), 6.57 (dd, J= 8.8 Hz, 
J= 2.4 Hz, 1H), 6.50 (d, J= 2.2 Hz, 1H), 3.88 (s, 3H), 3.91 (s, 3H);  δC (125 MHz, CDCl3): 190.0, 
164.3, 160.4, 140.3, 134.4, 132.9, 131.9, 129.6, 127.7, 124.0, 121.9, 105.2, 98.6, 55.7, 55.5;  
m/z (HR-ESI): theoretical mass (M+Li)+: 353.0365; found : 353.0384-355.0366 (Br isotope). 
 
 
 
 
 
 
 
 
O OMe
Br OMe
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1H NMR for compound 291f (500 MHz, CDCl3). 
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13C NMR for compound 291f (125 MHz, CDCl3). 
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(E)-3-(4-Bromophenyl)-1-(4-(dimethylamino)-2-methoxyphenyl)prop-2-
en-1-one (291g). 
 
 
 
 
 
NaOH (776mg, 19.4mmol) was added to a solution of bromobenzaldehyde (1.44g, 7.8mmol) 
and 1-(4-dimethylamino-2-methoxyphenyl)ethanone (1.5g, 7.8mmol) in 20 mL MeOH. The 
reaction mixture was stirred at room temperature for 24h. The solid was collected on a filter and 
washed with cold MeOH to afford the title compound (2.5 g, 89%) as a light yellow solid.  δH 
(500MHz, CDCl3): 7.81 (d, J = 8.9 Hz, 1H), 7.62 (m, 2H), 7.45 (m, 4H), 6.32 (dd, J = 8.9 Hz, J= 
2.4 Hz, 1H ), 6.09 (d, J = 2.4 Hz, 1H), 3.91 (s, 3H), 3.05 (s, 6H);  δC (125MHz, CDCl3): 188.4, 
161.3, 154.8, 139.0, 135.0, 133.3, 131.9, 129.5, 128.4, 123.5, 116.8, 104.7, 94.0, 55.5, 40.1;  
m/z (HR-ESI) theoretical mass (M+Li)+ C18H18BrLiNO2 366.0681; found 366.0584. 
O OMe
Br NMe2
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1H NMR for compound 291g (500 MHz, CDCl3). 
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13C NMR for compound 291g (125 MHz, CDCl3). 
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(E)-3-(4-bromophenyl)-1-(4-iodophenyl)prop-2-en-1-one (291h).11 
 
 
 
 
 
4-Bromobenzaldehyde (20.0 g, 0.11 mol), 4-iodoacetophenone (26.6 g, 0.11 mol) and 
sodium hydroxide (0.432 g, 0.01 mol) were dissolved in a 1:1 mixture of methanol:water (400 
mL)  and stirred under reflux for 12 h.  After cooling to room temperature, the product was 
filtered and washed with methanol.  The title product was obtained as a white solid (42.7 g, 
96%).  δH (500 MHz, CDCl3): 7.88 (d, J= 8.6 Hz, 2H), 7.75 (d, J= 15 Hz, 2H), 7.73 (d, J= 8.6 Hz, 
2H), 7.51 (d, J= 8.6 Hz, 2H), 7.45 (d, J= 15 Hz, 2H);  δC (125 MHz, CDCl3): 189.4, 143.9, 137.9, 
137.2, 133.6, 132.3, 129.9, 129.8, 125.1, 121.9, 100.8. 
O
Br I
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1H NMR for compound 291h (500 MHz, CDCl3) 
 
 
 
 
 
 
13C NMR for compound 291h (125 MHz, CDCl3) 
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General Procedure For The Synthesis of Michael Adduct 292a – g 
 
A solution of chalcone (8.5 mmol), nitromethane (170 mmol) and KOH (1.7 mmol) in ethanol 
(8.5 mL) was heated at reflux for 12 h.  After cooling to room temperature, the solvent was 
removed in vacuo and the oily residue obtained was extracted twice with ethyl acetate.  The 
combined organic layers were washed with brine, dried over sodium sulfate and concentrated to 
give the target compound as a yellow solid in quantitative yield. 
 
 
1-(4-iodophenyl)-3-(4-methoxyphenyl)-4-nitrobutan-1-one (292a). 
 
  
 
 
 
δH (500 MHz, CDCl3): 7.82 (d, J= 8.3 Hz, 2H), 7.61 (d, J= 8.3 Hz, 2H), 7.18 (d, J= 8.8 Hz, 
2H), 6.86 (d, J= 8.8 Hz, 2H), 4.78 (ddAB system, J= 12.5 Hz, J= 6.8 Hz, 1H), 4.64 (ddAB system, 
J=12.5 Hz, J=7.8 Hz, 1H), 4.15 (apparent quint, J=7.1 Hz, 1H), 3.77 (s, 3H), 3.37 (ddAB system, J= 
7.3 Hz, J= 1.2 Hz, 2H);  δC (125 MHz, CDCl3):196.3, 159.1, 138.0, 135.6, 130.7, 129.3, 128.4, 
114.4, 101.6, 79.7, 55.2, 41.5, 38.5;  m/z (APCI): theoretical mass (M)+: 425.01; found : 425.1. 
O
O2N
MeO I
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1H NMR for compound 292a (500 MHz, CDCl3) 
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13C NMR for compound 292a (125 MHz, CDCl3) 
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3-(4-Bromophenyl)-1-(4-methoxyphenyl)-4-nitrobutan-1-one (292b).   
 
 
 
 
 
δH (500 MHz, CDCl3): 7.89 (d, J= 8.8 Hz, 2H), 7.45 (d, J= 8.5 Hz, 2H), 7.17 (d, J= 8.5 Hz, 
2H), 6.93 (d, J=8.8 Hz, 2H), 4.8 (ddAB system, J= 12.5 Hz, J= 6.1 Hz, 1H), 4.65 (ddAB system, J= 12.5 
Hz, J= 8.3 Hz, 1H), 4.19 (apparent quint, J= 7.1 Hz, 1H), 3.87 (s, 3H), 3.37 (2 coalesced ddAB 
system, J= 17.6 Hz, J= 6.6 Hz, 2H);  δC (125 MHz, CDCl3):194.9, 163.9, 138.2, 132.1, 130.3, 129.2, 
129.2, 121.7, 113.9, 79.3, 55.5, 40.8, 38.8;  m/z (APCI): theoretical mass (M)+: 377.02; found : 
377.9-379.9 (Br isotope) 
O
Br OMe
O2N
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1H NMR for compound 292b (500 MHz, CDCl3) 
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13C NMR for compound 292b  (125 MHz, CDCl3). 
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1-(2-methoxyphenyl)-4-nitro-3-phenylbutan-1-one (292c).   
 
 
 
 
 
 δH (500 MHz, CDCl3): 7.62 (dd, J= 7.8 Hz, J= 1.9 Hz, 1H), 7.48 (td, J= 7.3 Hz, J= 1.9 Hz, 
1H), 7.34-7.30 (m, 2H), 7.25-7.24 (m, 3H), 7.00-6.96 (m, 2H), 4.8 (dd, J= 1.2 Hz, J= 7.6 Hz, 1H), 
4.65 (dd, J= 8.3 Hz, J= 1.2 Hz, 1H), 4.18 (quint, J= 7.1 Hz, 1H), 3.89 (s, 3H), 3.46 (dd, J= 2.9 Hz, 
J= 3.7 Hz, 2H);  δC (125 MHz, CDCl3): 198.9, 158.6, 139.4, 134.0, 130.4, 128.8, 127.6, 127.5, 
127.4, 120.8, 111.5, 79.9, 55.5, 46.7, 39.7; m/z (HR-ESI): theoretical mass (M+H)+: 300.1236; 
found : 300.1237. 
O
O2N
OMe
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1H NMR for compound 292c (500 MHz, CDCl3) 
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13C NMR for compound 292c (125 MHz, CDCl3) 
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3-(4-Bromophenyl)-1-(2-methoxyphenyl)-4-nitrobutan-1-one (292d) 
 
 
 
 
 
δH (500 MHz, CDCl3): 7.64 (dd, J= 7.6 Hz, J= 1.7 Hz, 1H), 7.49 (td, J= 7.6 Hz, J= 1.7 Hz, 
1H), 7.45 (d, J= 8.5 Hz, 2H), 7.14 (d, J= 8.5 Hz, 2H), 7.00-6.97 (m, 2H), 4.78 (ddAB system, J= 12.5 
Hz, J= 6.3 Hz, 1H), 4.62 (ddAB system, J= 12.5 Hz, J= 8.3 Hz, 1H), 4.16 (apparent quint, J= 6.8 Hz, 
1H), 3.91 (s, 3H), 3.42 (dd, J= 6.8 Hz, J= 1.7 Hz, 2H);  δC (125 MHz, CDCl3): 158.5, 138.4, 134.1, 
131.8, 130.3, 129.2, 127.0, 121.3, 120.7, 111.4, 79.4, 55.3, 46.4, 39.0 (signal for CO missing); 
m/z (HR-ESI): theoretical mass (M+Li)+: 384.0423; found : 384.0429-386.0451 (Br isotope). 
O
O2N
Br
OMe
  
282 
 
 
1H NMR for compound 292d (500 MHz, CDCl3) 
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13C NMR for compound 292d (125 MHz, CDCl3) 
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3-(4-Iodophenyl)-1-(2-methoxyphenyl)-4-nitrobutan-1-one (292e). 
 
 
 
 
 
δH (500MHz, CDCl3): 7.66 – 7.63 (m, 3H), 7.50 (2 touching dd, J = 7.3 Hz, J = 1.9 Hz, 1H ), 
7.02 (d, J = 8.3 Hz, 2H), 6.98 (t, J = 8.3 Hz, 2H), 4.78 (m, 1H), 4.62 (m, 1H), 4.12 (m, 1H), 3.90 
(s, 3H), 3.42 (m, 2H);  δC (125MHz, CDCl3): 158.6, 139.2, 137.9, 134.2, 130.5, 129.5, 127.1, 
120.8, 111.5, 93.1, 79.5, 55.5, 46.5, 39.3 (C for carbonyl group not seen). 
O
O2N
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1H NMR for compound 292e (500 MHz, CDCl3) 
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13C NMR for compound 292e (125 MHz, CDCl3) 
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3-(4-Bromophenyl)-1-(2,4-dimethoxyphenyl)-4-nitrobutan-1-one (292f) 
 
 
 
 
 
δH (500 MHz, CDCl3): 7.76 (d, J= 8.8 Hz, 1H), 7.44 (d, J= 8.5 Hz, 2H), 7.14 (d, J= 8.5 Hz, 
2H), 6.51 (dd, J= 8.8 Hz, J= 2.4 Hz, 1H), 6.45 (d, J= 2.2 Hz, 1H), 4.77 (ddAB system, J= 12.4 Hz, J= 
6.3 Hz, 1H), 4.61 (ddAB system, J= 12.4 Hz, J= 8.8 Hz, 1H), 4.13 (apparent quint, J= 7.1 Hz, 1H), 
3.87 (s, 3H), 3.85 (s, 3H), 3.39 (ddAB system, J= 17.6 Hz, J= 6.6 Hz, 1H), 3.34 (ddAB system, J= 17.6 
Hz, J= 7.6 Hz, 1H) ;  δC (125 MHz, CDCl3): 196.0, 164.9, 160.8, 138.8, 132.9, 131.9, 129.2, 
121.4, 119.9, 105.4, 98.2, 79.6, 55.5, 55.4, 46.4, 39.2;  m/z (HR-ESI): theoretical mass (M+Li)+: 
414.0528; found : 414.0537-416.0497 (Br isotope). 
 
 
 
 
 
 
 
 
 
 
 
O
O2N
Br OMe
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1H NMR for compound 292f (500 MHz, CDCl3) 
 
 
 
  
289 
 
 
13C NMR for compound 292f (125 MHz, CDCl3) 
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3-(4-bromophenyl)-1-(4-(dimethylamino)-2-methoxyphenyl)-4-
nitrobutan-1-one (292g).  
 
 
 
  
 
δH (500MHz, CDCl3): 7.75 (d, J = 8.9 Hz, 1H), 7.41 (m, 2H), 7.13 (m, 2H), 6.26 (dd, J = 8.9, 
J= 2.3 Hz, 1H), 6.00 (d, J = 2.3 Hz, 1H), 4.78 (ddAB system, J= 12.7 Hz, J= 5.8 Hz, 1H), 4.58 (ddAB 
system, J= 12.7 Hz, J= 9.1 Hz, 1H), 4.12 (m, 1H), 3.86 (s, 3H), 3.34 (ddAB system, J= 17.0 Hz, J= 6.3 
Hz, 1H), 3.26 (ddAB system, J= 17.0 Hz, J= 8.0 Hz, 1H), 3.03 (s, 6H);  δC (125MHz, CDCl3): 194.7, 
161.5, 155.1, 139.3, 132.8, 131.9, 129.3, 121.2, 114.8, 104.6, 93.3, 79.7, 55.1, 46.2, 40.1, 39.4. 
O
O2N
Br
OMe
NMe2
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1H NMR for compound 292g (500 MHz, CDCl3) 
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13C NMR for compound 292g (125 MHz, CDCl3) 
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2-(4-Bromophenyl)-4-(4-iodophenyl)-4-oxobutanenitrile (294). 
 
 
 
 
 
6 mL of a solution of 10% sodium carbonate was added to a solution of (E)-3-(4-
bromophenyl)-1-(4-iodophenyl)prop-2-en-1-one 292h (1.0 g, 2.42 mmol) and acetone 
cyanohydrin (0.5 g, 6.05 mmol) in acetone (20 mL).  After refluxing for 12h, the reaction mixture 
allowed to cool to room temperature.  The content of the flask was poured into an Erlenmeyer, 
and water was added to induce the separation of the product.  Compound 7 was obtained as a 
yellow powder in 75 % yield (0.805 g).  δH (500 MHz, CDCl3): 7.82 (d, J= 8.6 Hz, 2H), 7.59 (d, J= 
8.6 Hz, 2H), 7.50 (d, J= 8.3 Hz, 2H), 7.30 (d, J= 8.3 Hz, 2H,), 4.49 (apparent t, J= 7.6 Hz, J= 6.3 
Hz, 1H), 3.65 (ddAB system, J= 18.1 Hz, J= 7.6 Hz, 1H), 3.44 (ddAB system, J= 18.1 Hz, J= 6.3 Hz, 
1H);  δC (125 MHz, CDCl3): 193.7, 138.1, 134.5, 133.9, 132.3, 129.6, 129.2, 122.4, 119.9, 98.8, 
43.9, 31.2. 
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1H NMR for compound 294 (500 MHz, CDCl3) 
 
 
 
 
 
 
13C NMR for compound 294 125 MHz, CDCl3) 
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General Procedure for the Synthesis of Azadipyrromethene 293a - g. 
 
A 100 mL round-bottomed flask was charged with 5 (1 eq.), ammonium acetate (35 eq.), and 
butanol and heated under reflux for 24h.  After cooling to room temperature, the solvent was 
concentrated to a quarter of its original volume, filtered, and the isolated solid was washed with 
ethanol to yield the desired product as a dark blue-black solid in about 50% yield.   
 
 
Azadipyrromethene 293a 
 
 
 
 
 
 
 
 
 
δH (500 MHz, CDCl3): 3.96 (s, 6H), 7.04 (d, J=8.3 Hz, 2H), 7.08 (t, J=7.3 Hz, 2H), 7.33-7.44 
(m, 10H), 8.07 (d, J=7.3 Hz, 4H), 8.13 (d, J=7.8 Hz, 2H);  δC (75 MHz, CDCl3): 137.9, 126.3, 
125.5, 115.3, 114.1, 104.4, 55.3  ; m/z (APCI): theoretical mass (M)+: 762.01; found: 762.1.  
Because of poor solubility or aggregation, a good 13C spectrum could not be obtained. 
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1H NMR for compound 293a (500 MHz, CDCl3). 
 
 
 
 
 
13C NMR for compound 293a (125 MHz, CDCl3). 
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Azadipyrromethene 293b  
 
 
 
 
 
 
 
 
 
 
δH (500 MHz, CDCl3): 8.13 (d, J=7.8 Hz, 2H), 8.07 (d, J=7.3 Hz, 4H), 7.33-7.44 (m, 10H), 
7.08 (t, J=7.3 Hz, 2H), 7.04 (d, J=8.3 Hz, 2H), 3.96 (s, 6H),;  m/z (ESI): theoretical mass 
(M+H)+: 666.03; found: 666.3-668.2 (Br isotope).  Attempt to take nmr in CDCl3 only gave 
broad signals probably because of aggregation. 
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1H NMR for compound 293b (500 MHz, CDCl3).  
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Azadipyrromethene 293c 
 
 
 
 
 
 
 
 
δH (500 MHz, CDCl3): 8.13 (d, J= 7.8 Hz, 2H), 8.07 (d, J= 7.3 Hz, 4H), 7.44-7.33 (m, 10H), 
7.08 (t, J= 7.3 Hz, 2H), 7.04 (d, J= 8.3 Hz, 2H), 3.96 (s, 6H);  δC (125 MHz, CDCl3): 158.0, 153.5, 
148.5, 141.0, 134.1, 130.9, 129.1, 128.1, 127.9, 127.5, 121.4, 121.0, 117.8, 111.8, 55.9; m/z 
(HR-ESI): theoretical mass (M+H)+: 510.2182; found: 510.2174. 
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1H NMR for compound 293c (500 MHz, CDCl3). 
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13C NMR for compound 293c (125 MHz, CDCl3). 
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Azadipyrromethene 293d 
 
 
 
 
 
 
 
 
 
δH (500 MHz, CDCl3): 3.95 (s, 6H), 7.02-7.09 (m, 4H), 7.28 (s, 2H), 7.41 (dt, J=1.7 Hz, J=7.3 
Hz, 2H), 7.51 (d, J=8.8 Hz, 4H), 7.87 (d, J=8.5 Hz, 4H), 8.08 (d, J=7.3 Hz, 2H);  δC (125 MHz, 
CDCl3): 157.9, 153.5, 148.2, 139.5, 132.9, 131.1, 130.4, 129.1, 121.7, 121.1, 121.0, 117.9, 
117.8, 111.7, 55.9;  m/z (ESI): theoretical mass (M+H)+: 666.0392; found: 666.0399-668.0366 
(Br isotope) 
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1H NMR for compound 293d (500 MHz, CDCl3). 
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13C NMR for compound 293d (125 MHz, CDCl3). 
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Azadipyrromethene 293e 
 
 
 
 
 
 
 
 
δH (500 MHz, CDCl3): 8.09 (dd, J= 7.6 Hz, J= 1.7 Hz, 2H), 7.75 (apparent doublet of quart, 
J= 8.5 Hz, J= 2.2 Hz, 8H,), 7.41 (dt, J= 7.3 Hz, J= 1.7 Hz, 2H), 7.30 (s, 2H), 7.08 (dt, J= 7.6 Hz, 
J= 1.0 Hz, 2H), 7.04 (d, J= 8.5 Hz, 2H), 3.95 (s, 6H);  δC (125 MHz, CDCl3): 158.1, 153.7, 148.4, 
139.8, 137.3, 133.5, 131.3, 130.7, 129.2, 121.2, 121.1, 117.9, 111.8, 93.6, 55.9.  
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1H NMR for compound 293e (500 MHz, CDCl3). 
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13C NMR for compound 293e (125 MHz, CDCl3). 
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Azadipyrromethene 293f 
 
 
 
 
 
 
 
 
 
 
δH (500 MHz, CDCl3): 8.03 (d, J=8.5 Hz, 2H), 7.88 (d, J=8.3 Hz, 4H), 7.51 (d, J=8.3 Hz, 4H), 
7.21 (s, 2H), 6.60 (dd, J=8.5 Hz, J=2.4 Hz, 2H), 6.56 (d, J=2.4 Hz, 2H), 3.95 (s, 6H), 3.90 (s, 
6H);  δC (125 MHz, CDCl3): 162.5, 159.4, 152.9, 148.1, 139.3, 133.2, 131.2, 130.5, 130.3, 121.6, 
117.2, 114.5, 105.9, 98.8, 56.0, 55.6;  m/z (HR-ESI): theoretical mass (M+H)+: 726.0603; found: 
726.0587-728.0555 (Br isotope). 
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1H  NMR for compound 293f (500 MHz, CDCl3) 
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13C NMR for compound 293f (125 MHz, CDCl3). 
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General Procedure for the Synthesis of AzaBODIPY 288a – g . 
A flame dried Schlenk flask was charged with the azapyrromethene (1 eq.) and flushed with 
nitrogen.   Dry dichloromethane and dry diisopropylethylamine (11 eq.) were then added.  The 
solution was stirred at 25 °C for 15 min, then distilled BF3•OEt2 (15.6 eq.) was added.  After 
stirring at 25 °C for 24h, the mixture was washed with water, and the organic layer dried over 
sodium sulfate and concentrated in vacuo to give the target compound. 
 
 
AzaBODIPY 288a 
 
 
 
 
 
 
 
 
 
 
δH (500 MHz, CDCl3): 8.04 (d, J=8.8 Hz, 4H), 7.83 (d, J=8.5 Hz, 4H), 7.75 (d, J=8.8 Hz, 4H), 
7.00 (d, J=8.5 Hz, 4H), 6.89 (s, 2H), 3.91 (s, 6H);  δC (125 MHz, CDCl3): 161.1, 157.9, 145.6, 
144.1, 137.8, 131.1, 130.9, 130.8, 125.1, 117.2, 114.3, 98.0, 55.4;  δB (128 MHz, CDCl3): 0.84 (t, 
1B, J B-F = 31 Hz);  δF (376 MHz, CDCl3): -134.89 (q, 2F, J B-F = 31 Hz); MS (maldi) m/z calcd for 
(M+H)+ C34H25BI2F2N3O2:810.0097; found :810.0071;  λmax abs (PhMe)/nm 680 (ε/dm3mol-1cm-1 
108 996);  λmax emis (PhMe)/nm 711;  Φ = 0.18 in 1% pyridine in toluene. 
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1H NMR for compound 288a (500 MHz, CDCl3) 
 
 
 
 
13C NMR 1H NMR for compound 288a (125 MHz, CDCl3). 
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11B NMR for compound 288a (MHz, CDCl3). 
 
 
 
 
 
 
19F NMR for compound 288a (MHz, CDCl3). 
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AzaBODIPY 288b 
 
 
 
 
 
 
 
 
 
δH (500 MHz, CDCl3): 8.08 (d, J=8.8 Hz, 4H), 7.91 (d, J=8.5 Hz, 4H), 7.60 (d, J=8.5 Hz, 4H), 
7.04 (s, 2H), 7.02 (d, J=8.8 Hz, 4H), 3.90 (s, 6H);  δC  not taken due to poor solubility of 
compound;  δB (128 MHz, CDCl3): 1.05 (t, 1B, J B-F = 32 Hz);  δF (376 MHz, CDCl3): -132.36 (q, 
2F, J B-F = 32 Hz);  MS (ESI) m/z calcd for (M+H)+ C34H25BBr2F2N3O2: 714.03; found : 714.2-
716.2 (Br isotope);  λmax abs (PhMe)/nm 702 (ε/dm3mol-1cm-1 84 118);  λmax emis (PhMe)/nm 731;  Φ 
= 0.42 in 1% pyridine in toluene. 
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1H NMR for compound 288b (500 MHz, CDCl3). 
 
 
 
 
 
11B NMR for compound 288b (500 MHz, CDCl3). 
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19F NMR for compound 288b (500 MHz, CDCl3). 
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AzaBODIPY 288c 
 
 
 
 
 
 
 
 
δH (500 MHz, CDCl3): 8.07-8.08 (m, 4H), 7.89 (dd, J= 7.8 Hz, J= 1.7 Hz, 2H), 7.48-7.38 (m, 
8H), 7.04 (dd, J= 15.1 Hz, J= 0.9 Hz, 2H), 7.03 (s, 2H), 6.97 (d, J= 8.3 Hz, 2H), 3.80 (s, 6H);  δC 
(125 MHz, CDCl3): 158.0, 156.7, 144.9, 142.8, 132.6, 131.7, 129.3, 129.2, 129.1, 128.5, 121.3, 
121.1, 120.5, 111.1, 55.9;  δB (128 MHz, CDCl3): 0.558 (t, 1B, J B-F = 30 Hz);  δF (376 MHz, 
CDCl3): - 133.37 (q, 2F, J B-F = 30 Hz);  HRMS (ESI) m/z calcd (M+H)+ C34H27BF2N3O2: 
558.2164; found : 558.2166;  λmax abs (PhMe)/nm 640 (ε = 73 858 dm3mol-1cm-1);  λmax emis 
(PhMe)/nm 688;  Φ = 0.07 in 1% pyridine in toluene. 
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1H NMR for compound 288c (500 MHz, CDCl3). 
 
 
 
 
13C NMR for compound 288c (125 MHz, CDCl3). 
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11B NMR for compound 288c (MHz, CDCl3). 
 
 
 
 
 
 
 
 
 
 
19F NMR for compound 288c (MHz, CDCl3). 
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AzaBODIPY 288d 
 
 
 
 
 
 
 
 
 
δH (500 MHz, CDCl3): 7.90 (d, J= 8.8 Hz, 4H), 7.87 (dd, J= 7.6 Hz, J= 1.7 Hz, 2H), 7.60 (d, 
J= 8.8 Hz, 4H), 7.41 (dt, J= 7.6 Hz, J= 1.7 Hz, 2H), 7.05-7.01 (m, 4H), 6.97 (d, J= 7.8 Hz, 2H), 
3.86 (s, 6H);  δC (125 MHz, CDCl3): 158.0, 157.0, 144.7, 141.4, 131.9, 131.8, 131.7, 131.4, 
130.6, 123.7, 121.4, 120.7, 120.5, 111.0, 55.8;  δB (128 MHz, CDCl3): 0.51 (t, 1B, J B-F = 30 Hz);  
δF (376 MHz, CDCl3): -137.46 (q, 2F, J B-F = 30 Hz);  MS (MALDI) m/z calcd for (M+H)+ 
C34H25BBr2F2N3O2: 714.03; found : 714.04;  λmax abs (PhMe)/nm 650 (ε = 55 014 dm3mol-1cm-1);  
λmax emis (PhMe)/nm 694;  Φ = 0.10 in 1% pyridine in toluene. 
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1H NMR for compound 288d (500 MHz, CDCl3). 
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13C NMR for compound 288d (125 MHz, CDCl3). 
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AzaBODIPY 288e.   
 
 
 
 
 
 
 
 
 
δH (500 MHz, CDCl3): 7.86 (dd, J = 7.8 Hz, J = 1.7 Hz, 2H), 7.79 (apparent quart, J = 8.3 Hz, 
8H), 7.40 (td, J = 9 Hz, J = 1.7 Hz, 2H), 7.03 (td, J = 7.8 Hz, J = 1 Hz, 2H), 7.02 (s, 2H), 6.97 (d, 
J = 8.3 Hz, 2H), 3.85 (s, 6H);  δC (125MHz, CDCl3): 158.3, 157.3, 141.9, 138.0, 132.3, 132.2, 
131.9, 130.9, 121.7, 121.6, 121.0, 120.8, 111.3, 96.1, 56.2;  δF (376MHz, CDCl3): 45.45 (q, 2F, J 
= 31.5 Hz). HRMS (ESI) m/z calcd for (M+Li)+ C34H24BI2F2N3O2 816.0179; found 816.0019; λmax 
abs (PhMe)/nm 653 (ε/dm3mol-1cm-1 71 600);  λmax emis (PhMe)/nm 701;  Φ = 0.10 in 1% pyridine in 
toluene. 
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1H NMR for compound 288e  (500 MHz, CDCl3). 
 
 
 
CH2Cl2 
H2O 
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13C NMR for compound 288e  (125 MHz, CDCl3). 
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AzaBODIPY 288f 
 
 
 
 
 
 
 
 
 
 
δH (500 MHz, CDCl3): 7.96 (d, J=8.8 Hz, 2H), 7.90 (dd, J=1.8 Hz, J= 6.7 Hz, 4H), 7.58 (dd, 
J=1.8 Hz, J= 6.7 Hz, 4H), 7.06 (s, 2H), 6.58 (dd, J=8.8 Hz, J=2.4 Hz, 2H), 6.51 (d, J=2.4 Hz, 2H), 
3.86 (s, 6H), 3.85 (s, 6H);  δC (125 MHz, CDCl3): 163.1, 159.8, 155.9, 144.6, 140.6, 133.2, 131.7, 
131.6, 130.5, 123.4, 121.5, 113.8, 104.8, 98.8, 55.8, 55.5;  δB (128 MHz, CDCl3): 0.71 (t, 1B, J B-
F = 30 Hz);  δF (376 MHz, CDCl3): -170.14 (q, 2F, J B-F = 30 Hz);  HRMS (ESI) m/z calcd for 
(M+H)+ C36H29BBr2F2N3O4 774.0586; found : 774.0573-776.0550 (Br isotope);  λmax abs 
(PhMe)/nm 692 (ε/dm3mol-1cm-1 66 200);  λmax emis (PhMe)/nm 738;  Φ = 0.20 in 1% pyridine in 
toluene. 
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1H NMR for compound 288f (500 MHz, CDCl3). 
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13C NMR for compound 288f (500 MHz, CDCl3). 
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11B NMR for compound 288f (MHz, CDCl3). 
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19F NMR for compound 288f (MHz, CDCl3). 
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AzaBODIPY 288g (from butyrophenone 291g). 
 
 
 
 
 
 
 
 
 
 
NH4OAc (17.4g, 0.23mol) was added to the solution of 5g (2.73g, 6.5mmol) in 50mL n-
BuOH. The reaction mixture was heated at reflux for 24h. After cooling to room temperature, the 
solution was concentrated to half its original volume. The solid was filtered and washed with cold 
EtOH to afford 6g (1.0 g, 41%) as a green solid which was used in the next step without further 
purification.  DIEA (1.8 ml, 10.3 mmol) was added to the solution of 6g (970mg, 1.3 mmol) in 
30mL dry DCM. The solution was stirred at room temperature for 15min and BF3•OEt2 (1.6 ml, 
12.9mmol) was added. After stirring at room temperature for 24h, the mixture was washed with 
water (1 x 30 mL) and brine (1 x 30 mL). The organic layer was dried over Na2SO4 and 
concentrated under reduced pressure. The crude product was purified by flash chromatography 
on silica gel eluting with 2 : 3 EtOAc-hexane to afford 1g (867mg, 84%) as a purple solid.  δH 
(500MHz, CDCl3): 8.03 (d, J = 9.2 Hz, 2H), 7.90 (d, J = 8.5 Hz, 4H), 7.53 (d, J = 8.5 Hz, 4H), 
7.14 (s, 2H), 6.34 (d, J = 9.1 Hz, 2H), 6.13 (d, J = 2.3 Hz, 2H), 3.84 (s, 6H), 3.01 (s, 12H);  δC 
(125MHz, CDCl3): 160.2, 154.5, 153.2, 144.4, 138.5, 133.4, 132.2, 131.4, 130.4, 122.6, 121.5, 
109.3, 104.8, 94.8, 55.6, 40.1;  δF (376MHz, CDCl3): 45.45 (q, 2F, J = 31.5 Hz). HRMS (ESI) m/z 
calcd for (M+H)+ C38H35BBr2F2N5O2 800.1219; found 800.1275; λmax abs (PhMe)/ nm 798 
(ε/dm3mol-1cm-1 68 610);  λmax emis (PhMe)/ nm 830;  Φ = 0.07 in 1% pyridine in toluene. 
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1H NMR for compound 288g (500 MHz, CDCl3). 
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13C NMR for compound 288g (125 MHz, CDCl3). 
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Compound 298.   
 
 
 
 
 
 
 
 
 
 
 
 
A flame dried Schlenk tube was charged with ethynyl fluorescein diacetate 29612,13 (0.24 g, 
0.54 mmol), aza-BODIPY 288a (0.2 g, 0.25 mmol), Pd (PPh3)4 (17 mg, 0.025 mmol), CuI (2.4 
mg, 0.012 mmol), THF (15 mL) and triethylamine (0.4 mL, 2.5 mmol).  The reaction mixture was 
deoxygenated 3 times using the freeze-pump-thaw technique.  It was then stirred at room 
temperature for 28h.  The solvent was then removed in vacuo, and the residue purified by flash 
chromatography (dry loading).  The column was first eluted with 50% Hexanes:CH2Cl2 to 100% 
CH2Cl2, then 2% ethyl acetate:CH2Cl2 to get the mono-coupling product and finally with 5% ethyl 
acetate:CH2Cl2 to get the bis-coupling product.  The bis-coupling product coeluted with the 
ethynyl fluorescein bis acetate homo-coupling product and is obtained in a pure form after a 
second flash chromatography eluted with 50% ethyl acetate:hexanes (107 mg, 30%).  δH (500 
MHz, CDCl3): 8.18 (s, 2H), 8.10 (d, J= 8.1 Hz, 4H), 8.06 (d, J= 8.3 Hz, 4H), 7.83 (d, J= 8.1 Hz, 
2H), 7.66 (d, J= 8.3 Hz, 4H), 7.19 (d, J= 8.1 Hz, 2H), 7.11 (d, J= 2.2 Hz, 4H), 7.02 - 6.99 (m, 6H), 
6.88 - 6.83 (m, 8H), 3.91 (s, 6H), 2.32 (s, 12H);  δC (125 MHz, CDCl3): 168.8, 168.2,  161.1, 
157.7, 152.2, 152.1, 151.5, 145.9, 143.9, 138.3, 131.9 (2C), 130.9, 129.6, 128.9, 128.2, 126.6, 
125.5, 125.1, 124.6, 124.2, 117.8, 117.6, 115.9, 114.2, 110.5, 91.7, 89.9, 81.8, 55.4, 21.1;  δB 
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(128 MHz, CDCl3): 0.97 (t, 1B, J B-F = 31 Hz);  δF (376 MHz, CDCl3): -130.72 (q, 2F, J B-F = 31 
Hz);  m/z (ESI) calculated mass for C86H54BF2N3O16 (M+H)+: 1434.3643; found: 1434.3638. 
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1H NMR for compound 298 (500 MHz, CDCl3). 
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13C NMR for compound 298 (125 MHz, CDCl3). 
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19F NMR for compound 298 (376 MHz, CDCl3). 
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11B NMR for compound 298 (128 MHz, CDCl3). 
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Compound 289.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 A solution of 298 in a mixture of methanol and THF (1:1) was treated with baked potassium 
carbonate.  The reaction mixture was stirred at room temperature for 2 h.  When the reaction 
was complete according to TLC, the solvent was removed in vacuo to afford the pure product.   
δH (500 MHz, CD3OD): 8.30 (d, J=8.5 Hz, 4H), 8.18 (d, J=1.7 Hz, 2H), 8.15 (d, J=8.8 Hz, 4H), 
7.72 (dd, J=1.7 Hz, J=7.8 Hz, 2H), 7.66 (d, J=8.5 Hz, 4H,), 7.26 (s, 2H), 7.24 (d, J=7.8 Hz, 2H), 
7.06 (d, J=9.3 Hz, 4H), 7.05 (d, J=8.8 Hz, 4H), 6.54 (dd, J=2.2 Hz, J= 9.3 Hz, 4H), 6.49 (d, J=2.2 
Hz, 4H), 3.90 (s, 6H);  δC (125 MHz, CD3OD): 182.6, 173.2, 162.6, 160.3, 159.9, 148.3, 144.6, 
142.3, 134.9, 133.7, 133.6, 132.8, 132.5, 132.2, 132.1, 131.4, 131.3, 126.6, 126.2, 125.1, 124.1, 
119.4, 115.3, 114.8, 113.1, 104.4, 92.1, 91.4, 55.9;  δB (128 MHz, CD3OD): 5.34;  δF (376 MHz, 
CD3OD): -187.46;  m/z (MALDI) calculated for C78H46BF2N3O12: 1267.3984;  λmax abs (50% 
EtOH:H2O)/nm 500 (fluorescein) and 698 (AzaBODIPY);  λmax emis (50% EtOH:H2O)/nm 530 and 
733 when excited at 498 nm;  λmax emis (50% EtOH:H2O)/nm 733 when excited at 690 nm. 
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1H NMR for compound 289 (500 MHz, CD3OD). 
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13C NMR for compound 289 (125 MHz, CD3OD). 
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Compound 297.  
 
  
 
 
 
 
 
 
 
 
BBr3 (1.0 mol solution in hexane) (4.9 mmol, 1.9 mL) was added to a solution of iodoaza-
BODIPY 288a (0.49 mmol, 0.4 g) in dry CH2Cl2 (200 mL) at 0 °C and stirred at 25 °C for 2h.  
After dichloromethane was removed, EtOAc and H2O (1:1, 300 mL) were added.  The organic 
layer was separated, dried over anhydrous MgSO4, filtered and finally THF (10 X 50 mL) was 
used to dissolve sticky material during filtration.  The filtrate was concentrated and dried under 
vacuum.  The crude product  was used in next step without further purification. 
NaH (60% suspension in paraffin oil) (4.9 mmol, 290 mg) was added to a solution of the 
crude deproteced product (49.0 mmol, 383 mg; assumed quantity) and methyl bromoacetate 
(1.86 mmol, 1.47 mL) in dry THF (150 mL).  After stirring for 12 h at 25 °C, flash silica gel was 
added to quench the NaH as well as to make slurry for column chromatography.  The solvents 
were removed and chromatographed (SiO2; 50 % hexanes/EtOAc) to afford 297 (79 mg) in 17 % 
yield as a dark blue amorphous solid;  δH (500 MHz, CDCl3): 7.93 (d, J = 9.0 Hz, 4H), 7.77 (d, J = 
9.0 Hz, 4H,), 7.68 (d, J = 9.0 Hz, 4H), 6.92 (d, J = 9.0 Hz, 4H), 6.82 (s, 2H), 4.66 (s, 4H), 3.85 (s, 
6H);  δC (75 MHz, CDCl3): 169.2, 159.2, 158.1, 143.7, 138.1, 131.1(3C), 126.2, 117.7, 115.0, 
98.4, 65.4, 52.6; MS (MALDI) calcd for C38H28BF2I2N3O6 925.0129 found 925.6324. 
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1H NMR for compound 297 (500 MHz, CDCl3). 
 
 
 
13C NMR for compound 297 (125 MHz, CDCl3). 
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Compound 299.   
 
 
 
Ethynyl fluorescein diacetate 296 (0.43 mmol, 0.187 g) was added to a solution of aza-
BODIPY 297 (0.085 mmol, 0.79 g), PdCl2(PPh3)2 (25 mol %, 15 mg), CuI (5 mol %, 1 mg) and 
Et3N (1 mL) in dry THF (30 mL).  The resulting solutition was degassed by freeze-pump-thaw 
method (3 cycles).  After stirring for 18 h at 40 °C, the solvents were removed and the crude 
residue chromatographed (SiO2; 12% EtOAc/CH2Cl2) to afford 299 (53 mg) in 40 % yield as a 
dark brown solid;  δH (500 MHz, CDCl3): 8.18 (s, 2H), 8.08 (d, J = 8.5 Hz, 4H), 8.02 (d, J = 8.5 
Hz, 4H),  7.84-7.80 (m, 2H), 7.65 (d, J = 8.5 Hz, 4H), 7.18 (d, J = 7.5 Hz, 2H), 7.13 (d, J = 2.0 
Hz, 4H), 6.99-7.01 (m, 6H), 6.84-6.85 (m, 8H), 4.73 (s, 4H), 3.85 (s, 6H), 2.31 (s, 12H);  δC (75 
MHz, CDCl3): 179.3, 169.1, 168.5, 159.45, 158.2, 152.5 (2C), 151.8, 146.2, 143.9, 138.7, 132.3, 
132.1, 131.3, 129.3 (2C), 129.3, 128.5, 126.9, 126.4, 125.8, 125.1, 124.6, 118.2, 116.3, 115.2, 
110.8, 92.0, 90.4, 82.1, 65.5, 52.7, 21.4; IR (neat); ν (cm-1); 1684; MS (MALDI) calcd for 
C90H58BF2N2O20 1549.3637 found  (M-F)+ 1530.1506. 
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1H NMR for compound 299 (500 MHz, CDCl3). 
 
 
 
 
 
13C NMR for compound 299 (125 MHz, CDCl3). 
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19F NMR for compound 299 (376 MHz, CDCl3). 
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Compound 290.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Solid TMSOK (0.37 mmol, 48 mg) was added to a solution of compound 299 (0.031 mmol, 
48 mg) in THF (20 mL).  After stirring for 2.5 h at 25 °C, the reaction mixture was neutralized with 
2N HCl (1 mL) and subsequently water was added (5 mL). After stirring for 5 min, THF was 
removed and the aqueous layer was extracted with 25% iPrOH in CH2Cl2  (pH = 2-3).  To obtain 
pure product in 90 % yield (38 mg) solvents were removed and was dried under vacuum.  1H and 
13C NMR could not be obtained because of aggregation.  MS (MALDI) calcd for C80H46BF2N3O6 
1353.2939 found 1354.10212 (M+H)+; Pure compound 290 (< 1 mg) was dissolved in 1:1 
(CH3CN:H2O) (2 mL) and subjected to reverse phase analytical HPLC {C18, 5:95 (CH3CN:H2O) 
and 0.1 % TFA , tR = 16.5 min}. 
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C18 Reverse Phase HPLC – UV Detector (λmax abs 488 nm) – Solvent: 5/95 (CH3CN/H2O) + 0.1% TFA - 
retention time: 3.35 min. 
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APPENDIX B 
EXPERIMENTAL DATA FOR CHAPTER III 
 
General Experimental Procedures.   
All chemicals were obtained from commercial suppliers and used without further purification.  
Thin layer chromatography was performed using silica gel 60F254 flash. Chromatography on 
silica gel was performed using a forced flow of the indicated solvent on EM reagents silica gel 60 
(230-400 mesh).  The solvents were dried/degassed by passing them down an alumina column.  
1H and 13C NMR spectra were recorded on an Inova Instrument at 500 MHz (1H), 125 MHz (13C).  
11B and 19F NMR spectra were recorded on a Inova 400 Broad Band instrument at 128 MHz 
(11B) and 376 MHz (19F).  NMR chemical shifts are expressed in ppm relative to internal solvent 
peaks (CDCl3: 7.27 ppm for 1H and 77.0 ppm for 13C; DMSO-d6: 2.50 ppm for 1H and 39.5 ppm 
for 13C; CD3OD: 3.30 ppm for 1H and 49.0 ppm for 13C) and coupling constants were measured 
in Hz.  For 11B NMR, BF3.OEt2 has been used as an external reference; similarly, CFCl3 was 
used as an external standard for the 19F spectra. 
UV spectra were recorded in 1 cm path length quartz cuvettes on a Cary 100 Bio UV-Visible 
spectrophotometer at 5 µM.  Fluorescence emission spectra were recorded in 1 cm path length 
quartz cuvettes on a Photon Counting Spectrofluorometer PC1 SSI instrument equipped with an 
R928P photomultiplier tube which is sensitive up to ~ 850-900 nm.  Fluorescence spectra were 
recorded at concentrations between 1 and 5 µM.  Fluorescence quantum yield measurements 
were performed on the same instrument.  The slit width was 0.5 nm for both excitation and 
emission.  Relative quantum efficiencies of fluorescence of BODIPY derivatives were obtained 
by comparing the areas under the corrected emission spectrum of the test sample in 1% pyridine 
in toluene with that of a solution of zinc phthalocyanine, which has a quantum efficiency of 0.30 
according to the literature.1  Non-degassed, spectroscopic grade toluene and a 10 mm quartz 
cuvette were used.  Dilute solutions (0.01<A<0.05) were used to minimize reabsorption effects.  
The excitation wavelength was 671 nm for both compound 4 and 1, and the reference. 
Quantum yields were determined using the equation (1):2 
 
equation (1)  ΦX = Φst (IX/Ist) (Ast/AX)(ηX2/ηst2) 
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Where Φst is the reported quantum yield of the standard, I is the integrated emission spectra, 
A is the absorbance at the excitation wavelength and η is the refractive index of the solvent used 
(η=1 if same solvent). X subscript denotes unknown, and st denotes standard.  
 Cyclic voltammograms were recorded on a BAS-100A electrochemical analyzer using three 
electrodes. The working electrode consisted of 3.0 mm glassy carbon electrode. A Ag/AgCl was 
used as reference electrode, and a platinum coil served as a counter electrode. Tetrabutyl 
ammonium tetrafluoroborate was used as the electrolyte. All potentials were calibrated versus 
SCE by the addition of ferrocene (Fc) as an internal standard, taking E (Fc/Fc+) = 0.46 V, vs 
SCE.  The potentials are then reported versus NHE.  Measurements were obtained with solution 
concentrations of 1 mM in 0.1 M TBABF4 in 10 mL of CH2Cl2 at a scan rate of 200 mV/s. 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Vincett, P. S.; Voigt, E. M.; Rieckhoff, K. E. J. Chem. Phys. 1971, 55, 4131-40. 
(2) Williams, A. T. R.; Winfield, S. A.; Miller, J. N. Analyst 1983, 108, 1067-71. 
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AzaBODIPY 300a 
 
 
 
 
 
 
 
 
 
A solution of 288c (0.09 mmol) in dry dichloromethane (2.5 mL) was cooled to 0°C, then 
BBr3 (0.90 mmol) was added dropwise over 1 min.  The solution was then allowed to reach room 
temperature and stirring was continued for an additional 10h.  The reaction was then quenched 
with water at 0°C, and extracted with ethyl acetate.  The combined organic layers were washed 
with sat’d NH4Cl, dried over sodium sulfate and concentrated in vacuo.  The product was then 
purified by column chromatography on silica gel eluted with 5% ethyl acetate/hexanes to give the 
desired product in 62 % yield (0.03 g) as a dark solid.  δH (500 MHz, CDCl3): 8.17 (dd, J= 5.6 Hz, 
J= 1.5 Hz, 4H), 7.89 (dd, J= 7.8 Hz, J= 1.7 Hz, 2H), 7.51-7.41 (m, 8H), 7.26 (s, 2H), 7.13 (td, J= 
7.3 Hz, J= 0.9 Hz, 2H), 7.04 (d, J= 8.3 Hz, 2H);  δC (125 MHz, CDCl3):155.8, 149.8, 144.9, 142.2, 
133.4, 132.4, 129.3, 129.0, 128.7, 126.6, 120.9, 120.2, 118.9, 113.3;  δB (128 MHz, CDCl3): -
1.58 (s);  m/z (HR-ESI): theoretical mass (M+H)+: 490.1727; found : 490.1722;  λmax abs (PhMe)/ 
728 nm (ε = 8.187 E4 dm3mol-1cm-1);  λmax emis (PhMe)/ 746 nm;  Φ = 0.51 in 1% pyridine in 
toluene. 
N N
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1H NMR for compound 300a (500 MHz, CDCl3). 
 
 
 
 
 
 
13C NMR for compound 300a (125 MHz, CDCl3). 
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11B NMR for compound 300a (128 MHz, CDCl3). 
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AzaBODIPY 300b 
 
 
 
 
 
 
 
 
 
A solution of corresponding aza-BODIPY 288d (0.07 mmol) in dry dichloromethane (10 mL) 
was cooled to 0°C, then BBr3 (0.18 mmol) was added dropwise over 1 min.  The solution was 
then allowed to reach room temperature and stirring was continued for an additional 10 h.  The 
reaction was then quenched with water sat’d NH4Cl at 0°C, and extracted with ethyl acetate.  
The combined organic layers were washed with sat’d NH4Cl, dried over sodium sulfate and 
concentrated in vacuo.  The product was then purified by column chromatography on silica gel 
eluted with 10% ethyl acetate/hexanes to give the desired product in 36 % yield (0.018 g) as a 
dark purple solid. δH (500 MHz, C6D6): 7.80 (d, J= 8.6 Hz, 4H), 7.67 (dd, J= 7.8 Hz, J= 1.6 Hz, 
2H), 7.46 (d, J= 8.6 Hz, 4H), 7.31 (bs, 2H), 7.00 (bs, 2H), 6.96 (dd, J= 7.8 Hz , J= 1 Hz, 2H), 
6.89 (td, J= 7.3 Hz, J= 1 Hz, 2H); m/z (MALDI): theoretical mass (M)+: 645.0; found : 644.5, 
646.5, 647.5, 648.6 (Br isotopes);  λmax abs (PhMe)/745 nm (ε/dm3mol-1cm-1 );  λmax emis (PhMe)/ 
760 nm;  Φ = 0.46 in 1% pyridine in toluene.  Not enough sample was prepared to allow 
determination of the molar extinction coefficient.  
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1H NMR for compound 300b (500 MHz, C6D6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
X CDCl3 
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AzaBODIPY 300c 
 
 
 
 
 
 
 
 
 
5% Ethyl acetate/hexanes gave rise the desired product in 41% yield (0.370 g) as a off pink 
dark solid. δH (300 MHz, CDCl3): 6.98-7.04 (m, 2H), 7.10-7.20 (m, 2H), 7.27 (s, 1H), 7.43-7.48 
(m, 2H), 7.58 (d, J= 8.5 Hz, 2H), 7.67 (d, J= 8.5 Hz, 2H), 7.79 (d, J= 8.5 Hz, 2H), 7.86 (dd, J= 6.5 
Hz, J= 1.5 Hz, 1H), 7.98 (d, J= 8.5 Hz, 2H), 8.56 (dd, J= 6.5 Hz, J= 1.5 Hz, 1H);  δC (75 MHz, 
CDCl3):156.1, 156.0, 152.4, 146.2, 144.1, 143.2, 142.3, 137.9, 134.9, 133.7, 132.3(2C), 132.2, 
131.7(2), 130.8, 130.5(2C), 130.1, 127.8, 127.3, 124.8, 124.0, 121.6, 121.1, 120.6, 120.2, 119.1, 
118.4, 114.8, 105.6;  δB (128 MHz, CDCl3): -1.73 (s);  m/z (MALDI): theoretical mass (M)+: 
722.9; found : 722.7, 723.7, 724.7, 725.7, 726.7, 727.7 (Br isotopes);  λmax abs (PhMe)/747 nm;  
λmax emis (PhMe)/769 nm;  Φ = 0.35 in 1% pyridine in toluene. Not enough sample was 
prepared to allow determination of the molar extinction coefficient. 
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1H NMR for compound 300c (300 MHz, CDCl3). 
 
 
 
 
 
 
 
 
 
 
 
13C NMR for compound 300c (75 MHz, CDCl3). 
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AzaBODIPY 300d 
 
 
 
 
 
 
 
 
 
A solution of corresponding aza-BODIPY 288d (1.4 mmol) in dry dichloromethane (250 mL) 
was cooled to 0°C, then BBr3 (14.0 mmol) was added dropwise over 10 min.  The solution was 
then allowed to reach room temperature and stirring was continued for an additional 24 h.  The 
reaction was then quenched with water sat’d NH4Cl at 0°C, and extracted with ethyl acetate.  
The combined organic layers were washed with sat’d NH4Cl, dried over sodium sulfate and 
concentrated in vacuo.  The product was then purified by column chromatography on silica gel 
eluted with 5% ethyl acetate/hexanes to give the desired product in 21% yield (0.19 g) as a pink 
dark solid. δH (300 MHz, CDCl3): 7.04 (d, J= 8.4 Hz, 2H), 7.16-7.20 (m, 2H), 7.45-7.48 (m, 2H), 
7.62 (d, J= 7.7 Hz, 4H), 7.76 (d, J= 7.7 Hz, 4H), 8.17 (dd, J= 6.6 Hz, J= 1.5 Hz, 2H);  δC (75 
MHz, CDCl3):156.4, 146.7, 144.4, 139.8, 135.1, 132.6, 132.2, 130.0, 128.6, 124.9, 121.8, 120.8, 
119.1, 107.6;  δB (128 MHz, CDCl3): -1.81 (s);  m/z (MALDI): theoretical mass (M)+: 800.8 ; found 
: 800. 6, 801.6, 803.6, 804.6, 805.6, 807.6, 808.6, 809.6 (Br isotopes);  λmax abs (PhMe)/755 nm;  
λmax emis (PhMe)/776 nm;  Φ = 0.35  in 1% pyridine in toluene.  Not enough sample was prepared 
to allow determination of the molar extinction coefficient. 
 
N
B
N
N
O O
BrBr
BrBr
  
360 
 
 
1H NMR for compound 300d (300 MHz, CDCl3). 
 
 
 
 
 
 
13C NMR for compound 300d (75 MHz, CDCl3). 
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X-Ray Structure of Compound 300d 
 
 
 
 
 
Table 1.  Crystal data and structure refinement for KBB0908. 
 
Identification code  kbb0908 
Empirical formula  C32 H16 B Br4 N3 O2 
Formula weight  804.93 
Temperature  110(2) K 
Wavelength  1.54178 Å 
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Table 1.  Continued 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 17.565(4) Å α= 90°. 
 b = 4.9506(12) Å β= 105.322(11)°. 
 c = 32.855(9) Å γ = 90°. 
Volume 2755.4(12) Å3 
Z 4 
Density (calculated) 1.940 Mg/m3 
Absorption coefficient 7.441 mm-1 
F(000) 1560 
Crystal size 0.12 x 0.01 x 0.01 mm3 
Theta range for data collection 2.61 to 59.04°. 
Index ranges -19<=h<=19, -5<=k<=5, -36<=l<=36 
Reflections collected 19775 
Independent reflections 3948 [R(int) = 0.1217] 
Completeness to theta = 59.04° 98.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9293 and 0.4688 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3948 / 402 / 507 
Goodness-of-fit on F2 1.018 
Final R indices [I>2sigma(I)] R1 = 0.0564, wR2 = 0.1172 
R indices (all data) R1 = 0.1030, wR2 = 0.1372 
Largest diff. peak and hole 1.139 and -2.080 e.Å-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 
103) for KBB0908.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
B(1) 1906(6) 2450(20) 1788(3) 26(2) 
Br(1) 4433(1) -4321(2) 2171(1) 33(1) 
Br(2) 133(1) 8807(3) 555(1) 69(1) 
N(1) 2585(4) 696(13) 1728(2) 20(2) 
N(2) 2644(4) 2445(13) 1056(2) 21(2) 
N(3) 1691(4) 4176(14) 1393(2) 22(2) 
O(1) 1183(3) 1004(11) 1808(2) 26(1) 
O(2) 2209(3) 3861(11) 2188(2) 25(1) 
C(1) 2902(5) 786(16) 1387(3) 22(2) 
C(2) 2053(5) 4102(16) 1067(3) 22(2) 
C(3) 3071(5) -664(16) 2049(2) 20(2) 
C(4) 3665(5) -1856(16) 1882(3) 24(2) 
C(5) 3591(5) -939(16) 1476(3) 25(2) 
C(6) 981(5) 5473(17) 1260(3) 26(2) 
C(7) 947(5) 6614(16) 858(3) 26(2) 
C(8) 1596(5) 5750(17) 731(3) 25(2) 
C(9) 3004(5) -145(17) 2469(3) 27(2) 
C(10) 2560(5) 2220(17) 2518(3) 25(2) 
C(11) 2513(5) 2950(17) 2922(3) 27(2) 
C(12) 2892(5) 1480(18) 3268(3) 33(2) 
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Table 2.  Continued 
C(13) 3344(5) -778(18) 3218(3) 31(2) 
C(14) 3391(5) -1592(18) 2832(3) 29(2) 
C(15) 425(5) 4979(17) 1506(3) 27(2) 
C(16) 546(5) 2693(18) 1770(3) 29(2) 
C(17) 1(5) 2030(20) 1995(3) 36(2) 
C(18) -674(6) 3596(19) 1950(3) 38(2) 
C(19) -803(5) 5810(20) 1685(3) 38(2) 
C(20) -270(5) 6553(18) 1466(3) 32(2) 
C(21) 4168(13) -1280(60) 1213(7) 21(3) 
C(22) 4381(9) -3940(30) 1127(5) 24(3) 
C(23) 4884(9) -4340(30) 864(5) 28(3) 
C(24) 5183(13) -2130(60) 711(7) 26(3) 
C(25) 4983(9) 510(30) 780(5) 29(3) 
C(26) 4460(9) 870(30) 1035(5) 25(3) 
Br(3) 5835(10) -2930(20) 343(6) 38(2) 
C(27) 4047(13) -1420(60) 1184(7) 21(3) 
C(28) 4874(8) -1300(30) 1342(5) 25(3) 
C(29) 5376(9) -1630(30) 1075(5) 30(3) 
C(30) 5039(12) -2070(60) 656(6) 25(3) 
C(31) 4232(8) -2120(30) 485(5) 26(3) 
C(32) 3737(8) -1730(30) 754(4) 20(3) 
Br(4) 5773(9) -2280(20) 320(5) 33(2) 
C(33) 1798(16) 6300(70) 318(7) 21(3) 
C(34) 2590(8) 6740(30) 310(4) 22(3) 
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Table 2.  Continued 
C(35) 2774(8) 7250(30) -72(4) 24(3) 
C(36) 2165(15) 7330(70) -434(7) 26(3) 
C(37) 1379(8) 6880(30) -442(4) 27(3) 
C(38) 1212(8) 6440(30) -53(4) 24(3) 
Br(5) 2419(11) 8310(20) -945(4) 25(2) 
C(39) 1756(18) 6220(70) 314(8) 21(3) 
C(40) 2034(9) 4130(30) 97(4) 21(3) 
C(41) 2199(9) 4650(30) -291(4) 25(3) 
C(42) 2130(18) 7270(70) -435(7) 26(3) 
C(43) 1862(9) 9380(30) -234(4) 27(3) 
C(44) 1681(9) 8800(30) 150(4) 23(3) 
Br(6) 2372(11) 7660(20) -966(4) 29(2) 
________________________________________________________________________________ 
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 Table 3.   Bond lengths [Å] and angles [°] for  KBB0908. 
 
B(1)-O(2)  1.459(12) 
B(1)-O(1)  1.474(11) 
B(1)-N(3)  1.517(12) 
B(1)-N(1)  1.529(12) 
Br(1)-C(4)  1.880(8) 
Br(2)-C(7)  1.861(8) 
N(1)-C(3)  1.348(9) 
N(1)-C(1)  1.378(10) 
N(2)-C(2)  1.331(10) 
N(2)-C(1)  1.341(10) 
N(3)-C(6)  1.367(10) 
N(3)-C(2)  1.384(10) 
O(1)-C(16)  1.376(10) 
O(2)-C(10)  1.364(10) 
C(1)-C(5)  1.447(11) 
C(2)-C(8)  1.436(11) 
C(3)-C(4)  1.429(11) 
C(3)-C(9)  1.439(11) 
C(4)-C(5)  1.380(12) 
C(5)-C(27)  1.423(18) 
C(5)-C(21)  1.506(17) 
C(6)-C(7)  1.421(12) 
C(6)-C(15)  1.446(12) 
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Table 3. Continued 
C(7)-C(8)  1.382(11) 
C(8)-C(39)  1.488(18) 
C(8)-C(33)  1.513(17) 
C(9)-C(14)  1.403(12) 
C(9)-C(10)  1.439(12) 
C(10)-C(11)  1.401(12) 
C(11)-C(12)  1.366(12) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.406(13) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.355(12) 
C(13)-H(13)  0.9500 
C(14)-H(14)  0.9500 
C(15)-C(16)  1.407(12) 
C(15)-C(20)  1.423(12) 
C(16)-C(17)  1.394(12) 
C(17)-C(18)  1.391(13) 
C(17)-H(17)  0.9500 
C(18)-C(19)  1.379(13) 
C(18)-H(18)  0.9500 
C(19)-C(20)  1.376(12) 
C(19)-H(19)  0.9500 
C(20)-H(20)  0.9500 
C(21)-C(26)  1.38(2) 
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Table 3. Continued 
C(21)-C(22)  1.42(3) 
C(22)-C(23)  1.404(15) 
C(22)-H(22)  0.9500 
C(23)-C(24)  1.37(3) 
C(23)-H(23)  0.9500 
C(24)-C(25)  1.39(3) 
C(24)-Br(3)  1.912(12) 
C(25)-C(26)  1.407(15) 
C(25)-H(25)  0.9500 
C(26)-H(26)  0.9500 
C(27)-C(32)  1.38(2) 
C(27)-C(28)  1.41(2) 
C(28)-C(29)  1.407(16) 
C(28)-H(28)  0.9500 
C(29)-C(30)  1.37(3) 
C(29)-H(29)  0.9500 
C(30)-C(31)  1.38(2) 
C(30)-Br(4)  1.909(12) 
C(31)-C(32)  1.407(15) 
C(31)-H(31)  0.9500 
C(32)-H(32)  0.9500 
C(33)-C(38)  1.37(3) 
C(33)-C(34)  1.42(3) 
C(34)-C(35)  1.402(15) 
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Table 3. Continued 
C(34)-H(34)  0.9500 
C(35)-C(36)  1.37(3) 
C(35)-H(35)  0.9500 
C(36)-C(37)  1.39(3) 
C(36)-Br(5)  1.911(12) 
C(37)-C(38)  1.404(15) 
C(37)-H(37)  0.9500 
C(38)-H(38)  0.9500 
C(39)-C(44)  1.38(3) 
C(39)-C(40)  1.41(3) 
C(40)-C(41)  1.405(15) 
C(40)-H(40)  0.9500 
C(41)-C(42)  1.37(3) 
C(41)-H(41)  0.9500 
C(42)-C(43)  1.39(3) 
C(42)-Br(6)  1.909(12) 
C(43)-C(44)  1.410(15) 
C(43)-H(43)  0.9500 
C(44)-H(44)  0.9500 
 
O(2)-B(1)-O(1) 107.8(7) 
O(2)-B(1)-N(3) 116.7(7) 
O(1)-B(1)-N(3) 106.8(7) 
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Table 3. Continued 
O(2)-B(1)-N(1) 106.1(7) 
O(1)-B(1)-N(1) 116.2(7) 
N(3)-B(1)-N(1) 103.6(7) 
C(3)-N(1)-C(1) 110.1(6) 
C(3)-N(1)-B(1) 122.4(7) 
C(1)-N(1)-B(1) 125.7(7) 
C(2)-N(2)-C(1) 117.0(7) 
C(6)-N(3)-C(2) 109.4(7) 
C(6)-N(3)-B(1) 122.6(7) 
C(2)-N(3)-B(1) 125.9(7) 
C(16)-O(1)-B(1) 113.0(6) 
C(10)-O(2)-B(1) 114.2(6) 
N(2)-C(1)-N(1) 123.8(7) 
N(2)-C(1)-C(5) 127.7(7) 
N(1)-C(1)-C(5) 108.2(7) 
N(2)-C(2)-N(3) 124.0(7) 
N(2)-C(2)-C(8) 127.7(8) 
N(3)-C(2)-C(8) 107.6(7) 
N(1)-C(3)-C(4) 106.4(7) 
N(1)-C(3)-C(9) 117.8(7) 
C(4)-C(3)-C(9) 134.0(7) 
C(5)-C(4)-C(3) 110.0(7) 
C(5)-C(4)-Br(1) 125.0(6) 
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Table 3. Continued 
C(3)-C(4)-Br(1) 125.0(6) 
C(4)-C(5)-C(27) 132.1(10) 
C(4)-C(5)-C(1) 104.5(7) 
C(27)-C(5)-C(1) 123.4(10) 
C(4)-C(5)-C(21) 127.7(10) 
C(27)-C(5)-C(21) 8(2) 
C(1)-C(5)-C(21) 127.1(10) 
N(3)-C(6)-C(7) 107.2(7) 
N(3)-C(6)-C(15) 115.8(8) 
C(7)-C(6)-C(15) 136.0(8) 
C(8)-C(7)-C(6) 108.8(7) 
C(8)-C(7)-Br(2) 126.6(7) 
C(6)-C(7)-Br(2) 124.5(6) 
C(7)-C(8)-C(2) 106.3(7) 
C(7)-C(8)-C(39) 127.0(10) 
C(2)-C(8)-C(39) 126.5(10) 
C(7)-C(8)-C(33) 128.6(10) 
C(2)-C(8)-C(33) 125.1(9) 
C(39)-C(8)-C(33) 3(3) 
C(14)-C(9)-C(10) 118.4(8) 
C(14)-C(9)-C(3) 125.5(8) 
C(10)-C(9)-C(3) 115.8(7) 
O(2)-C(10)-C(11) 118.1(8) 
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Table 3. Continued 
O(2)-C(10)-C(9) 122.8(8) 
C(11)-C(10)-C(9) 119.0(8) 
C(12)-C(11)-C(10) 120.9(8) 
C(12)-C(11)-H(11) 119.5 
C(10)-C(11)-H(11) 119.5 
C(11)-C(12)-C(13) 119.5(8) 
C(11)-C(12)-H(12) 120.3 
C(13)-C(12)-H(12) 120.3 
C(14)-C(13)-C(12) 121.6(8) 
C(14)-C(13)-H(13) 119.2 
C(12)-C(13)-H(13) 119.2 
C(13)-C(14)-C(9) 120.5(8) 
C(13)-C(14)-H(14) 119.7 
C(9)-C(14)-H(14) 119.7 
C(16)-C(15)-C(20) 119.0(8) 
C(16)-C(15)-C(6) 117.8(8) 
C(20)-C(15)-C(6) 123.0(8) 
O(1)-C(16)-C(17) 117.7(8) 
O(1)-C(16)-C(15) 122.2(7) 
C(17)-C(16)-C(15) 120.1(8) 
C(18)-C(17)-C(16) 119.9(9) 
C(18)-C(17)-H(17) 120.0 
C(16)-C(17)-H(17) 120.0 
C(19)-C(18)-C(17) 120.1(9) 
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Table 3. Continued 
C(19)-C(18)-H(18) 120.0 
C(17)-C(18)-H(18) 120.0 
C(20)-C(19)-C(18) 121.6(9) 
C(20)-C(19)-H(19) 119.2 
C(18)-C(19)-H(19) 119.2 
C(19)-C(20)-C(15) 119.3(9) 
C(19)-C(20)-H(20) 120.4 
C(15)-C(20)-H(20) 120.4 
C(26)-C(21)-C(22) 119.1(13) 
C(26)-C(21)-C(5) 122.6(18) 
C(22)-C(21)-C(5) 118.2(18) 
C(23)-C(22)-C(21) 119.7(13) 
C(23)-C(22)-H(22) 120.2 
C(21)-C(22)-H(22) 120.2 
C(24)-C(23)-C(22) 118.7(13) 
C(24)-C(23)-H(23) 120.6 
C(22)-C(23)-H(23) 120.6 
C(23)-C(24)-C(25) 123.7(12) 
C(23)-C(24)-Br(3) 114.8(17) 
C(25)-C(24)-Br(3) 121.3(15) 
C(24)-C(25)-C(26) 116.9(13) 
C(24)-C(25)-H(25) 121.6 
C(26)-C(25)-H(25) 121.6 
C(21)-C(26)-C(25) 121.8(14) 
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Table 3. Continued 
C(21)-C(26)-H(26) 119.1 
C(25)-C(26)-H(26) 119.1 
C(32)-C(27)-C(28) 118.1(13) 
C(32)-C(27)-C(5) 124.7(17) 
C(28)-C(27)-C(5) 117.0(19) 
C(29)-C(28)-C(27) 121.4(14) 
C(29)-C(28)-H(28) 119.3 
C(27)-C(28)-H(28) 119.3 
C(30)-C(29)-C(28) 118.1(14) 
C(30)-C(29)-H(29) 121.0 
C(28)-C(29)-H(29) 121.0 
C(31)-C(30)-C(29) 122.6(12) 
C(31)-C(30)-Br(4) 122.9(15) 
C(29)-C(30)-Br(4) 114.3(16) 
C(30)-C(31)-C(32) 118.8(13) 
C(30)-C(31)-H(31) 120.6 
C(32)-C(31)-H(31) 120.6 
C(27)-C(32)-C(31) 121.0(13) 
C(27)-C(32)-H(32) 119.5 
C(31)-C(32)-H(32) 119.5 
C(38)-C(33)-C(34) 119.0(13) 
C(38)-C(33)-C(8) 120.4(19) 
C(34)-C(33)-C(8) 120.6(19) 
C(35)-C(34)-C(33) 120.4(13) 
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Table 3. Continued 
C(35)-C(34)-H(34) 119.8 
C(33)-C(34)-H(34) 119.8 
C(36)-C(35)-C(34) 118.0(13) 
C(36)-C(35)-H(35) 121.0 
C(34)-C(35)-H(35) 121.0 
C(35)-C(36)-C(37) 123.8(12) 
C(35)-C(36)-Br(5) 117.2(18) 
C(37)-C(36)-Br(5) 118.9(16) 
C(36)-C(37)-C(38) 116.9(13) 
C(36)-C(37)-H(37) 121.6 
C(38)-C(37)-H(37) 121.6 
C(33)-C(38)-C(37) 121.9(14) 
C(33)-C(38)-H(38) 119.0 
C(37)-C(38)-H(38) 119.0 
C(44)-C(39)-C(40) 119.4(13) 
C(44)-C(39)-C(8) 119(2) 
C(40)-C(39)-C(8) 121.6(19) 
C(41)-C(40)-C(39) 120.4(13) 
C(41)-C(40)-H(40) 119.8 
C(39)-C(40)-H(40) 119.8 
C(42)-C(41)-C(40) 117.8(13) 
C(42)-C(41)-H(41) 121.1 
C(40)-C(41)-H(41) 121.1 
C(43)-C(42)-C(41) 123.8(12) 
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Table 3. Continued 
C(43)-C(42)-Br(6) 123.0(16) 
C(41)-C(42)-Br(6) 113.1(17) 
C(42)-C(43)-C(44) 117.3(13) 
C(42)-C(43)-H(43) 121.4 
C(44)-C(43)-H(43) 121.4 
C(39)-C(44)-C(43) 121.2(14) 
C(39)-C(44)-H(44) 119.4 
C(43)-C(44)-H(44) 119.4 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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 Table 4.   Anisotropic displacement parameters  (Å2x 103) for KBB0908.  The anisotropic 
displacement factor exponent takes the form:  -2π 2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
B(1) 25(6)  28(6) 24(5)  6(5) 7(4)  2(5) 
Br(1) 38(1)  25(1) 30(1)  3(1) 2(1)  7(1) 
Br(2) 44(1)  124(1) 44(1)  36(1) 20(1)  54(1) 
N(1) 20(4)  19(4) 19(4)  2(3) 2(3)  -1(3) 
N(2) 12(4)  19(4) 31(4)  -5(3) 5(3)  2(3) 
N(3) 15(4)  27(4) 23(4)  -2(3) 3(3)  0(3) 
O(1) 29(3)  26(3) 24(3)  -2(3) 11(3)  -4(3) 
O(2) 26(3)  28(3) 22(3)  -1(3) 5(3)  -4(3) 
C(1) 17(4)  18(4) 29(5)  7(4) 5(4)  1(4) 
C(2) 17(4)  21(5) 27(5)  3(4) 3(4)  -7(4) 
C(3) 30(5)  13(4) 14(4)  6(4) 0(4)  -5(4) 
C(4) 22(5)  19(5) 28(5)  -6(4) 2(4)  6(4) 
C(5) 32(5)  15(4) 23(5)  -8(4) -1(4)  -1(4) 
C(6) 21(5)  25(5) 33(5)  -1(4) 7(4)  -4(4) 
C(7) 25(5)  24(5) 29(5)  -2(4) 7(4)  8(4) 
C(8) 16(4)  28(5) 30(5)  5(4) 6(4)  6(4) 
C(9) 27(5)  26(5) 25(5)  -4(4) 3(4)  -7(4) 
C(10) 19(5)  27(5) 28(5)  2(4) 4(4)  -14(4) 
C(11) 29(5)  27(5) 28(5)  -5(4) 13(4)  -4(4) 
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Table 4. Continued 
C(12) 43(6)  39(6) 20(5)  7(5) 13(4)  -7(5) 
C(13) 37(6)  31(5) 26(5)  12(5) 8(4)  1(5) 
C(14) 33(5)  30(5) 26(5)  -2(4) 11(4)  -9(4) 
C(15) 24(5)  27(5) 30(5)  -12(4) 8(4)  -8(4) 
C(16) 30(5)  39(6) 24(5)  -7(5) 16(4)  -8(5) 
C(17) 37(6)  43(6) 28(5)  -6(5) 10(4)  -7(5) 
C(18) 33(6)  34(6) 50(6)  -10(5) 17(5)  -6(5) 
C(19) 22(5)  46(6) 48(6)  -15(6) 13(5)  -4(5) 
C(20) 36(6)  28(5) 32(5)  -9(4) 11(4)  -5(4) 
C(21) 18(5)  16(5) 28(5)  0(4) 6(4)  1(5) 
C(22) 21(5)  14(5) 34(5)  1(5) 3(5)  0(5) 
C(23) 24(5)  20(5) 37(5)  -3(5) 3(5)  2(5) 
C(24) 25(5)  21(5) 32(5)  -5(5) 6(5)  -2(5) 
C(25) 30(5)  26(5) 31(5)  -3(5) 8(5)  0(5) 
C(26) 23(5)  18(5) 33(5)  -2(5) 5(5)  2(5) 
Br(3) 53(3)  12(4) 61(3)  -3(3) 36(2)  7(3) 
C(27) 18(5)  15(5) 30(5)  0(4) 5(4)  1(5) 
C(28) 24(5)  20(5) 31(5)  4(4) 5(4)  0(4) 
C(29) 25(5)  26(5) 34(5)  -2(5) 0(5)  0(5) 
C(30) 23(5)  21(5) 32(5)  -6(5) 7(5)  0(5) 
C(31) 23(6)  22(5) 31(6)  -6(5) 3(5)  -3(5) 
C(32) 13(5)  18(5) 29(5)  -4(5) 4(5)  -3(5) 
Br(4) 41(3)  11(4) 57(3)  -5(3) 31(2)  2(3) 
C(33) 17(4)  23(5) 24(5)  -2(4) 6(4)  2(4) 
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Table 4. Continued 
C(34) 21(5)  22(5) 24(5)  -3(5) 9(4)  2(4) 
C(35) 24(5)  20(5) 29(5)  -3(5) 7(4)  1(5) 
C(36) 28(5)  20(4) 28(5)  -2(4) 4(4)  0(4) 
C(37) 27(5)  23(5) 29(5)  -6(5) 1(5)  7(5) 
C(38) 22(5)  26(5) 24(5)  0(5) 5(4)  4(5) 
Br(5) 45(3)  9(4) 25(2)  -5(3) 14(2)  -10(3) 
C(39) 17(5)  23(5) 24(5)  -2(4) 6(4)  2(4) 
C(40) 20(5)  20(5) 25(5)  1(5) 6(4)  -2(5) 
C(41) 25(5)  22(5) 28(5)  -1(5) 4(5)  1(5) 
C(42) 28(5)  20(5) 27(5)  -2(4) 5(4)  0(4) 
C(43) 26(5)  23(5) 27(5)  -2(5) 2(5)  9(5) 
C(44) 21(5)  25(5) 22(5)  -1(5) 3(4)  6(5) 
Br(6) 51(2)  13(4) 26(2)  -8(3) 15(2)  -15(4) 
______________________________________________________________________________ 
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 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for KBB0908. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(11) 2213 4491 2956 32 
H(12) 2851 1979 3541 40 
H(13) 3623 -1756 3460 38 
H(14) 3689 -3156 2806 35 
H(17) 92 520 2180 43 
H(18) -1047 3139 2102 45 
H(19) -1271 6837 1654 45 
H(20) -364 8101 1289 38 
H(22) 4185 -5449 1247 29 
H(23) 5014 -6114 794 33 
H(25) 5189 1999 662 35 
H(26) 4305 2651 1086 30 
H(28) 5097 -986 1634 30 
H(29) 5933 -1545 1184 36 
H(31) 4015 -2414 192 31 
H(32) 3181 -1686 638 24 
H(34) 2999 6689 566 26 
H(35) 3305 7530 -82 29 
H(37) 975 6873 -700 33 
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Table 5. Continued 
H(38) 678 6241 -45 29 
H(40) 2110 2371 215 26 
H(41) 2354 3243 -448 30 
H(43) 1803 11150 -350 32 
H(44) 1504 10205 299 28 
________________________________________________________________________________  
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 APPENDIX C 
EXPERIMENTAL DATA FOR CHAPTER IV 
 
General Procedures. 
  Melting points are uncorrected.  High field NMR spectra were recorded on Varian Unity 
Plus (1H at 300 MHz, 13C at 75 MHz) NMR spectrometers.  Chemical shifts are reported in units 
of ppm relative to solvent (CDCl3: 7.27 ppm for 1H, 77.0 ppm for 13C; Acetone-d6: 2.04 ppm for 
1H, 29.9 ppm for 13C;  DMSO-d6: 2.50 ppm for 1H, 39.5 ppm for 13C; D2O: 4.63 ppm for 1H; 
CD3OD: 3.30 ppm for 1H, 49.0 ppm for 13C;  77.0 ppm for 13C; CD3CN: 1.93 ppm for 1H, 1.3 ppm 
for 13C).  Mass spectra were obtained from the Mass Spectrometry Applications Laboratory at 
Texas A&M University.  Thin layer chromatography was performed using silica gel (230-600 
mesh).  CH2Cl2, THF, DMF, methanol, triethylamine, and toluene were distilled from appropriate 
drying agents.  Other chemicals were purchased from commercial suppliers and used as 
received. 
 UV spectra were recorded in 1 cm path length quartz cuvettes on a Milton Roy Spectronic 
3000 diode array UV spectrometer at concentrations between 1 and 10 µM.  Fluorescence 
emission spectra were recorded in 1 cm path length quartz cells on a SLM Aminco Fluorimeter.  
All fluorescence spectra were recorded at a concentration of 1.0 µM. 
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5-iodo-2,3,3-trimethyl-3H-indole  
 
  
 
  
5-Iodo-2,3,3-trimethyl-3H-indole was synthesized according to the procedure described in the 
literature.[Moreau, 1974 #7750]  The data obtained matched the ones reported in the literature.  
δH (300 MHz, CDCl3): 7.45 – 7.42 (m, 2H), 7.10 (m, 1H); δC (75.4 MHz, CDCl3): 187.9, 153.2, 
147.9, 136.4, 130.4, 121.6, 89.7, 60.0, 53.7, 20.7, 13.9. 
 
N
I
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Ethyl 2-(5-iodo-3,3-dimethyl-2-methyleneindolin-1-yl)acetate (305b) 
 
 
 
 
  5-Iodo-2,3,3-trimethyl-3H-indole (1.00 g, 3.50 mmol) and ethyl iodoacetate (0.901 g, 
4.21 mmol) were weighed into a sealed tube.  The mixture was heated at 85°C for 12 h.  After 
cooling to room temperature, 1N NaOH solution (20 mL) was added and stirred for 1 h.  The 
reaction mixture was extracted with dichloromethane three times.  The organic layers were 
combined and evaporated to a residue which was purified by flash column chromatography in 
10% EtOAc/hexane to give the product as a brown oil (0.988 g, 76%). δH (300 MHz, CDCl3): 7.40 
(dd, J=9.0 Hz, J= 2.0 Hz, 1H), 7.36 (d, J=2.0 Hz, 1H), 6.30 (dd, J=9.0 Hz, J= 2.0 Hz, 1H), 4.19 
(q, J=8.0 Hz, 2H), 4.19 (s, 2H), 3.94 (d, J=3.0 Hz, 1H), 3.87 (d, J=3.0 Hz, 1H),1.35 (s, 6H), 1.24 
(t, J=8.0 Hz, 3H);  δC (75.4 MHz, CDCl3): 168.6, 160.8, 145.35, 140.27, 136.30, 131.07, 107.51, 
80.71, 75.53, 61.47, 44.41, 44.25, 30.04, 14.34; HR-MS (MALDI) for C15H19INO2 (M+H+) calc'd 
372.0461, found 372.0445. 
 
 
 
 
 
N
I
EtO2C
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1H NMR for compound 305b  (300 MHz, CDCl3). 
 
 
 
 
  
386 
 
13C  NMR for compound 305b  (75 MHz, CDCl3). 
 
  
387 
Ethyl 2-(5-(9H-carbazol-9-yl)-3,3-dimethyl-2-methyleneindolin-1-yl)acetate 
(306b) 
 
 
 
 
 
  Compound 305b (200 mg, 0.54 mmol), carbazole (90 mg, 0.54 mmol), 1,2-trans-
diaminocyclohexane (12 mg, 0.11 mmol), CuI (5 mg, 0.03 mmol), and Cs2CO3 (369 mg, 
1.13 mmol) were weighed into a round-bottom flask, then dioxane (2 mL) was added.  The 
mixture was heated at 100°C for 17 h.  After cooling to room temperature, the reaction mixture 
was diluted with ether and filtered through a pad of celite.  The residue after removal of solvent 
was purified by flash column chromatography using 20% EtOAc/hexane to give the product as a 
white solid (134 mg, 53%). δH (300 MHz, CDCl3): 8.16 (d, J=8.0 Hz, 2H), 7.43–7.26 (m, 8H), 6.68 
(d, J=8.0 Hz, 1H), 4.33 (s, 2H), 4.28 (q, J=8.0 Hz, 2H), 4.02 (d, J=3.0 Hz, 1H), 3.96 (d, J=3.0 Hz, 
1H), 1.45 (s, 6H), 1.32 (t, J=8.0 Hz, 3H); δC (300 MHz, CDCl3): 168.94, 161.48, 144.99, 141.71, 
139.22, 136.35, 131.12, 129.38, 126.95, 125.96, 123.21, 121.67, 120.47, 120.41, 119.67, 
119.54, 110.76, 110.00, 107.53, 105.79, 75.71, 61.59, 44.63, 44.52, 30.20,14.43. 
 
 
N
N
EtO2C
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1H NMR for compound 306b (300 MHz, CDCl3). 
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13C NMR for compound 306b (75 MHz, CDCl3). 
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Compound 303b 
 
 
 
 
 
 
 
 
 Compound 306b (24 mg, 0.06 mmol) and squaric acid (3 mg, 0.03 mmol) were placed in a 
round-bottom flask.  A mixture of n-BuOH/toluene (15 mL, 1:1 v/v) was added.  The mixture was 
refluxed for 16 h.  Water was azeotropically removed by using a Dean–Stark trap.  After cooling 
to room temperature, the reaction mixture was filtered to give a dark-blue solid, which was 
further washed with ether three times (15 mg, 66%).  A sample for analysis was obtained by 
further purification through flash column chromatography. δH (300 MHz, CDCl3) 8.16 (d, 
J=8.0 Hz, 4H), 7.56–7.27 (m, 16H), 7.10 (d, J=8.0 Hz, 2H), 6.02 (s, 2H), 4.33 (q, J=7.2 Hz, 4H), 
1.83 (br s, 12H), 1.36 (t, J=7.2 Hz, 6 H); δC (75 MHz, CDCl3) 171.1, 141.2, 134.3, 127.1, 126.2, 
123.5, 121.8, 121.7, 120.6, 120.3, 110.1, 109.7, 88.2, 67.0, 62.7; HR-MS (MALDI) for 
C58H51N4O6 (M+H+) calcd 899.3809, found 899.3825. 
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1H NMR for compound 303b (300 MHz, CDCl3). 
 
 
 
 
 
13C NMR for compound 303b (75 MHz, CDCl3). 
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Compound 311 
 
 
 
 
 
 
 A schlenk tube equipped with a stir bar is charged with phenothiazine (1.00 g, 5.02 mmol), 4-
bromophenylethynyl trimethyl silane 310 (1.15 g, 4.56 mmol), Pd2(dba)3 (0.05 g, 0.06 mmol) and 
sodium tert-butoxide (0.61 g, 6.38 mmol).  The tube is purged with nitrogen, then the ligand (0.05 
g, 0.18 mmol) is added inside the glove box.  Toluene (5 mL) is finally added and the reaction 
mixture is heated at 85 °C until completion of the reaction according to tlc (~ 3 h).  The reaction 
is then cooled to room temperature, diluted with ether and filtered over celite.  After removal of 
the solvents, the residue obtained is purified by column chromatography eluted with 5 % ethyl 
acetate:hexanes.  The titled compound is obtained in 34 % yield (0.57 g) as a white solid. δH 
(300 MHz, CDCl3) 7.64 (d, J= 8.5 Hz, 2H), 7.28 (d, J= 8.5 Hz, 2H), 7.07 – 7.04 (m, 2H), 6.92 – 
6.82 (m, 4H), 6.32 – 6.29 (m, 2H), 0.28 (s, 9H) ; δC (75 MHz, CDCl3) 143.8, 141.7, 134.4, 129.2, 
127.2, 127.0, 123.2, 122.4, 122.0, 117.4, 104.4, 95.6, 0.15. 
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1H NMR for compound 311 (300 MHz, CDCl3). 
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13C NMR for compound 311 (75 MHz, CDCl3). 
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Compound 312 
 
 
 
 
  
 
 
To a solution of 311 (0.57g, 1.54 mmol) in freshly distilled THF (5 mL) was added a solution 
of tetrabutyl ammonium fluoride (1.0 M, in THF, 2.15 mL).  The reaction mixture was stirred at 
room temperature for 1h, and the solvent removed in vacuo.  The residual oil obtained was then 
purified on silica gel with 5 % ethyl acetate:hexanes to give the desired product in 25 % (0.52 g). 
δH (300 MHz, CDCl3) 7.64 (d, J= 8.5 Hz, 2H), 7.28 (d, J= 8.5 Hz, 2H), 7.09 – 7.06 (m, 2H), 6.94 – 
6.83 (m, 4H), 6.38 – 6.35 (m, 2H), 3.14 (s, 1H). 
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1H NMR for compound 312 (300 MHz, CDCl3). 
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Compound 313c 
 
 
 
 
 
 
 
 
 A dried-flame Schlenk tube is charged with 312 (0.07g, 0.23 mmol), 305b (0.06g, 0.15 
mmol), copper iodide (0.001 g, 0.007 mmol), Pd(PPh3)4 (0.009g, 0.007 mmol), triethyl amine 
(0.31g, 3.02 mmol) and 2 mL of toluene.  The reaction mixture is heated under nitrogen at 85 °C 
for 12h.  After cooling to room temperature, it is then diluted with ether and filtered over celite.  
The solvent are removed in vacuo and the residual oil purified on silica gel with 30% ethyl 
acetate:hexanes to give the titled compound in 19% yield (0.09 g). δH (300 MHz, CDCl3) 7.70 (d, 
J= 8.5 Hz, 2H), 7.38 – 7.26 (m, 4H), 7.06 (dd, J= 7 Hz, J= 1.4 Hz, 2H), 6.94 – 6.83 (m, 4H), 6.50 
(d, J= 8Hz, 1H), 6.33 (dd, J= 8 Hz, J= 1.4 Hz, 2H), 4.25 (s, 2H), 4.21 (q, J= 7 Hz, 2H), 3.96 (dd, 
J= 22.7 Hz, J= 2.7 Hz, 2H), 1.41 (s, 6H), 1.26 (t, J=7 Hz, 3H); δC (300 MHz, CDCl3) 168.6, 161.1, 
145.9, 144.0, 140.7, 137.8, 133.7, 132.1, 129.8, 127.8, 127.0, 125.6, 123.5, 123.0, 121.5, 113.3, 
105.3, 91.9, 86.9. 76.1, 61.5, 44.3, 30.8, 14.3 (2 carbons not seen). 
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1H NMR for compound 313 (300 MHz, CDCl3). 
 
 
 
 
13C NMR for compound 313 (75 MHz, CDCl3). 
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Compound 309c 
 
 
 
 
 
 
 
  
 
Compound 313c (17 mg, 0.03 mmol) and squaric acid (2 mg, 0.02 mmol) were placed in a 
round-bottom flask.  A mixture of n-BuOH/toluene (20 mL, 1:1 v/v) was added.  The mixture was 
refluxed for 48 h.  Water was azeotropically removed by using a Dean–Stark trap.  After cooling 
to room temperature, the reaction mixture was filtered to give a dark-blue solid, which was 
further washed with ether three times.  The titled compound was further purified by flash column 
chromatography eluted first with 40% ethyl acetate:CH2Cl2 then with 20% acetone: CH2Cl2 + 1% 
MeOH. δH (300 MHz, CDCl3) 7.71 (d, J= 8.3 Hz, 4 H), 7.55 (bs, 2H), 7.52 (d, J= 8 Hz, 2H), 7.34 
(d, J= 8.3 Hz, 4 H), 7.10 (dd, J= 1.7 Hz, J= 7.3 Hz, 4H), 6.97 – 6.86 (m, 10H), 6.41 (dd, J= 1.4 
Hz, J= 7.8 Hz, 4H), 5.91 (bs, 2H), 4.28 (q, J=7 Hz, 4H), 1.62 (s, 12 H), 1.30 (t, J=7 Hz, 6H) ; δC 
(75 MHz, CDCl3) 170.9, 143.9, 141.8, 133.9, 132.1, 129.1, 127.3, 127.2, 125.9, 123.4, 122.5, 
122.3, 119.1, 117.8, 109.2, 90.5, 89.4, 62.7, 27.5, 14.3 (5 carbons not seen). 
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1H NMR for compound 309c (300 MHz, CDCl3). 
 
 
 
 
13C NMR for compound 309c (75 MHz, CDCl3). 
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APPENDIX D 
EXPERIMENTAL DATA FOR CHAPTER V 
 
General Procedures. 
  Melting points are uncorrected.  High field NMR spectra were recorded on Varian Unity 
Plus (1H at 300 MHz, 13C at 75 MHz) NMR spectrometers.  Chemical shifts are reported in units 
of ppm relative to solvent (CDCl3: 7.27 ppm for 1H, 77.0 ppm for 13C; Acetone-d6: 2.04 ppm for 
1H, 29.9 ppm for 13C;  DMSO-d6: 2.50 ppm for 1H, 39.5 ppm for 13C; D2O: 4.63 ppm for 1H; 
CD3OD: 3.30 ppm for 1H, 49.0 ppm for 13C;  77.0 ppm for 13C; CD3CN: 1.93 ppm for 1H, 1.3 ppm 
for 13C).  Mass spectra were obtained from the Mass Spectrometry Applications Laboratory at 
Texas A&M University.  Thin layer chromatography was performed using silica gel (230-600 
mesh).  CH2Cl2, THF, DMF, methanol, triethylamine, and toluene were distilled from appropriate 
drying agents.  Other chemicals were purchased from commercial suppliers and used as 
received. 
 UV spectra were recorded in 1 cm path length quartz cuvettes on a Milton Roy Spectronic 
3000 diode array UV spectrometer at concentrations between 1 and 10 µM.  Fluorescence 
emission spectra were recorded in 1 cm path length quartz cells on a SLM Aminco Fluorimeter.  
All fluorescence spectra were recorded at a concentration of 1.0 µM. 
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Carboxy-fluorescein diacetate (5- and 6-isomers, 334)  
 
  
 
 
 
 Trimellitic anhydride (10g, 52 mmol) was added to a solution of resorcinol (11.5g, 104 mmol) 
in methanesulfonic acid (1M).  The resulting mixture was heated under dry nitrogen at 80 – 85 
°C for 48h.  The cooled mixture was poured into 7 volumes of ice water, and filtered.  The 
product is then dried in vacuo at 60  °C to constant weight. 
 The dried fluorescein was then converted to the diacetate by refluxing in acetic anhydride for 
2 h.  After cooling, the solvent was removed and the residue dried in vacuo.  The product 
obtained was used such as in the next step. 
Crude δH (CDCl3, 300 MHz) 11.2 (s, 2H), 8.36 (d, J= 14.3 Hz, 1H), 8.03 – 7.97 (m, 2H), 7.80 – 
7.75 (m, 1H), 7.49 (d, J=18.4 Hz), 6.98 – 6.91 (m, 2H), 6.77 (s, 3H), 6.50 – 6.42 (m, 8H), 1.96 (s, 
6H), 1.86 (s, 6H). 
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Crude 1H NMR for compound 334 (300 MHz, CDCl3). 
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5- and 6-(Hydroxymethy)fluorescein Diacetate (335) 
 
 
 
 
 
 
 
  5- (6)-Carboxyfluorescein diacetate 334 (3.83 g, 8.3 mmol) and triethylamine (1.3 mL, 
9.1 mmol) were dissolved in THF (40 mL) under a nitrogen atmosphere and cooled to 0 °C.  
Ethyl chloroformate (0.9 mL, 9.1 mmol) was added at once and the mixture stirred for 1 h.  
Afterward, the mixture was filtered and added to a sodium phosphate buffer (23 mL, 1 M, pH 6) 
which had been cooled to 0 °C.  NaBH4  (0.755 mg, 20 mmol) in water (7.5 mL) was then added 
portionwise with efficient stirring over 5 min.  The reaction was then immediately poured into cold 
water (125 mL) and extracted with ethyl acetate (3 x 75 mL).  The extracts were washed with 
saturated sodium chloride (2 x 30 mL), dried over anhydrous sodium sulfate, and evaporated to 
give the mixed 5- and 6- (hydroxymethyl) fluorescein diacetate.  The isomers were separated by 
column chromatography eluted with CH2Cl2/Et2O (9:1).  The first eluting compound was the 6- 
isomer (0.55 g, 15 %), the second eluting compound was the 5-isomer (0.94 g, 25 % ) 
6-isomer:  δH (300 MHz, CDCl3) 7.98 (d, J= 8 Hz, 1H), 7.58 (dd, J= 8Hz, J= 1.2 Hz, 1H), 7.15 (s, 
1H), 7.08 (d, J= 2 Hz, 2H), 6.85 – 6.79 (m, 4H), 4.78 (s, 2H), 2.30 (s, 6H); δC (75 MHz, CDCl3) 
169.0, 168.8, 153.6, 151.9, 151.3, 149.5, 128.9, 128.1, 125.1, 124.8, 121.3, 117.7, 116.3, 110.3, 
81.4, 64.1, 21.0. 
5-isomer:  δH (500 MHz, CDCl3) δ 8.03 (d, J= 8 Hz, 1H), 7.67 (dd, J= 8Hz, J= 1.2 Hz, 1H), 7.14 
(d, J= 8 Hz, 1H), 7.08 (d, J= 2 Hz, 2H), 6.82 – 6.78 (m, 4H), 4.82 (s, 2H), 2.30 (s, 6H); δC 
(125 MHz, CDCl3) δ 169.1, 168.8, 151.9, 151.8, 151.4, 143.8, 133.9, 128.8, 126.3, 124.0, 122.9, 
117.6, 116.3, 110.3, 81.7, 63.9, 21.0. 
These data matches the ones reported in the literature.1 
(1) Mattingly, P. G. Bioconjugate Chem. 1992, 3, 430-1. 
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1H NMR for compound 335  (5-isomer)  (500 MHz, CDCl3). 
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13 C NMR for compound 335 (5-isomer)  (125 MHz, CDCl3). 
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1H NMR for compound 335  (6- isomer)  (300 MHz, CDCl3). 
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13C NMR for compound 335 ( 6- isomer)  (75 MHz, CDCl3).  
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5- Carboxyaldehyde Fluorescein Diacetate (332) 
 
 
 
 
 
 
 
  PCC (0.67 g, 3.1 mmol) was added to a suspension of 5-(hydroxymethyl) fluorescein 
diacetate 335 (0.94 g, 2.1 mmol), molecular sieves 4Å, celite in 50 mL of CH2Cl2.  After stirring at 
room temperature for 30 min, the reaction mixture is filtered over a pad of silica.  The desired 
product was obtained as an off white solid (0.76 g, 82%) after the solvent was evaporated. δH 
(500 MHz, CDCl3) 10.1 (s, 1H), 8.21 – 8.15 (m, 2H), 7.68 (s, 1H), 7.14 (d, 2H, J= 2Hz), 6.86 – 
6.81 (m, 4H), 2.33 (s, 6H); δC (125 MHz, CDCl3) 190.0, 168.7, 167.6, 157.7,  152.2, 151.3, 138.0, 
135.3, 128.6, 127.2, 127.0, 125.0, 117.9, 115.3, 110.6, 81.8, 21.0; MS (APCI) for C25H16O8 
(M+H+) calcd 445.39, found 445.0. 
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1H NMR for compound 332 (500 MHz, CDCl3).  
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13C NMR for compound 332 (125 MHz, CDCl3). 
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Compound 330 
 
 
 
 
 
 
 
 
 5-Carboxyaldehyde fluorescein diacetate 332 (50 mg, 0.1 mmol) and 8-hydroxyjulodinone 
(42 mg, 0.2 mmol) in 2 mL of trifluoromethane sulfonic acid were heated at 85 °C for 12h.  The 
cooled reaction mixture was then extracted with 25% iPrOH:CHCl3 (3 x 25 mL).  The combined 
organic layer were concentrated to half, and then oxidized with chloranil (50 mg) for 30 min.  The 
solution was filtered over celite, and the solvent evaporated.  The residue was purified by column 
chromatography with 5% MeOH:CH2Cl2. A sample for analysis was obtained by further 
purification by HPLC. δH (500 MHz, 1:1 CDCl3:CD3OD) δ 8.20 (d, 1H, J = 7.8 Hz), 7.58 (dd, 1H, J 
= 7.8 Hz, J = 1.5 Hz), 7.07 (s, 1H), 6.70 – 6.57 (m, 8H), 3.50 -  3.37 (m, 8H), 2.96 (t, 4H, J = 6.1 
Hz), 2.67 – 2.63 (m, 2H), 2.58 – 2.54 (m, 2H), 2.07 – 2.05 (m, 4H), 1.96 – 1.92 (m, 4H); δC (125 
MHz, 1:1 CDCl3:CD3OD) δ 169.2, 152.8, 152.1, 151.7, 151.4, 139.5, 131.2, 128.8, 127.8, 126.0, 
125.8, 124.3, 112.8, 112.1, 109.0, 53.5, 51.0, 50.5, 27.6, 20.5, 19.9, 19.6; MS (ESI - pos) for 
C45H37N2O6+ (M+) calcd 701.26, found 701.4. 
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1H NMR for compound 330 (500 MHz, 1:1 CDCl3:CD3OD). 
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13C NMR for compound 330 (125 MHz, 1:1 CDCl3:CD3OD). 
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Compound 331 
 
 
 
 
 
 
 
 5-Carboxyaldehyde fluorescein diacetate 332 (50 mg, 0.1 mmol) and 3-dimethylaminophenol 
(31 mg, 0.2 mmol) in 2 mL of trifluoromethane sulfonic acid were heated at 85 °C for 12h.  The 
cooled reaction mixture was then extracted with 25% iPrOH:CHCl3 (3 x 25 mL).  The combined 
organic layer were concentrated to half, and then oxidized with chloranil (50 mg) for 30 min.  The 
solution was filtered over celite, and the solvent evaporated.  The residue was purified by column 
chromatography with 5 to 10 % MeOH:CH2Cl2. A sample for analysis was obtained by further 
purification by HPLC. δH (500 MHz, CD3OD) 8.11 (s, 1H), 7.84 (dd, J= 8 Hz, J= 2 Hz, 1H), 7.50 
(d, J= 8 Hz, 1H), 7.44 (d, J= 9 Hz, 2H), 7.16 (dd, J= 9 Hz, J= 2 Hz, 2H), 7.03 (d, J= 2 Hz, 2H), 
6.81 (d, J= 8 Hz, 2H), 6.71 (d, J= 2 Hz, 2H), 6.61 (dd, J= 8 Hz, J= 2 Hz, 2H), 3.34 (s. 12H); δC 
(500 MHz, 1:1 CDCl3:CD3OD) δ 157.8, 157.6, 155.1, 138.4, 131.5, 131.0, 129.8, 125.1, 121.9, 
118.8, 115.6, 115.0, 113.1, 102.9, 96.8, 40.6 ;  MS (ESI - pos) for C37H29N2O6+ (M+) calcd 597.2, 
found 597.1973. 
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1H NMR for compound 331 (500 MHz, CD3OD). 
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13C NMR for compound 331 (125 MHz, 1:1 CDCl3: CD3OD). 
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APPENDIX E 
EXPERIMENTAL DATA FOR CHAPTER VI 
 
 General Procedures.  
  Melting points are uncorrected.  High field NMR spectra were recorded on Varian 
Unity Plus (1H at 300 MHz, 13C at 75 MHz) NMR spectrometers.  Chemical shifts are reported 
in units of ppm relative to solvent (CDCl3: 7.27 ppm for 1H, 77.0 ppm for 13C; Acetone-d6: 2.04 
ppm for 1H, 29.9 ppm for 13C;  DMSO-d6: 2.50 ppm for 1H, 39.5 ppm for 13C; D2O: 4.63 ppm 
for 1H; CD3OD: 3.30 ppm for 1H, 49.0 ppm for 13C;  77.0 ppm for 13C; CD3CN: 1.93 ppm for 
1H, 1.3 ppm for 13C).  Mass spectra were obtained from the Mass Spectrometry Applications 
Laboratory at Texas A&M University.  Thin layer chromatography was performed using silica gel 
(230-600 mesh).  CH2Cl2, THF, DMF, methanol, triethylamine, and toluene were distilled from 
appropriate drying agents.  Other chemicals were purchased from commercial suppliers and 
used as received. 
 UV spectra were recorded in 1 cm path length quartz cuvettes on a Milton Roy 
Spectronic 3000 diode array UV spectrometer at concentrations between 1 and 10 µM.  
Fluorescence emission spectra were recorded in 1 cm path length quartz cells on a SLM Aminco 
Fluorimeter.  All fluorescence spectra were recorded at a concentration of 1.0 µM. 
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3,6-Diphenylpyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione (342a) 
 
 
 
  
 
 
 
 
To a 25 mL round bottom flask was added benzonitrile (2.6 g, 25 mmol), potassium tert-
butoxide (8.4 g, 75 mmol) and tert-butanol (12 mL).  This mixture was heated to 108 - 110 °C.  
Then, diethyl succinate (2.3 g, 13 mmol) was slowly added over a period of time of 2 hours.  The 
reaction mixture was then allowed to be stirred for an additional 2 hours at 108 – 110 °C, while 
the ethanol generated during the reaction is distilled off.  After cooling, the resulting dark red 
solid is then transferred to a 125 mL erlenmeyer flask and 35 mL of MeOH and 4.4 mL of acetic 
acid were added consecutively.  The red solution is then filtered, the solid washed seeral time 
with MeOH then dried overnight in vacuo. The product was obtained as a red solid in 4 % yield 
(0.27 g). δH (300 MHz, dmso-d6) 7.57 (bs, 6H), 8.47 (bs, 4H), 11.32 (bs, 2H); mp > 300 °C 
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1H NMR for compound 342a (300 MHz, dmso-d6)  
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3,6-Bis(4-chlorophenyl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione (342b). 
 
 
 
  
 
 
 
 
 
 
To a 3 necks 250 mL round bottom flask was added 4-chlorobenzonitrile (5.0 g, 36.3 mmol), 
potassium tert-butoxide (12.2 g, 109.0 mmol) and tert-butanol (30 mL).  This mixture was heated 
to 108 - 110 °C.  Then, diethyl succinate (3.3 g, 18.9 mmol) was slowly added over a period of 
time of 2 hours.  The reaction mixture was then allowed to be stirred for an additional 2 hours at 
108 – 110 °C, while the ethanol generated during the reaction is distilled off.  After cooling, the 
resulting dark red solid is then transferred to a 125 mL erlenmeyer flask and 40 mL of MeOH and 
5 mL of acetic acid were added consecutively.  The red solution is then filtered, the solid washed 
several time with MeOH and ethyl acetate then dried overnight in vacuo.  The product was 
obtained as a dark purple solid in 11 % yield (1.5 g); mp > 300 °C. 
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3,6-Bis(4-bromophenyl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione (342c). 
 
 
 
 
 
 
 
 
 
To a 3 necks 250 mL round bottom flask was added 4-bromobenzonitrile (5.0 g, 27.5 mmol), 
potassium tert-butoxide (9.2 g, 82.4 mmol) and tert-butanol (40 mL).  This mixture was heated to 
108 - 110 °C.  Then, diethyl succinate (2.5 g, 14.3 mmol) was slowly added over a period of time 
of 2 hours.  The reaction mixture was then allowed to be stirred for an additional 2 hours at 108 – 
110 °C, while the ethanol generated during the reaction is distilled off.  After cooling, the 
resulting dark red solid is then transferred to a 125 mL erlenmeyer flask and 40 mL of MeOH and 
5 mL of acetic acid were added consecutively.  The red solution is then filtered, the solid washed 
several time with MeOH and ethyl acetate then dried overnight in vacuo. The product was 
obtained as a dark purple solid in 7 % yield (0.85 g); mp > 300 °C. 
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Ethyl 3-(4-bromophenyl)-3-oxopropanoate (343). 
 
 
 
 
  
Ethyl acetate (4 g, 45.5 mmol) is added dropwise to a cooled solution (- 78 °C) of freshly 
prepared LDA.  The resulting mixture is stirred for an additional 10 min, then 4-bromobenzoyl 
chloride (10 g, 45.5 mmol) is added.  Stirring at - 78 °C is continued for another 10 min, then the 
reaction is quenched with addition of 30 mL of 20 % HCl.  The reaction mixture is then allowed to 
warm up to room temperature.  The organic layer is separated and washed with a solution of 
sodium bicarbonate.  The solvent is removed in vacuo, and the residue distilled (bp 129 – 131 °C 
at 0.6 mm Hg) to give the title product in 67 % (8.3 g) as a clear oil. δH (300 MHz, CDCl3): 7.69 
(d, J = 8.5 Hz, 2H), 7.48 (d, J = 8.5 Hz, 2H), 4.12 (q, J = 7.6 Hz, 2H), 3.87 (s, 2H), 1.14 (t, J = 7.6 
Hz, 3H); δC (75 MHz, CDCl3): 191.1, 169.6, 134.3, 131.3, 129.6, 125.3, 61.0, 45.3, 13.6. 
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1H NMR for compound 343 (300 MHz, CDCl3).  
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13C NMR for compound 343 (75 MHz, CDCl3). 
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Compound 344. 
 
 
 
 
   
 
 
Compound 343 was prepared as described in the literature.1 After sodium metal (0.28 g, 
12.2 mmol) was dissolved in absolute ethanol, ethyl 3-(4-bromophenyl)-3-oxopropanoate (3 g, 
11.1 mmol) was added at room temperature for 1 hour.  The corresponding sodium salt of β-
ketoester, obtained by removing the solvent under reduced pressure at room temperature, was 
suspended in dry ether and a solution of iodine (1.4 g, 5.5 mmol) in dry THF was added 
dropwise with vigorous stirring.  Stirring was continued for 2 days.  The dimerized β-ketoester 
was obtained by simple filtration and distillation. The reaction mixture was stirred at room 
temperature for 2 days, the iodine. δH (300 MHz, CDCl3): 8.04 (d, J = 9 Hz, 4H), 7.68 (d, J = 9 
Hz, 4H), 5.54 (s, 2H), 3.99 (q, J = 7.7 Hz, 4H), 1.01 (t, J = 7.7 Hz, 6H); δC (75 MHz, CDCl3): 
193.2, 136.0, 132.2, 131.1, 130.1, 62.7, 53.5, 14.1. 
 
 
 
 
 
 
 
 
(1) Queignec, R.; Kirschleger, B.; Lambert, F.; Aboutaj, M. Synth. Commun. 1988, 18, 1213-
23 
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1H NMR for compound 344 (300 MHz, CDCl3).  
 
 
 
 
 428 
 
 
13C NMR for compound 344 (75 MHz, CDCl3). 
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Compound 345 
 
 
 
  
 
 
 
 
 
Compound 344 (50 mg, 0.2 mmol) and potassium tert-butoxide (4 mg, 0.4 mmol) in tert-
butanol were stirred at room temperature for 4h.  The solvent was then removed and the product 
was obtained as a yellow solid in 60 % crude yield (25 mg). Crude δH (300 MHz, CD3OD):    7.82 
(d, J = 9.2 Hz, 4H), 7.48 (d, J = 9.2 Hz, 4H). 
O O
O
O
Br
Br
 430 
 
 
Crude 1H NMR for compound 345 (300 MHz, CD3OD).  
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Compound 346. 
 
 
 
 
  
 
 
 
 
 
Sodium tert-butoxide was freshly prepared by reacting sodium metal (1.89 g, 82.40 mmol) in 
freshly distilled tert-butanol (100 mL) at 70 °C, under nitrogen.  The solution was heated up to 
100 °C, then a solution of 4-bromobenzonitrile (10.00 g, 54.94 mmol) in tert-butanol (100 mL) 
was added to it.  The reaction mixture was stirred for 10 minutes, then diethyl succinate (4.78 g, 
27.47 mmol) was added over a 15 minutes period.  Stirring is continued for 4 hours, then bromo-
tert-butyl acetate (16.07 g, 82.40 mmol) was added dropwise.  After addition, the reaction 
mixture was stirred for another hour at 100 °C.  The solution was finally allowed to cool to room 
temperature, and the product was isolated by filtration (14.4 g, 77 % yield). δH (500 MHz, CDCl3) 
7.65 (s, 8H), 4.38 (s, 4H), 1.39 (s, 18H); δC (125 MHz, CDCl3) 167.3, 161.9, 147.3, 132.3, 130.0, 
126.5, 126.1, 109.8, 82.9, 44.1, 27.8; HR-MS (ESI/TOF) for C30H30Br2N2O6 (M+H+) calc'd 
673.05, found 673.0479. 
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1H NMR for compound 346 (500 MHz, CDCl3).  
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13C NMR for compound 346 (125 MHz, CDCl3).
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DPP 347. 
 
 
 
  
 
 
 
 
 
 
DPP 346 (1 g, 1.49 mmol) was treated with 200 mL of a cocktail mixture of 95% TFA, 2.5 % 
water and 2.5 % TIS at room temperature for 1 hour.  The solvents were then removed in vacuo 
and the residual solid was rinced several times with hexanes.  The product was obtained in near 
quantitative yield. δH (500 MHz, dmso-d6): 8.29 (s, 1H), 7.81 (d, J = 9.0 Hz, 4H), 7.73 (d, J = 9.0 
Hz, 4H), 4.46 (s, 4H); HR-MS (ESI-neg) for C22H13Br2N2O6 (M-H+) calc'd 558.91, found 
560.8798; HR-MS (ESI-pos) for C22H14Br2N2O6 (M+H+) calc'd 563.16, found 562.9524; Analytical 
HPLC: 95 % purity. 
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1H NMR for compound 347 (500 MHz, dmso-d6).  
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Diethyl benzoylsuccinate (348). 
 
 
 
 
  
 
Diethyl benzoyl succinate was synthesized as described in the literature.1 A suspension of 
ethyl benzoylacetate (5.0 g, 25 mmol), K2CO3 (5.2 g, 38 mmol), NaI (0.94 g, 6 mmol), and ethyl 
bromoacetate (4.6 g, 28 mmol) was heated at 65 °C for 2 h.  After cooling to room temperature, 
the residual solid is filtered and washed several time with CH2Cl2. The combined filtrates were 
evaporated to dryness under reduced pressure affording the titled compound (6.5 g, 93%) as a 
yellow oil. A sample was extra purifiedby column chromatography on silica gel (CH2Cl2) affording 
4b as a colorless to green oil. δH (300 MHz, CDCl3): 8.01 (d, J = 7.3 Hz, 2H), 7.56 – 7.52 (m, 
1H), 7.43 (t, 2H, J = 7.3 Hz), 4.83 (app t, J = 8 Hz, 1H), 4.02 – 4.12 (m, 4H), 2.92 – 3.10 (m, 2H), 
1.15 (t, J =7.7 Hz, 3H), 1.08 (t, J =7.7 Hz, 3H); δC (75 MHz, CDCl3): 193.9, 170.9, 168.4, 135.7, 
133.4, 128.6, 128.2, 61.5, 60.7, 49.4, 33.0, 13.8, 13.6. All spectral data match those reported. 
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1H NMR for compound 348 (CDCl3, 300 MHz).  
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13C NMR for compound 348 (CDCl3, 75 MHz). 
 439 
 
 
Ethyl 4,5-dihydro-5-oxo-2-phenyl-1H-pyrrole-3-carboxylate (349). 
 
 
 
 
  
 
A solution of diethylbenzoyl succinate 348 (28.44 g, 102.18 mmol), ammnonium acetate 
(63.00 g, 817.50 mmol) in glacial acetic acid (20 mL) was heated at reflux for 16h.  After cooling, 
the reaction mixture is poured into 200 mL of ice, and the product is filtered, and washed with 
water.  Recrystalliztion from CH2Cl2 gives ethyl 4,5-dihydro-5-oxo-2-phenyl-1H-pyrrole-3-
carboxylate as a pale green solid in 35 % yield (8.40 g). δH (300 MHz, CDCl3): 8.97 (bs, 1H),  
7.64 – 7.60 (m, 2H), 7.47 – 7.44 (m, 2H), 4.13 (q, J =7.1 Hz, 2H), 3.51 (s, 2H), 1.21 (t, J =7.1 Hz, 
3H); δC (75 MHz, CDCl3): 177.6, 163.1, 151.3, 130.5, 129.1, 128.6, 128.1, 104.3, 60.1, 38.8, 
14.2. All spectral data match those reported. 
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1H NMR for compound 349 (300 MHz, CDCl3).  
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13C NMR for compound 349 (75 MHz, CDCl3). 
 442 
 
 
DPP 350 
 
 
 
  
 
 
 
 
 
Sodium tert-butoxide is freshly prepared by reacting sodium metal (0.89 g, 38.92 mmol) in 
freshly distilled tert-butanol 50 mL) at 70 °C, under nitrogen.  The solution is heated up to 100 
°C, then a solution of 4-bromobenzonitrile (4.72g, 25.95 mmol) in tert-butanol is added to it.  The 
reaction mixture is stirred for 10 minutes, then ethyl 4,5-dihydro-5-oxo-2-phenyl-1H-pyrrole-3-
carboxylate (3.0 g, 12.9 mmol)is added over a 15 minutes period.  Stirring is continued for 4 
hours, then bromo-tert-butyl acetate (7.60 g, 38.92 mmol) is added dropwise.  After addition, the 
reaction mixture is stirred for another hour at 100 °C.  After cooling to room temperature, water 
(~ 100 mL) is added. The solution is allowed to stand for 1 hour, then the product is isolated by 
filtration and dried in vacuo overnight (5.2 g, 67 % yield). δH (500 MHz, CDCl3): 7.76 – 7.73 (m, 
2H), 7.64 (s, 4H), 7.50 – 7.48 (m, 3H), 4.42 (s, 2H), 4.39 (s, 2H), 1.40 (s, 9H), 1.38 (s, 9H); δC 
(75 MHz, CDCl3): 167.5, 162.3,148.9, 146.9, 132.5, 131.6, 130.2, 129.2, 128.8, 127.8, 126.8, 
126.1, 110.1, 109.6, 83.1, 44.4, 28.3. 
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1H NMR for compound 350 (500 MHz, CDCl3).  
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13C NMR for compound 350 (125 MHz, CDCl3). 
 445 
 
 
DPP 351. 
 
 
 
 
  
 
 
 
 
 
 
A solution of DPP 350 (0.5 g, 0.84 mmol) , N-BOC propargyl amine (0.1 g, 0.67 mmol), Pd 
(PPh3)4 (0.03 g, 5 mol%), CuI (0.005 g, 5 mol%), and triethyl amine (1,12 g, 11.07 mmol) in 
freshly distilled toluene (10 mL) was heated at 90 °C for 12h.  After cooling to room temperature, 
ether was added, and the reaction mixture was filered over celite.  The solvent were removed in 
vacuo, and the residue was purified by column chromatography, with 30 % ethyl acetate: 
hexanes as solvent.  The title compound was isolated in 58 % yield (0.2 g). δH (300 MHz, 
CDCl3): 7.72 – 7.69 (m, 4H), 7.49 – 7.45 (m, 5H), 4.99 (bs, 1H), 4.40 (s, 4H), 4.15 (bs, 2H), 1.47 
(s, 9H), 1.36 (s, 8H); δC (75 MHz, CDCl3): 167.1, 161.8, 155.1, 148.4, 146.9, 131.9, 131.2, 128.8, 
128.4, 128.2, 127.5, 127.2, 125.6, 109.7, 109.4, 88.5, 82.5, 82.2, 44.1, 31.2, 28.3, 27.7. 
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1H NMR for compound 351 (300 MHz, CDCl3).  
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13C NMR for compound 351 (75 MHz, CDCl3). 
 448 
 
 
DPP 352. 
 
 
 
  
 
 
 
 
 
 
 
 
DPP 351 (50 mg, 0.07 mmol) is treated with a cocktail mixture of 95% TFA, 2.5 % water and 
2.5 % TIS at room temperature until completion of reaction according to tlc (~ 2 hours).  Ether is 
added to the reaction mixture to precipitate the product.  The product is then filtered and dried in 
vacuo.  The solvents were then removed in vacuo and the residual solid was rinced several 
times with hexanes.  The product was obtained in near quantitative yield. δH (300 MHz, CD3OD): 
7.82 – 7.79 (m, 4H), 7.65- 7.56 (m, 5H), 4.51 (s, 4H), 4.06 (s, 2H); δC (75 MHz, CD3OD): 171.5, 
163.5, 150.7, 148.4, 133.2, 132.7, 130.0, 129.9, 129.3, 128.6, 125.6, 111.1, 110.4, 86.8, 84.2, 
44.2, 30.7; HR-MS (ESI-pos) for C25H19N3O6 (M+H+) calc'd 458, found 458.1222; HPLC purity : 
96.7 %. 
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1H NMR for compound 352 (300 MHz, CD3OD).  
 
 
 
 
 450 
 
 
13C NMR for compound 352 (75 MHz, CD3OD). 
 451 
 
 
DPP 353. 
 
 
 
  
 
 
 
 
 
 DPP 350 (50 mg, 0.08 mmol) was treated with a cocktail mixture of 95% TFA, 2.5 % water 
and 2.5 % TIS at room temperature until completion of reaction according to tlc (~ 2 hours).  
Ether was then added to the reaction mixture to precipitate the product.  The product was then 
filtered and dried in vacuo.  The solvents were then removed in vacuo and the residual solid was 
rinced several times with hexanes.  The product was obtained in near quantitative yield. δH (500 
MHz, CD3OD): 7.78 – 7.77 (m, 2H), 7.72 (s, 4H), 7.56 – 7.55 (m, 3H), 4.51 (s, 2H), 4.49 (s, 2H); 
MS (ESI-neg) for C22H15BrN2O6  (M-H-) calc'd 481, found 481.1 – 483.0 (Br isotope). 
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1H NMR for compound 353 (500 MHz, CD3OD) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 453 
 
DPP 354. 
 
 
 
 
  
 
 
 
 
 
 
 
 
DPP 346 (5.00g, 7.41 mmol), TMS acetylene (4.37 g, 44.5 mmol), Pd(PPh3)4 (0.86 g, 0.74 
mmol), CuI (0.14 g, 0.74 mmol) and triethylamine (29.6 g, 296.6 mmol) in freshly distilled toluene 
was heated at 85 °C for 5h.  After cooling to room temperature, ether was added and the 
reaction mixture was filtered over celite.  The solvent was removed and the residue purified by 
chromatography on silica gel, with Hexanes, then 10%  Ethyl acetate:Hexanes as solvent. 1,4-
Bis(trimethylsilyl)buta-1,3-diyne was obtained from the elution with hexanes as the major product 
of the reaction.  The title compound was obtained in 20 % yield (1.04 g). δH (300 MHz, CDCl3): 
7.74 (d, J = 8.7 Hz, 4H), 7.58 (d, J = 8.7 Hz, 4H), 4.40 (s, 4H), 1.40 (s, 18H), 0.27 (s, 18H); δC 
(75 MHz, CDCl3): 167.6, 162.4, 147.8, 132.7, 128.7, 127.6, 126.5, 110.4, 104.4, 98.2, 83.1, 44.6, 
28.1, 0.1. 
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1H NMR for compound 354 (300 MHz, CDCl3).  
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13C NMR for compound 354 (75 MHz, CDCl3). 
 456 
 
 DPP 355. 
 
 
 
 
  
 
 
 
 
 
 
A solution of DPP 354 (0.4 g, 0.6 mmol) in freshly distilled CH2Cl2 (10 mL) is cooled to - 78 
°C.  Then tetrabutylammonium fluoride (1.7 mL, 1.7 mmol) is added.  Stirring is continued for 5 
min, then the reaction is quenched with acetic acid (0.06 mL).  After removal of the solvents, the 
crude residue is purified on silica gel, with CH2Cl2 as eluent.  The title compound is obtained in 
64% yield (0.2 g). δH (300 MHz, CDCl3): 7.75 (d, J = 8.1 Hz, 4H), 7.61 (d, J = 8.1 Hz, 4H), 4.39 
(s, 4H), 3.25 (s, 2H), 1.39 (s, 18H); δC (75 MHz, CDCl3): 167.6, 162.4, 147.9, 132.9, 128.9, 
128.1, 125.5, 110.4, 83.1, 80.4, 44.5, 28.2;  HR-MS (ESI-pos) for C34H32N2O6 (M+H+) calc'd 
564.23, found 565.2275. 
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1H NMR for compound 355 (300 MHz, CDCl3).  
 458 
 
 
13C NMR for compound 355 (75 MHz, CDCl3). 
 
 
 
 
 
 
 
 
 
 
 
 
 459 
 
Bis Fluorescein diacetate-DPP cassette 356. 
 
 
 
 A solution of DPP 355 (0.100 g, 0.18 mmol), bromo-fluorescein diacetate (0.117 g, 0.24 
mmol), Pd(PPh3)4 (0.007 g, 0.006 mmol), CuI (0.001 g, 0.006 mmol) and triethylamine (0.238 g, 
2.36 mmol) in dry THF (10 mL) was heated at 50 °C for 2 hours.  After cooling to room 
temperature, the solvent was removed under reduced pressure and the residue purified by 
chromatography with 50% ethyl acetate/ Hexanes to give 0.050 g (10%) of the title compound. 
δH (300 MHz, CDCl3): 8.19 (s, 2H), 7.84 (d, J = 11.4 Hz, 6H), 7.70 (d, J = 8.7 Hz, 4H) 7.20 (d, J= 
7.8 Hz, 2 H), 7.11 (m, 4H), 6.85 (m, 8H), 4.46 (s, 4H), 2.32 (s, 12H), 1.42 (s, 18H); δC (75 MHz, 
CD3OD): 169.1, 168.4, 167.6, 162.4, 152.7, 152.4, 151.8, 147.8, 138.6, 132.6, 129.2, 129.0, 
128.5, 128.2, 126.9, 125.7, 125.5, 124.6, 118.1, 116.2, 110.8, 110.7, 110.5, 91.4, 90.4, 83.2, 
82.1, 44.6, 28.2, 21.4. 
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1H NMR for compound 356 (300 MHz, CDCl3). 
 461 
 
13C NMR for compound 356 (75 MHz, CDCl3). 
 
 
 
 
 
 
 
 
 
 
 
 
 462 
 
Bis Naphthofluorescein diacetate - DPP cassette 357. 
 
 
 
 
 A solution of DPP 355 (0.095 g, 0.17 mmol), bromo-naphthofluorescein diacetate (0.200 
g, 0.34 mmol), Pd(PPh3)4 (0.009 g, 0.008 mmol), CuI (0.002 g, 0.008 mmol) and triethylamine 
(0.34 g, 3.36 mmol) in dry DMF (10 mL) was heated at 80 °C for 2 hours.  After cooling to room 
temperature, the solvent was removed under reduced pressure and the residue purified by 
chromatography with 20% Hexanes/dichloromethane then 2% MeOH/dichloromethane to give 
0.244 g (91%) of the title compound. δH (300 MHz, CD3OD):  8.88 (d, J = 9.0 Hz, 4H), 8.27 (s, 
2H), 7.86 – 7.79 (m, 6 H), 7.71 (d, J = 8.1 Hz, 4H), 7.62 (d, J = 2.1 Hz, 4H), 7.54 – 7.49 (m, 
10H), 7.11 (d, J = 8.1 Hz, 2H), 6.92 (d, J = 8.7 Hz, 4H), 4.46 (s, 4H), 2.41 (s, 12H), 1.42 (s, 18H); 
δC (75 MHz, CD3OD):  169.6, 168.9, 167.6, 162.4, 153.8, 150.5, 146.7, 138.7, 135.5, 132.6, 
129.0, 128.6, 128.2, 126.9, 125.8, 125.4, 124.9, 124.5, 124.1, 122.4, 122.2, 119.2, 112.3, 110.6, 
91.3, 90.6, 83.4, 83.2, , 44.4, 28.7, 20.3; MS (ESI-pos) for C98H68N2O20 (M+H+) calc'd 1593.44, 
found1594.27.
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1H NMR for compound 357 (300 MHz, CDCl3). 
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13C NMR for compound 357 (75 MHz, CDCl3). 
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